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ABSTRACT 
Manufacturing of large biomolecules such as viral vectors used in emerging gene therapies 
suffers from low product yields due to limitations of traditional resin-based chromatography in 
downstream processing.  Ultrafiltration based purification techniques are being considered for 
purification of such viral vectors by separating these viral vectors from impurities such as host 
cell proteins.  Improvements in yields of viral vectors have so far concentrated on the design of 
new chromatography stationary phases such as monoliths, membrane adsorbers, nanofibers 
and gigaporous resins. Improvement in the architecture of ultrafiltration membranes has not 
been studied for application in viral vector purifications. Porous anodic alumina (PAA) 
membranes, exhibit narrow pore size distribution and straight through pore channels compared 
to traditional polymeric membranes which have broad pore size distributions and tortuous 
channels. The present work evaluated porous anodic alumina membranes for potential 
applications in virus ultrafiltration using model protein solutes.  
Protein nanoparticles of 80-90nm diameter and thyroglobulin of 20 nm diameter were used as 
the physical mimics for two of the most commonly used viral vectors, Adenovirus and Adeno-
associated viruses respectively and a small protein of 8 nm, bovine serum albumin was used as 
the model impurity. A reproducible and high yielding protocol was developed for the synthesis of 
protein nanoparticles from bovine serum albumin using a de-solvation process. Based on 
comparable hydraulic permeability, dextran sieving curve and mean pore size 20 nm rated PAA 
membrane and 300 kDa rated polymeric ultrafiltration membranes were compared for filterability 
of the model solutes. PAA membranes were found to have superior fouling resistance (1.5-2.5 
times higher values of recoverable membrane permeability) and up to 4 times higher 
transmission than the polymeric membranes for large model solutes. These findings were 
attributed to the differences in the membrane architecture resulting in different sieving 
behaviour. PAA membranes were found to be susceptible to leaky transmissions of large 
solutes due to the presence of surface defects.  
Separation performance of binary mixtures of model solutes was studied using a diafiltration 
process. Electrostatic interactions and transmembrane pressure were identified as crucial 
process parameters to improve separation performance of the alumina membranes. Lot-to-lot 
variations in the alumina membranes were also characterised using electron microscopy and 
were found to influence the separation performance. PAA membranes were found to be 
compatible for virus processing as similar infectivity recovery of 60-70% was observed for both 
PAA and the polymeric membranes along with 60 % removal of the impurities.  
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IMPACT STATEMENT  
The work presented in this thesis is related to the design of new materials for challenging 
bioseparations. For the membrane manufacturing industry, the work lays out recommendations 
to improve the quality of commercial porous anodic alumina membranes and suggests a new 
application of the membranes. This work identifies manufacturing issues such as defects and 
variations among lots which are hindering the application of these membranes in 
bioseparations. The study demonstrated superior fouling resistance and flux performances by 
PAA membranes compared to traditional polymeric membranes. This outcome is appealing to 
the bioprocessing industry for potential applications of such membranes in continuous 
bioprocessing by avoiding long cleaning cycles and reducing overall processing times. 
However, membrane manufacturer needs further developmental work to market these 
membranes as high retention and low fouling membranes for high-value products such as viral 
vectors. Such development work includes reducing membrane defects, lot variations and design 
of scalable membrane modules compatible with the fragile ceramic membranes. 
Academic interest in the present work relates to understanding the mechanistic differences in 
particle retention between alumina and polymeric membranes especially with respect to drastic 
differences in their pore morphology. A possible step would be to utilise these differences to 
bring greater tuning of protein fractionations especially for purification of larger biomolecules 
such as viral vectors. Tuneability can be established by altering the chemical composition of the 
membranes to achieve separations through multiple mechanisms along with size exclusion. The 
present work also suggests an investigation into block copolymer membranes, membranes 
resembling porous anodic alumina membrane in architecture but without some of the 
challenges associated with the brittle nature of the alumina membranes. 
An ideal situation for further development in this field would be a collaborative work with 
commercial membrane manufacturers, academia and end users such as biopharmaceutical 
manufacturers. Most of the manufacturers of porous alumina membranes are recently founded 
start-ups who can utilise the findings and challenges elaborated in the present work for the 
design of their products. A collaborative approach will be helpful to develop cheaper and 
commercially viable membrane products tailored for viral vector separations at large scales with 
minimum wastage of resources. Development of highly retentive and selective membranes with 
minimal cleaning requirements could contribute to lowering the manufacturing costs of viral 
vectors thus bringing affordability to gene therapy. 
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CHAPTER 1 INTRODUCTION, AIM AND 
OBJECTIVES OF THE THESIS 
  
  
[25] 
 
1.1 Overview of the thesis 
The thesis examines highly ordered porous anodic alumina (PAA) membranes for use in the 
separation of large biomolecules such as viral vectors used in gene therapy. The PAA 
membranes were evaluated by comparison with traditionally used polymeric membranes. 
Chapter 1 provides an introduction to the emerging therapies based on viral vectors and the 
associated manufacturing challenges, motivation and objectives for the present work. 
Chapter 2 discusses viral vectors and their purification challenges in depth. The chapter 
focuses on chromatography and membranes based processes. The chapter also reviews the 
literature for porous anodic alumina membranes and protein nanoparticles.  
Chapter 3 covers experimental work directed at the synthesis of protein nanoparticles and 
subsequent characterisation studies prior to use as a model system for virus particles. 
Chapter 4 describes the characterisation of porous anodic alumina membranes, filtration 
performance of porous anodic alumina membranes using model nanoparticle solutes, including 
analysis of fouling mechanisms. 
Chapter 5 presents an analysis of new experimental data on the separation performance of the 
porous anodic alumina membranes focused on methods to improve performance and retention 
of Adenovirus during processing of a biological feedstock. 
Chapter 6 offers the conclusion for the present work and future studies. 
 
1.2 Emerging therapies in the biopharmaceutical industry 
The 35-year-old bio-pharmaceutical industry began with small therapeutic proteins such as 
insulin, growth factors etc. in the early 1980s, progressed to monoclonal antibodies in the late 
1990s onwards and gene and cell therapies from the early 2010s. This shift is the result of 
advances made in the field of genomics, which has helped identify the genetic elements 
responsible for many disorders. These advances have helped the industry design new therapies 
to cure such disorders which were otherwise considered untreatable. So far, traditional 
therapies had focussed on management of such disorders by supplementation of a missing 
functional protein. Emerging therapies such as gene therapy, however, aim to cure the disorder 
by supplementation of the genetic element. These emerging therapies are expected to reduce 
the dependence on a burdensome lifetime treatment regime for patients using traditional 
therapies. 
  
[26] 
 
The number of clinical trials for various gene and cell therapies has grown from 2 in 1990 to 132 
in 2017 with a total of 2600 clinical trials undertaken or ongoing so far worldwide (Ginn et al., 
2018).  These clinical trials have targetted a variety of indications with the majority in cancer and 
monogenic diseases and supplemented genes for a variety of proteins such as antigens, cell 
receptors, cytokines and deficient enzymes. These therapies involve the transfer of genes to 
cells in cell therapies or directly to the patient. Viruses, known to infect human beings, are used 
as the vector to transfer the genes. Cell therapies involve the use of these vectors outside the 
human body to transfer genes to cells harvested from patients and gene therapies, generally, 
involve direct injection of the viruses carrying the gene of interest into patients. These vectors 
are usually engineered to remove the virulence-related viral genes and inserted with a desired 
human gene (which is identified to be missing or dysfunctional in a disorder). In the past five 
years, western regulatory agencies have approved two viral vector gene therapies, Glybera 
(UniQure, NL) and Luxturna (Spark Therapeutics, USA) for treatment of a genetic lipase 
deficiency and inherited eye blindness respectively. Three more cell-based therapies, Kymriah 
(Novartis, CH), Strimvelis (GlaxoSmithKline, UK) and Yescarta (Gilead Sciences, USA) have 
been approved in the past two years. 
 
 
Another healthcare area where new therapies are emerging is vaccines where antigen 
presentation is crucial and the antigen presenting surface can have an impact on potency as 
well as the efficacy of the vaccine. Traditional vaccines are often attenuated strains of the 
pathogen itself. Engineered recombinant viruses and virus-like particles (VLPs) are being 
investigated as vaccine candidates. Protein engineering of VLPs to display multiple antigens is 
also being considered to create a single multivalent vaccine that can be used for a number of 
infections or to protect from multiple strains of pathogens. These approaches can have a long-
term impact on strategies for accessibility and ease of manufacturing of the much-needed 
vaccines, especially in pandemic situations.  
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1.3 Viral vectors for gene therapy and vaccines 
The shift from traditional therapies to cell and gene therapies have also changed the nature and 
complexity of the therapeutic agent. The most apparent change is the size of the therapeutic 
agent used. Traditional therapies are small protein molecules such as insulin and monoclonal 
antibodies, but emerging therapies use supramolecular assemblies such as cells and viruses as 
therapeutic agents. Viral vectors can be a magnitude larger than the traditional biologics. 
Monoclonal antibodies which are approximately 150 kilodaltons in molecular weight have 
dimensions of 10 nm in diameter (Nobbmann et al., 2007). Viral vectors, on the other hand, can 
range from 20 nm to 400 nm in diameter and megadaltons in their molecular weights. 
Parvoviruses, the smallest known viruses, are approximately 22 nm in diameter.  
Both VLPs and recombinant viruses can be designated in a single class as viral vectors due to 
the similarity in the structural complexity. A distinction between virus-like particles and 
recombinant viruses is that the former does not carry any genetic material thus do not have 
infectivity associated with them. A typical viral vector is formed of a capsid, a highly ordered 
structure formed from the association of usually multiple proteins and may also have an 
additional lipid or lipoprotein envelope around it. The complexity of size and composition of the 
viral vectors in comparison to the traditional protein biologics is illustrated in Figure 1-1. Notice 
the different colour on capsids of the virus and VLPs signifying different viral proteins.  
 
 
 
Figure 1-1 Illustration of the range of the biopharmaceutical products used in various 
therapies including gene therapies showing increasing size and structural complexity 
for viral vectors.     
Cartoon structures for various molecules were obtained from protein database (PDB; 
http://www.rcsb.org/). MAb, AAV, VLP and AdV stands for monoclonal antibody, adeno-
associated virus, virus-like particles and adenovirus respectively. 
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1.4 Impact of viral vectors on biomanufacturing 
Production of smaller biologics especially monoclonal antibodies has dominated the 
biomanufacturing activities of the industry as well as academia. The size of the product has a 
significant impact on some of the unit operations in downstream processing of biologics, 
especially filtration and chromatography based processes. These processes use meso (pores 
dimensions of 2-50 nm) or macroporous material (pore dimensions above 50 nm) as solid 
matrices. These processes discriminate between product molecules and the impurities through 
a variety of properties such as size, charge or hydrophobicity and affinity. Accessibility of 
various molecules to the porous architecture of solid matrices often defines the recovery of the 
valuable product as both convection and diffusion drive the mass transfer. Diffusive mass 
transfer limitations are often observed in chromatography and filtrations.  
Chromatography processes, which are typically operated in a bind and elute mode, are 
expected to preferentially bind the protein of the interest to maximum amount with a minimum 
amount of the solid matrix and reject the impurities. Filtration processes are also expected to 
either retain or pass through the maximum amount of product with the minimum amount of the 
matrix used. The capacity of these chromatography or filtration matrices is thus defined by the 
amount of protein purified and recovered. For surface active processes such as 
chromatography, size and number of pores will determine the specific surface area (area per 
unit volume or amount) of such porous material. Diffusive mass transfer of any particular 
molecule is dependent on the size of the molecule with respect to the size of pores. A solute 
might not be able to penetrate deeper into the porous matrix if it encounters steric hinderances 
from pore walls thus only utilising a fraction of the maximum capacity of the matrix. In the case 
of viruses, binding capacities have been reported to be an order of magnitude lower than those 
for the smaller proteins (Trilisky and Lenhoff, 2007). Such a scenario may result in the adequate 
purity of the product but significant loss of the product or low recovery. 
Recovery of the product can be crucial especially for high value and low volume products which 
is usually the case for most of the biologics. The high cost of the materials used for these 
processes is also an essential factor when the selection of a chromatography or membrane 
material is required. A material with low capacity can result in significant losses of the product 
during processing or may result in significant investment for the increased amount of the often 
expensive porous matrices. Most of the porous materials have been developed and 
characterised concerning smaller biologics such as monoclonal antibodies and not for the viral 
vectors. It has been observed that the capacity of these processes which are optimised for 
monoclonal antibodies are very low for large biomolecules such as viral vectors.   
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1.5 Motivation and aim of the present thesis 
Only five gene and cell therapies have been approved so far, and at present, these therapies 
are expensive with a range of USD 0.2 to 1 million (Mullin, 2017). Cost is on the upper end of 
this range for the viral vector-based approved therapies which were mentioned in the section 
1.2. Such a high cost can affect the affordability of these therapies. High manufacturing cost 
and low dose frequency are reported to be a major contributing factor towards the high cost of 
these vector-based therapies (Waehler et al., 2007, Rader, 2018). Downstream challenges such 
as those described in the previous section (1.4) hinder the development of robust processes for 
viral vector purifications. Alternative materials such as monoliths and nanofibres are being 
looked into to debottleneck chromatography unit operation. These materials are of radically 
different design compared to conventional resins and aim to increase binding capacities for 
large biomolecules such as viral vectors thus reducing the loss of the valuable product (Trilisky 
et al., 2009, Ruscic et al., 2017). 
While new materials are being actively investigated for potential use as chromatography 
adsorbers, tradition membrane-based processes have received little attention. A possible 
reason for this could be that membrane-based processes are traditionally used for depth 
filtration, concentration and buffer exchange applications and not for high-resolution separation 
as in chromatography. Development of new membranes for biopharmaceutical processing is 
mostly confined to the refinement of polymeric membranes for fouling resistance or cleaning 
resistance. Nonetheless, development of novel membranes have been actively carried out in 
other fields such as water purification, gas purification with different membrane materials and 
different porous architectures have been fabricated and tested. 
A very common reason often cited for poor separation performance of membranes even as 
adsorbers is non-uniformities in the membrane architecture such as the presence of wide pore 
distribution (Orr et al., 2013). Thus, studying a membrane material with narrow pore size 
distribution is interesting for bioprocess applications and especially for viral vectors where the 
difference in size among viral vectors and smaller protein impurities could be utilised for 
effective separation using membranes. This thesis aims to characterise such membranes made 
of porous anodised alumina for viral vector separations and to compare them with traditionally 
used polymeric ultrafiltration membranes. To overcome the challenges of producing and 
studying actual viral vectors, protein nanoparticles have been used as physical mimics to the 
viral particles. Fouling mechanisms and separation performance of these membranes have 
been studied and compared with those of conventional polymeric ultrafiltration membranes. 
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1.6 Objectives defined for the thesis 
 
Objective 1: Preparation and characterisation of BSA protein nanoparticles as a mimic of 
virus particles 
The first objective of the present work will be to synthesise monodisperse preparations of BSA 
protein nanoparticles in the range of 70-100 nm particle diameter similar to the size of common 
viral vectors such as Adenovirus and lentivirus. A protocol will be developed to achieve high 
yield, high repeatability and shorter preparation time. Nanoparticle preparations will be 
characterised by the shape of nanoparticles, light scattering characteristics, surface charge 
characteristics and stability during storage.  Finally, nanoparticle preparations will be tested 
against viral feed to ensure the validity of the protein nanoparticles as mimic to viral particles in 
membrane separation processes. This study is explained in Chapter 3. 
Objective 2: Characterisation of porous anodic alumina (PAA) membranes for filterability 
of protein solutions of single model solutes 
The second objective of the thesis is to investigate the filtration performance of the PAA 
membranes using the protein model solutes of different hydrodynamic size representing smaller 
host cell protein impurities (bovine serum albumin), smaller viruses (thyroglobulin) and larger 
viral vectors (BSA nanoparticles). Parallel comparison of the PAA membranes and conventional 
polymeric ultrafiltration membranes for filterability of these protein model solutes will be carried 
out. Such a comparison has never been reported in the literature. Membranes will be compared 
for flux decline, fouling mechanism, fouling resistance and solute transmission. A systematic 
experimental approach will be used to select appropriate membrane ratings from both classes 
of the membranes so that the filtration performance of the membranes could be correlated to 
the difference in their morphology. Chapter 4 discusses the outcome for this objective in detail 
including the materials and methods used. 
Objective 3: Separation performance of porous anodic alumina (PAA) membranes for 
binary mixtures of the model solutes 
PAA membranes will be evaluated for fractionation of the mixture of the model solutes for 
viruses (protein nanoparticles and thyroglobulin) and model impurity (bovine serum albumin). 
Impact of process parameters such as operating conditions, transmembrane pressure and 
diafiltration mode will be studied. The utilisation of the electrostatic interactions of solutes and 
ceramic membranes will be studied for enhancing the fractionation. PAA membranes will also 
be investigated for compatibility with viral feeds by studying infectivity losses and comparing 
them with those observed for conventional ultrafiltration membranes. Chapter 5 discusses the 
outcomes of these experiments including the materials and methods used.  
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2.1 Overview of the chapter 
The chapter is arranged in six major sections (2.2 to 2.7) describing the manufacturing 
challenges for large biomolecules such as viral vector production especially for downstream 
processing (Section 2.2 and 2.3), a review of membrane-based processes for biologics 
purification including fundamentals of filtration processes (Section 2.4) inclduing studies 
reported for virus ultrafiltration, a review of the fabrication and applications of porous anodic 
alumina membranes (Section 2.5), a brief review of the challenges in working with viruses and 
the need for appropriate model systems (Section 2.6) and finally the literature on synthesis and 
applications of protein nanoparticles (Section 2.7).  
 
2.2 Common viral vectors 
Commonly used viral vectors in gene therapy clinical trials are illustrated in the bar chart below. 
 
 
Figure 2-1 Distribution of various vectors used in 2600 clinical trials up to 2017 for gene 
therapy clinical trials worldwide. Source: Ginn et al.,(2018).  
 
As shown in Figure 2-1, Adenovirus (AdV) and retrovirus form the most commonly used vectors 
for gene therapy. Non-viral vectors such as naked DNA and lipofection form a minority share in 
the clinical trials. However, very few gene therapy products approved so far are based on 
Adenovirus or adeno-associated virus (AAV). So most of the discussion in this chapter will be 
focused on the literature for these viruses. Non-gene therapy viral vectors such as virus-like 
particles will also be discussed to a limited extent. 
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Vector Genome 
size 
(kilobases) 
Capsid 
envelope 
Size (nm) Pathogenic 
Adenovirus (AdV) 40 Absent 90-110 Yes 
Adeno associated 
virus (AAV) 
5 Absent ~25 No 
Retrovirus 9 Present 120 Yes 
Hepes Simplex Viruse 12 Present 180 Yes 
Vaccinia virus 280 Present 350 Yes 
 
Table 2-1 Common viral vectors used in gene therapy and their characteristics 
Information sourced from Ponder et al.,(2002). 
Choice of the vector as a gene therapy candidate is influenced by many factors including the 
size of the genetic material to be transferred and the ability of the virus to accommodate that 
genetic material. From Table 2-1, it can be seen that the vaccinia virus has a large genome size 
and particle size. Enveloped viruses such as Vaccinia and Retrovirus have another layer of 
lipids or proteins around the proteinaceous capsid of the virus which plays a role in the 
infectivity of the virus. Generally, enveloped viruses are considered difficult to process due to 
the fragility of the envelope layer. Size of the virus vector used in the gene therapies can vary 
from 25 nm for AAVs to 350 nm for vaccinia virus. Tissue or organ specificity of various viruses 
and their serotypes can also influence the choice of the vector for a particular gene therapy 
application. 
 
2.3 Manufacturing challenges for viral vectors 
At present, there are no production processes specifically designed for mass production of 
virus-based therapeutics. Though production titres are improving, purification processes are still 
not optimised for these vectors. Implications are enormous on downstream processing as it 
contributes around 70% of total manufacturing cost (Morenweiser, 2005)  and overall process 
yields for viral vectors are about 30% at the moment  (Vijayaragavan et al., 2014).  Following 
sections discuss the reported studies on purification of viral vectors and factors identified for 
such low yields. 
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2.3.1 Downstream processing of viral vectors 
Viral vectors are relatively new to manufacturing floors and optimisation of processes and 
establishing a purification platform is still underway. Viral vectors have additional challenges to 
their purification due to their composition and structural differences from traditional protein 
biologics. These molecules are relatively large and supramolecular assembly called capsid 
made up of one or more protein subunits. Another complexity is the presence of nucleic acid 
inside this supramolecular assembly. Different components of a typical feed for virus purification 
as illustrated in Figure 2-2 Illustration showing the complexity of a typical cell lysate feed 
containing viral vector product along with various product and process related impurities. In 
gene therapy application, the most critical quality attribute of a viral vector is the infective titre in 
the dose being given to a patient. Preserving the intactness of the fragile capsid is crucial to 
maintaining the infectivity of the particles. 
 
 
 
 
 
Loss of infectivity can result from harsher treatment to viral capsid often encountered in various 
stages of processing. A typical purification train as shown in Figure 2-3 for viral vectors involves 
many unit operations exposing capsids to high shear. Even if intactness of capsids is preserved, 
a significant fraction of the capsids can be empty (without DNA) which do not have any 
therapeutic value for gene therapy. Titre of the empty particles can be 20-30 times than that of 
mature active virus particles increasing effective dose size  (Lock et al., 2010). These particles 
can induce an adverse immune response in patients thus reducing the overall efficacy of gene 
therapy (Mingozzi and High, 2013). Therefore high-resolution particle separation techniques 
such as ultracentrifugation are required for viral vector purifications.  
Figure 2-2 Illustration showing the complexity of a typical cell lysate feed containing 
viral vector product along with various product and process related impurities. 
Mature and empty viruses have very limited structural differences except presence of DNA. 
Exosomes and protein aggregates can be of similar in dimensions as of virus particles. Host 
cell DNA can interact with virus particles and alter their interaction with chromatography resin. 
Free viral protein or unassembled capsids have similar chemical composition as of fully formed 
virus particles. Another complexity can arise from presence of lipoprotein envelope around 
virus particles or aggregated particles. 
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Ultrafiltration, chromatography and ultracentrifugation are the key unit operations driving high-
resolution separation, so only their impact on virus processing is discussed further. 
 
2.3.2 Key unit operations for viral vector purifications 
2.3.2.1 Ultracentrifugation 
Ultracentrifugation uses very high centrifugal forces to separate molecules of different molecular 
weight in different layers typically through the density gradient fluid matrix. The technique has 
been primarily used as an analytical method. Ultracentrifugation is not a commonly used 
technique for process development or large-scale biomanufacturing for traditional biologics. 
However, for viral vector purifications, this technique is frequently employed due to its ability to 
resolve between empty and mature virus particles based on the difference in the mass due to 
the nucleic acid.  
However, issues of the scalability and co-sedimentation of high molecular weight impurities are 
often reported. The technique also exposes virus particles to the high shear environment due to 
high g-forces (above 50,000x g) used in centrifuges for long processing times with 2 to 3 cycles. 
CsCl used to establish density gradient is known to be highly cytotoxic, so extensive dialysis 
step is required to remove the salt after extracting the band containing virus particles. Extraction 
of the band itself is a difficult task. Loss of infectivity of the mature particle as high as 85 % has 
been reported with exposure to CsCl up to 72 hours (Auricchio et al., 2001). Use of idioxinal 
instead of CsCl has been suggested to significantly reduce the process time from 3 days to 1 
day but with compromise in the fractionation of the empty particles (Strobel et al., 2015). 
Cell lysis 
Centrifugation 
/MF 
Depth  
Filtration 
UF/DF 
Chromato- 
graphy 
UC UF/DF 
Figure 2-3 A typical downstream processing train for viral vector purifications. 
A variety of particle separation techniques such as centrifugation, microfiltration (MF), 
ultrafiltration (UF) and ultracentrifugation (UC) are used for downstream processing of viral 
vectors. 
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2.3.2.2 Chromatography 
Chromatography is considered as the workhouse of biopharmaceutical manufacturing. 
Chromatography utilises differential interaction of various components or solutes with a solid 
matrix to separate these components. Solid matrix or resin, usually porous beads of sub 100 um 
size, are used in chromatography. These beads can have inert surfaces or functionalised with 
ligands. Inert resins are solely used for size exclusion chromatography where particles are 
retained or excluded based on their ability to enter and extent of entry into the porous structure 
of the beads. Most commonly used chromatography for large-scale manufacturing, however, 
utilises functionalised porous beads. Theoretically, the chromatography techniques used for 
protein purification can also be used to purify viral vectors due to the proteinaceous makeup of 
the capsid. However, notable deviations from traditional protein purification have been observed 
when conventional chromatography resins were applied for virus purifications.  
Such deviations are : 
 Reduced pore accessibility for virus particles has been reported as a prime reason for low 
capacity of resins for viruses. Yu et al., (2014) have compared gigaporous media with large 
channels (120 and 280 nm) and traditional agarose-based resins with 20 and 35 nm pore 
channels for a 20 nm VLP and found higher loading capacities and recoveries for 
gigaporous media.  
 Reduced pore accessibility has also been reported for larger VLPs (100 nm) even in the 
gigaporous resins which have outer large (800-900 nm)  pores and smaller (50-100 nm) 
internal diffusive pores (Wu et al., 2013). These observations were supported using 
confocal microscopy of gigaporous resin for binding of fluorescent IgG and VLPs (see 
Figure 2-5). It signifies that even gigaporous resins would not have good capacities for 
large viral vectors such as Adenovirus and lentivirus. 
 Significant losses of infectivity or activity have been reported with traditional resins even for 
smaller viral particles such as VLPs.  The losses have been attributed to irreversible 
disassembly (see Figure 2-4) of the virus particles during the adsorption-desorption 
process in the narrow channels of resins. Gigaporous media have been demonstrated to 
reduce such disassembly (Yu et al., 2014).  
 Lack of a platform affinity chromatography resin for viral vectors, unlike Protein A 
chromatography used for a wide range of monoclonal antibodies is also a hindrance to 
process development. Few affinity ligands have been developed by utilising the specificity 
of the virus-host cell interactions. Development of such a platform affinity resins is restricted 
by the variety of viral vectors and serotypes of each vector used in clinical trials which have 
significantly different host cell receptors.  
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Figure 2-5 Effect of the solute size on utilisation of the resin capacity of a 
perfusive resin under dynamic conditions, demonstrated using confocal 
laser scanning microscopy of the resin beads. (Source: Wu et al., 2013). 
Resin was loaded with smaller protein, IgG and larger 100 nm solute, VLP. For 
intermediate sized (20 nm) solute, Thyroglobulin, perfusion resin was found to be 
fully saturated. Images were reproduced and modified with permission from Wu 
et al., (2013). 
2. Adsorption of 0.2 mg/mL VLP in flow cell at 1000 cm/hr 
1. Adsorption of 2 mg/mL IgG in flow cell at 1000 cm/hr 
Figure 2-4 Disassembly of the Hepatitis B VLP capsid illustrated for 
traditional agarose media and giga-porous media. (Source: Yu et al., 2014) 
Image reproduced with permission from Yu et al., (2014). 
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Ion exchange chromatography has been the most commonly used technique for the purification 
of various viral vectors. Significant differences have been observed for purification of different 
serotypes of the same virus using similar ion exchange methods (Potter et al., 2014). Methods 
have also found utility in the separation of empty and mature virus capsids by exploiting the 
small difference in the isoelectric points of these two capsids (Qu et al., 2007). No such 
separation has been reported for Adenovirus. Use of perfusive resin such as POROS has been 
widely reported for IEX purification of AAV vectors. Qu et al. (2015) have summarised various 
purification techniques used for AAV purification including ion exchange chromatography. Mixed 
mode resin such as ceramic hydroxyapatite has been found efficient for virus purifications (Zhou 
et al., 2011). Ion exchange chromatography has also been extensively used for Adenovirus 
purification. Most of the studies focus on the use of monoliths and membrane adsorbers for 
Adenovirus purification. One study reported only marginal improvement with 34% process 
recovery using Q derivatised monolith compared to 28% with Q sepharose (Lucero et al., 2017). 
Tentacled ion exchange resins such as Fractogel have been reported to improve the binding 
capacity for Adenovirus (Bo et al., 2015). 
Hydrophobic interaction chromatography has been used more commonly for VLPs. For viruses, 
it has been suggested that high salt concentration used in HIC can cause aggregation and 
negatively affect the infectivity of the virus particles (Qu et al., 2015). Chahal et al., (2007) have 
reported a step yield of 72% for HIC based polishing of AAV. Some reports have suggested 
high recoveries for gene therapy vectors as well such as 88% for canine Adenovirus (Segura et 
al., 2012).  
Methods describing the affinity-based purification of AAVs have been published as employing 
ligands such as heparin (Auricchio et al., 2001), mucin (Wilson et al., 2003) and VHH domain 
antibody fragments (Smith et al., 2009). No affinity-based method has been reported so far for 
purifications of Adenovirus and retrovirus. The high cost of the affinity-based resins and difficulty 
in cleaning in place are a significant factor in limiting their application at large scale. The cost of 
AVB sepharose resin with VHH domain ligand is approximately 50 times higher than a typical 
ion exchange resin such as SP-sepharose (Potter et al., 2014). Size exclusion chromatography 
has been less extensively used due to limited loading capacity and pressure tolerance though 
the technique is gentler than other chromatography modes. However, Nestola et al., (2014b) 
have advocated size exclusion chromatography in a two-column simulated moving bed mode  
to overcome these limitations and reported improvement of recovery from 56% in a batch 
process to 86% in simulated moving bed mode. 
. 
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2.3.2.3 Newer chromatography materials for virus purifications 
Challenges observed in the purification of large viral vectors with traditional resins are mainly 
due to the design of the architecture of the resins primarily developed for smaller proteins 
especially monoclonal antibodies. Thus, the focus of the resin manufacturers, as well as the 
research community studying viral purifications, has shifted to designing novel materials with 
improved pore accessibility for larger particles. These efforts have culminated in extensive 
studies on the use of highly convective materials such as membranes, monoliths and nanofibres 
as adsorbers. 
 
 
 
2.3.2.3.1 Membrane Adsorbers 
Membrane adsorbers have been tested extensively for viral purifications. Peixoto et al.,(2008) 
have reported a 62% step recovery for AdV purification using sartobind ion exchange 
membranes. It has been suggested that optimal ligand density for efficient binding of the viral 
vectors is much lower than the ligand density on the commercial membrane adsorbers and use 
of lower ligand density can increase recovery by 20 % (Nestola et al., 2014c). Irregularity in the 
pore size distribution of membranes has been reported to affect membrane performance such 
as sharpness of breakthrough curve, elution peak volume and binding capacity for large solutes 
(Wickramasinghe et al., 2006). 
 
Figure 2-6 Porous architectures of membranes and nanofiber based adsorbent compared 
to bead based adsorbents. Images were reused with permission from Dods et al., (2015).  
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2.3.2.3.2 Monoliths 
Monoliths resemble membranes in the porous architecture but can tolerate higher flow rates 
without affecting the binding capacities. Monoliths have a higher thickness (few mm to few cms) 
of the continuous stationary bed. Microscopically, monoliths are micro-granular structures unlike 
membranes with mesh-like structure, but both have interconnected channels of 0.5 to 1 um 
width. For membrane chromatography modules, multiple membranes are usually stacked which 
can result in inefficient flow distribution. Monoliths are continuous materials (no stacking) and 
are reported to have sharper breakthrough curves and higher binding capacities than 
membrane adsorbers.  
Monoliths have been used for purification of VLPs (Burden et al., 2012).  Recovery as low as 
6% (Wu et al., 2016)  and15-18 % (Zaveckas et al., 2015)  for some VLPs have been reported 
when purified using monoliths. Wu et al.,(2016) have speculated entrapment of the VLPs in the 
initial denser layer of the material in a monolithic bed resulting in significant loss of particles 
when compared with a gigaporous resin. Segura et al., (2012) reported a 58-69% step recovery 
of canine Adenovirus in monolith based cation exchange chromatography. Almost 100 % 
particle recovery was reported for Adenovirus purification using bio-based monoliths 
(Fernandes et al., 2015) but it was not clear if it was because of different material of monoliths 
or the structure of the monolith. Recently, application of monoliths for purification of vaccinia 
viruses has been reported (Vincent et al., 2017). 
2.3.2.3.3 Nanofibres 
Application of nanofibres has been more recent compared to membranes and monoliths. 
Nanofibers are non-woven fibres of nanometre diameters formed into a random mesh using 
electrospinning fabrication technique. Nanofibers not only have the robustness of monoliths by 
offering high flow rates due to large inter-fibre open spaces but also higher specific surface area 
compared to both monoliths and membranes (Dods et al., 2015). Hardick et al., (2013) 
described a method for synthesis of DEAE functionalised cellulose nanofibers and reported 
significantly higher productivity for nanofiber compared to the commercial resin (8 times) and 
membrane adsorber (2 times) with the similar functional group. Use of the functionalised 
chitosan nanofibers for high log removals of waterborne viruses from water has been published 
(Mi and Heldt, 2014). So far no application of nanofiber-based adsorbents for gene therapy viral 
vectors has been formally reported in the published literature, but active research is underway 
on such applications (Ruscic et al., 2017). Highly open structure of the nanofibers can 
potentially reduce polarisation and physical fouling effects observed with membranes and 
monolith based absorbers. 
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Broadly all of these materials could be classified as membranes. Additional benefits of these 
materials are the ease of scalability (often linear unlike column chromatography), robust 
performance at high flow rates (low-pressure drop), and minimal pre-use preparations such as 
packing and validation as required for the resins. Such benefits offer advantages in process 
design and overall productivity.   
2.3.2.4 Non-chromatography processes 
Purification of viral particles from protein and nucleic acid impurities has been studied for newer 
techniques like partitioning in aqueous two-phase systems (ATPS). ATPS separate molecules 
into two different immiscible aqueous phases in contact by differential partitioning of the 
molecules. Loss of particles as high as 60-72% for Adenovirus (Braas et al., 2000), 33-45% 
(Luechau et al., 2011) and around 35 % for parvoviruses, similar to AAV, (Vijayaragavan et al., 
2014, Ladd Effio et al., 2015) have been published. Such high losses of viral particles in ATPS 
are attributed to the localisation of the particles at the interface of the two aqueous phases, 
which is often difficult to recover. Other processes such as ultrafiltration have been widely used 
for viral vector purifications often with high recoveries. However, at large scales, ultrafiltration 
has primarily been used for concentration and buffer exchange steps, not for high-resolution 
separation. A detailed review of these processes is given in the next section of this chapter.  
General findings from this literature review are summarised as below:  
  
  
Figure 2-7 A summary of the literature findings on key purification tools used for 
purification of viral vectors and associated challenges. 
Ultracentrifugation 
•Can separate empty 
and mature particles 
(very high resolution) 
 
•Shear damage to the 
virus particles  
 
•Long and labourius 
procedure (>12 
hours) 
 
•Difficult to scale up 
Chromatography 
•High resolution 
separation  and 
scalable 
 
•Low particle binding 
capacities(diffusional 
limitations with 
resins due to narrow 
pores) 
 
•Virus and serotype 
specific methods 
(lack of platform 
affinity 
chromatography) 
 
•Monoliths, 
membranes and 
nanofibers are the 
emerging adsorber 
materials. 
Non-
chromatography 
•Ultrafiltration 
 
•High recoveries 
 
•Low resolution 
 
•Shear exposure 
 
•Traditional polymeric 
membranes used. 
 
•Aqueous two 
phase systems 
 
•Poor recoveries due 
to the losses at the 
interface between 
two phases 
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2.4 Membrane-based processes  
A membrane can be defined as a thin and porous barrier between two fluids which allow 
selective transport of one or more components across the barrier while retaining other 
components behind the barrier. Most common mode of selective transport is exclusion or 
inclusion of solutes by the size of the solute with respect to the size of the pores. 
Membranes are used for a variety of unit operations in the biopharmaceutical industry. Various 
applications of membranes in a typical bioprocess train includes: 
 Clarification of homogenised harvested feed (Depth filtration) 
 Separation of cells and supernatant (Microfiltration)  
 The concentration of clarified feed/output of the previous operation for subsequent unit 
operation such as chromatography (Ultrafiltration) 
 Buffer exchange of a feed or load to pre-condition before subsequent unit operation 
(Ultrafiltration) 
 Removal of impurities from the feed (Ultrafiltration)   
 Removal of contaminant viruses from the product (Virus filtration/ Nanofiltration) 
 Removal of any contaminant microbes before fill and finish of final drug product (Sterile 
filtration) 
 
All of the above applications of membranes can be summarised as filtration processes. A typical 
downstream processing train for biologics includes most of these filtration processes if not all. 
Membrane chromatography uses ligand-functionalised membranes called membrane adsorber 
used to bind proteins or impurities. Membrane adsorbers have been discussed in a previous 
section (2.3.2.3.1) of this chapter and are typically not included as filtration processes. 
The focus of subsequent sections will be on the classification of the filtration processes, type of 
membranes and membrane structure, mechanisms of filtrations including factors affecting the 
performance of filtration processes,  phenomenon observed during filtration processes such as 
fouling, concentration polarisation, separation etc. and finally on the reported literature on the 
applications in viral vector separations. For detailed information on membrane technology used 
in bioprocessing, a detailed review published by vanReis and Zydney (2007) can be referred. 
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Figure 2-8 shows the classification of various filtration processes with respect to the particle 
size and average pore size of the membranes used. The filtration processes can be categorised 
broadly into two categories by the size of retained species. The first category includes 
microfiltration, depth filtration and sterile filtration which are intended to separate large particles 
(above 0.2 µm) such as cells and cell debris which as complex assemblies of thousands of 
molecules. Depending upon membrane pore structure and mode of operation, the membranes 
or filters used these processes can retain these particles inside the porous structure or above 
the porous structure. The retention mechanism is size-based as well as adsorptive, especially in 
the depth filtration.  
The second category includes those filtration processes where solutes to be retained or 
removed are molecules or less complex molecular assemblies than cells. These molecules can 
be water, proteins, salts, nucleic acids and viruses. Ultrafiltration, nano-filtration, virus filtration 
processes and reverse osmosis are processes where separations are at the molecular level. 
Typically separation in ultrafiltration membrane occurs at membrane surface or in the active 
layer of the membranes. However, with virus filtration membranes, retention of the viruses 
occurs inside membrane bed similar to that observed in the depth filtration. Microfiltration and 
ultrafiltration membranes usually retain solutes at the surface and can be termed as screen 
filters (Cheryan, 1998).  
Figure 2-8 Variety of solutes and the range of membrane pore sizes used in 
corresponding membrane processes. Image reproduced with permission from Baker 
(2012).  
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2.4.1 Fundamentals of the filtration process  
All filtration processes are driven by an external driving force acting upon fluid being pushed or 
pulled through a static membrane. In general, filtration processes are carried out either at 
constant transmembrane pressure or constant filtrate flux.  Solvent transport across the 
membrane is given by the filtrate flux across, described by a simplified equation of Darcy’s law 
as below: 
Jv=
∆P
Rtμ
 
where 𝐽𝑣 refers to the filtrate flux across the membrane and can be calculated by dividing the 
volume of the filtrate by product of the membrane area and the time taken for filtration, ∆𝑃 is the 
transmembrane pressure (TMP) or applied pressure across the membrane, A is the active 
filtration area, 𝑅𝑡 is total resistance incurred by the fluid and 𝜇 is the viscosity of the fluid. Total 
resistance is the sum of the hydraulic resistance of the membrane material and additional 
resistances encountered in filtration processes. 
2.4.1.1 Goal and performance of a filtration process 
Filtration processes are used to separate different components of a feed, merely concentrate a 
feed or to replace the buffer in the feed. Separation in ultrafiltration processes is often termed as 
fractionation. Performance of filtration processes is described as filterability of the feed and 
separation performance of the membrane. Filterability is studied to evaluate the impact of 
phenomena such as fouling, concentration polarisation and osmotic pressure on the membrane. 
These phenomena can also impact the ability of the membrane to separate two components. 
Properties of feed influence both filterability and separation performance of a filtration process, 
membrane and the way filtration are carried out. Significant parameters of feed, membrane and 
filtration operation are outlined in Figure 2-9. The figure also outlines the parameters monitored 
to measure the performance of the filtration  
Parameters such as capacity, processing time and hydraulic permeability are universally 
measured for all filtration processes. The capacity of the membrane defined as the volume of 
feed filtered per unit area of membrane is often established at a minimum transmission or flux 
decline through the membrane. Impact of fouling on the membrane is assessed by 
measurement of the loss of the hydraulic permeability of the membrane after filtration. Cleaning 
efficiency of a cleaning method is established by its ability to reverse the loss of hydraulic 
permeability. Factors such concentration and viscosity of the feed and hydraulic permeability of 
the membrane will have a direct impact on filtrate flow rate through the membrane and hence 
the processing times. Processing conditions such as transmembrane pressure, feed flow rate, 
cross flow rate and choice of modules can alter the fouling thus affecting filtrate flow, 
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permeability loss of membrane and cleaning requirement. Throughout the filtration run, flux 
through the membrane is calculated by measuring the volume of filtrate collected. Mechanism of 
flux decline is deduced from the shape of the flux decline curve. Transmission of different 
solutes into filtrate solution is measured in terms of sieving coefficients. Sieving coefficients are 
obtained by normalising the solute concentration in filtrate to that in the initial feed solution. 
These parameters are studied during process design and monitored for consistent processing 
of a designed process. 
Yield and purity of the product to be retained or passed through the membrane are essential 
parameters for separation performance. Separation factor or selectivity of the membrane is 
obtained as the ratio of sieving coefficients of smaller solute to large solute. For fractionations, 
purification factor (ratio of the yield of product to that of impurity) and final purity of solution is 
used. Ideal membrane for fractionation should completely retain one component and pass 
through another one. Membrane morphology and pore size distribution are critical for such 
fractionation. Hence the selection of a suitable membrane is crucial. Some of these factors are 
discussed in detail in the next sections. 
  Figure 2-9 Parameters related to membranes, feed solution and processing conditions 
which impact performance of an ultrafiltration process. 
Performance of the ultrafiltration process depends upon properties of feed, membrane and 
operating conditions of the process. Equation for sieving coefficient, selectivity and purification 
factor is explained with respect to separation of two solutes (X and i). 
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2.4.2 Phenomena affecting the performance of the filtration processes 
2.4.2.1. Membrane fouling 
Membrane fouling is the result of deposition or interaction of the solutes or suspended solids in 
the feed being processed in a filtration operation with membrane material. Fouling can either 
add additional resistance to the convective flow or reduce the number of open pores or effective 
pore diameter available for the solvent flow. For constant transmembrane pressure operation, 
fouling manifests in the form of a decline in the filtrate flux. For constant flux operations, fouling 
results in increased transmembrane pressure required to maintain the flux. 
Fouling can alter the separation performance of the membrane and results in loss of the 
hydraulic permeability of the membrane. Regeneration of the permeability requires harsher 
cleaning regime depending upon the nature or foulant and compatibility of the membrane 
material with the cleaning agent.  Protein fouled membranes are often cleaned using highly 
alkaline solutions, sodium hypochlorite or protein degrading enzyme solutions. Such cleaning 
regime has been known to result in ageing of the membrane thus limiting the number of reuse. 
Control of fouling is thus necessary for consistent and repeated membrane operation, and 
remedial action often depends upon the mechanism of the fouling identified. 
2.4.2.1.1 Mechanism of fouling  
Generally, four fundamental mechanisms of the fouling have been proposed. Mathematical 
models and expression have been well defined. A majority of these mechanisms have been 
proposed for microfiltration or sterile filtration membranes (Boyd and Zydney, 1998, Ho and 
Zydney, 2001, Kelly and Zydney, 1997, Velasco et al., 2003, Zydney and Ho, 2003). Standard 
blocking model is based on the reduction of the internal pore diameter due to deposition of the 
fouling solute on pore walls and occurs when particles are much smaller than the pore diameter. 
Complete blocking model assumes that every particle arriving at membrane surface plugs the 
pore entrance thus reducing the number of open pores over time. Blocked pores do not 
participate in the fluid flow. The intermediate blocking model assumes that only a portion of 
particles approaching the membrane surface will directly plug the pores and other particles only 
participate in partial blockage. Both complete blocking and intermediate blocking models 
attempt to calculate the area of membrane available for flow. In cake filtration, a resistant layer 
of the particle is deposited on the membrane surface and thickness of the layer increases over 
time without a direct plugging of pores. Figure 2-10 gives a graphical representation of these 
mechanisms. 
 
 
  
[47] 
 
 
 
Mechanism Mathematical expression for filtrate volume (V) 
Standard blocking (SB) 𝑉 = (
1
𝐽𝑂𝑡
+
𝐾𝑠
2
)
−1
 
Complete blocking (CB) 𝑉 =
𝐽𝑂
𝐾𝑏
(1 − 𝑒𝑥𝑝(−𝐾𝑏𝑡)) 
Intermediate blocking (IB) 𝑉 =
1
𝐾𝑖
𝑙𝑛(1 + 𝐾𝑖𝐽𝑜𝑡) 
Cake filtration (CF) 𝑉 =
1
𝐾𝑐𝐽𝑜
(√(1 + 2𝐾𝑐𝐽𝑂
2𝑡) − 1) 
 
Table 2-2 Mathematical expression of fundamental mechanisms of membrane fouling.  
A mechanism is identified to be dominant mechanism by fitting these expressions to 
experimental data (volume filtered, V (m
3
/m
2
); time, t (s) and initial flux, Jo, (m/s)). Kx represents 
fouling constants for respective models. Expressions were described by Bolton et al., (2006) for 
constant pressure filtrations. Volume filtered is normalised to the membrane area. 
Figure 2-10 Illustration of the fundamental mechanisms of fouling in membranes 
Intermediate blocking Cake filtration 
Complete blocking Standard blocking 
Particle < pore Particle ~ pore 
Particle > pore Particle > pore 
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These models as semi-empirical and assume that only a single mechanism is responsible for 
the fouling. Simplified mathematical expression, as shown in Table 2-2 for different mechanisms 
of fouling relating volume of the filtration or pressure across the membrane with time and initial 
membrane permeability has been established. Complex mathematical expressions combining 
various fundamental mechanisms in sequence or concurrently have also been published 
(Bolton et al., 2006, Ho and Zydney, 2000, Palacio et al., 2002). Models accommodating protein 
adsorption along with classical pore plugging have also been elaborated assuming zero order 
kinetics of adsorption on pore walls. A drawback of these mechanisms is that they depend on 
the statistical fitting of the data to the mathematical expressions. Theoretically, initial flux 
through the membrane can also be predicted by these expressions but can result in overfitting 
of the data, resulting in unrealistic values for initial flux which otherwise can be measured 
experimentally. Bolton et al., (2006) have developed simplified expressions for these models 
with single parameters by providing experimentally measured initial flux. These expressions are 
also numerically simpler to implement than those developed previously (Ho and Zydney, 1999, 
Ho and Zydney, 2000) where details of feed concentration, pore density, pore diameter, 
membrane thickness etc. were required. 
 
2.4.2.2 Osmotic pressure  
Another contributing factor for reduced flux through a membrane is osmotic pressure across the 
membrane system. Separation of the solute above the membrane surface and a low solute 
concentration solution across the membrane can create the osmotic pressure. Osmotic 
pressure will tend to force the solvent in reverse direction. Thus osmotic pressure exerts itself in 
the direction opposite to the applied transmembrane pressure (see Figure 2-11). This results in 
a reduced effective transmembrane pressure across the membrane and consequently reduced 
flux. For monoclonal antibodies, significant osmotic pressures are observed at concentrations 
above 20 g/L in the feed solutions. Osmotic pressure depends upon intermolecular interactions 
among proteins, and solvent molecules thus can change with temperature, ionic environment 
(salt concentration and pH), concentration and nature of the protein (Binabaji et al., 2014) 
dramatically. 
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2.4.2.3 Concentration polarisation 
Concentration polarisation is the reversible build-up of entirely or partially retained solute near 
the membrane surface due to the balance of convective transport of the solute to the membrane 
surface and back-transport of the solute from membrane surface to the bulk solution (see 
Figure 2-11). A weaker back transport of solute results in high polarisation near the membrane 
surface and is controlled by the diffusivity of the solute and mass transfer capabilities of the 
module. The build-up results in additional resistance to convective flow thus decreasing the flux 
through the membrane. Additionally, the polarised layer can be less permeable to the smaller 
impurities thus reducing their transmission or removal from the feed. An unintended 
consequence of the concentration polarisation is leakage of the polarising solute across the 
membrane thus resulting in loss of the solute in the filtrate (Narsaiah and Agarwal, 2007).  So in 
a fractionation application, concentration polarisation can result in low yields of retained product 
and loss of separation performance as the transmission of impurities will also decrease. 
Concentration polarisation is a pressure dependent and reversible phenomenon and exists as 
long as the driving force, i.e. the transmembrane pressure is applied. A fundamental difference, 
thus, between fouling driven flux decline and that due to concentration polarisation is that 
membrane permeability can be recovered as soon as the driving force is removed (Porter, 
1972). Flux decline observed with concentration polarisation especially for a completely or 
significantly retained solute is not result of membrane fouling unless the concentration of solute 
near membrane results in solute-solute or solute-membrane interactions leading to another 
mode of fouling such as cake formation due to precipitation of the solute with low solubility.  
Mathematical models have been developed for concentration polarisation by assuming a 
stagnant film of solute above membranes surface alone (Zydney, 1997, Johnston et al., 2001) 
or in combination with osmotic pressure model (Tandon et al., 1994). It has been suggested to 
run ultrafiltration at constant wall concentrations by a feedback control on transmembrane 
pressure or the filtrate flux designed using the mathematical models developed for 
concentration polarisation (van Reis et al., 1997). Such an approach can ensure greater 
predictability in the performance of the ultrafiltration operation. 
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Concentration polarisation can be limited by changing the processing conditions. High 
membrane permeability, high flux or transmembrane pressure can increase the polarisation as 
the driving force pushing solute molecules towards the membrane will be high. Back transport of 
the solute from the polarised region to the bulk solution is diffusive. Thus concentration 
polarisation is challenging for large macromolecular solutes which have low diffusivity. 
Membrane module and cross flow over the membrane surface can aid in the back transport of 
the solute to alleviate the concentration polarisation to some extent.  
 
 
 
 
 
Fouling, concentration polarisation and osmotic pressure poses significant challenges to 
ultrafiltration processes by affecting the filterability of a feed, capacity of the membrane and 
selectivity of the membrane. So these phenomena must be studied in detail, and appropriate 
remediation strategies should be devised for any particular feed. This involves identifying the 
dominant mechanism of flux decline, its impact and optimisation of the processing conditions 
such as transmembrane pressure, cross-flow rate and cleaning strategy to reduce their impact. 
Following section will emphasise upon impact of properties of membranes, feed and operating 
conditions on these phenomena.  
Figure 2-11 Illustration showing concentration polarisation and osmotic pressure and 
how it affects filtrate flux (Jv) and effective trans-membrane pressure (TMP).  
Rm and Rs represent resistance to the convection offered by membrane itself and fouling or 
concentration polarisation respectively. The concentrations of solute at various locations are 
represented by Csubscript. Applied trans-membrane pressure and osmotic pressure are 
represented by ΔP and ΔΠ respectively.  
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2.4.3 Impact of membrane and feed properties on process performance 
2.4.3.1 Membrane architecture 
Membranes can be categorised as symmetric or asymmetric membranes based on the 
uniformity of the porous morphology across the membrane thickness. Symmetric membranes 
have a uniform porous network (with respect to pore size, porosity and interconnectivity) across 
the membrane thickness. Asymmetric membranes usually have a thin and tighter layer of 
smaller pores called the active layer, or skin side and an underlying layer of larger pores called 
the support layer. Support layer itself can have a gradient of pore structures from open, highly 
porous layer to a tighter porous structure at the junction of the skin layer. Figure 2-12 illustrates 
two categories of membranes.  
The implication of the porous structure of the membranes can be significant depending upon the 
application of the membrane. Usually, asymmetrical membranes are used more commonly in 
the bioprocesses. Sterile filtration, microfiltration and ultrafiltration membranes are operated with 
feed facing skin side. Virus filtration and depth filtrations are usually carried out with skin side 
down, i.e. more open side of the asymmetric membrane facing the input feed.  Transmission (or 
sieving) of the solutes can be significantly altered depending on which side of the membrane 
faces the feed solution (Bakhshayeshi et al., 2011a, Syedain et al., 2006). 
 
 
Figure 2-12 Symmetric (A) and asymmetric membranes (B and C): morphology of 
the porous structure of two membrane types as observed with electron 
microscopy (Source: van Reis and Zydney, 2007). 
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2.4.3.2 Membrane ratings 
Membranes are rated for their ability to screen or exclude a particle of a specific size to a 
specified extent. Such ratings are called nominal ratings. Usually, microfiltration and sterile 
filtration membranes are rated by a bacterial challenge test. These membranes are rated in 
terms of physical size (in µm) of the particles retained by the membranes to a specified extent. 
Ultrafiltration membranes are often rated in terms of molecular weight cut off (MWCO) limits, 
which are the molecular weight of the solute that would be retained by the membrane more than 
90 or 99%. Such ratings are assigned by performing a dextran sieving test with a mixture of 
dextran of varying molecular weights filtered through the membrane at almost no polarisation. 
These ratings are however merely indicative for membrane selection and do not predict 
membrane performance for any actual feed. Further, the standard operating procedure for such 
ratings can vary between manufacturers (Mulherkar and van Reis, 2004). Mehta and Zydney 
(2005) have put forward a selectivity permeability trade-off plot with a model protein solute as 
an alternative method to assess and compare performances of different membranes. 
 
2.4.3.3 Membrane material 
A majority of membranes used in bioprocess applications are polymeric especially made of low 
protein binding materials such as polyethersulfone (PES) and regenerated cellulose. Non-
specific binding to the membrane surface can result in fouling as well as yield loss of the 
product. The implication of the selection of appropriate material is highly significant for feeds 
with very low protein concentrations. Apart from size exclusion, electrostatic exclusion of solutes 
has also been observed in charged membranes. Altering the ionic environment around the 
solutes such as salt concentrations or pH of the feed can affect the fouling (Martinez et al., 
2000, Miao et al., 2017) and separation performance (Millesime et al., 1996, Shukla et al., 2000, 
Sorci et al., 2013). Such processes have been classified as high-performance tangential flow 
filtrations (HPTFF) which are capable of separating close sized molecules such as product 
variants and can achieve higher selectivity than conventional ultrafiltration. 
 
2.4.3.4 Membrane module 
Commercial membranes are available in a variety of formats such as circular discs, cassettes, 
spiral and hollow fibre modules with cassettes being used more commonly. Module designs 
such as cassette include turbulence promoting screen below and above the membrane surface. 
Selection of appropriate screen can help reduce concentration polarisation and improve 
filterability of a feed (Lutz et al., 2017).  
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2.4.4 Impact of operating conditions on process performance 
2.4.4.1 Mode of operation 
Filtration processes can be operated in two modes, Normal flow filtration (NFF) and Tangential 
flow filtration (TFF). Feed is applied perpendicularly or normal to the membrane surface in NFF. 
In TFF, the feed is applied parallel to the membrane surface along with the transmembrane 
pressure pushing the feed towards the membrane (see Figure 2-13). Thus, the feed hits the 
membrane at an angle. TFF mode of operation aids in the back-transport of the solutes and 
prevents plugging of pores. Thus TFF mode helps to reduce polarisation and can increase the 
capacity of the filtration process. Membrane capsules and stirred cells are used to perform NFF. 
NFF operations are typically batch operation. Sterile filtration, virus filtration and depth filtration 
are usually carried out in NFF mode. Cassettes and hollow fibre modules are commonly used 
for TFF. Ultrafiltration and microfiltration applications are typically carried out in TFF mode.  
 
 
 
2.4.4.2 Selection of the operating conditions  
Transmembrane pressure can affect fouling and concentration polarisation. In TFF mode, the 
feed flow rate and cross-flow velocity are optimised for a particular feed. Cross-flow velocity can 
impact concentration polarisation, as well as thickness and mass of fouling layer (Choi et al., 
2005),  and in conjunction with TMP can change retention of solutes (Pradanos et al., 1994). 
For the stirred cell, cross-flow is controlled by stirring speed though is difficult to be quantified in 
terms of fluid velocity. With feeds containing large solutes, concentration polarisation can lead 
Figure 2-13 Two modes of filtrations: Normal flow filtration (NFF) and Tangential flow 
filtrations (TFF).  
Cross flow helps to clean membrane surface by sweeping off the large solutes from depositing 
on the membranes.  
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to a pressure-independent flux after a certain transmembrane pressure. Operating at fluxes 
below the critical flux is thus crucial. 
2.4.4.3 Impact of filtration modules 
Cassettes and hollow fibre modules are used in cross-flow filtration systems and are the 
preferred systems for large-scale operations due to ease of the scale up. Disc membranes can 
only be used in stirred cell modules. Mass transfer properties of cross-flow filtration modules are 
superior compared to that of the stirred cells which result in higher polarisation in the later. 
Becht et al. (2008) have demonstrated significantly higher protein rejection and filtrate fluxes for 
filtration of serum albumin through a 50 kDa membrane when stirred cell and cross flow setups 
were compared. However, stirred cells are used more commonly for characterisation studies or 
comparison of membranes as they have uniform mass transfer characteristics across the 
membrane surface. Hollow fibre and cassette modules can have a significant pressure drop 
across the length of the membrane and axial variation of the transmembrane pressure resulting 
in a module with zones of different membrane performance (Bakhshayeshi et al., 2011b). Such 
variations need to be accounted for when studying overall separation performance and scale up 
an ultrafiltration process. Module shear can also impact the activity of the shear-sensitive 
protein. 
2.4.4.4 Constant flux and constant pressure operation 
Constant transmembrane pressure ensures that a constant force is applied to the fluid being 
pushed or pulled across the membrane. However, as the filtration proceeds, resistance to the 
fluid increases due to various reasons and hence flow rate across the membrane decreases. 
Here, the filtration process is limited by output flow rate at a particular transmembrane pressure. 
Constant filtrate flux mode, on the other hand, maintains the same output flow rate through the 
membrane and does not control the transmembrane pressure. Resistance to the fluid flow 
increases due to similar reasons but filtration system responds to increased resistance by 
increasing the transmembrane pressure to maintain the same output flow rate. Such a process 
is limited by maximum pressure that will be tolerable to the membrane without damaging the 
membrane. 
2.4.4.5 Concentration and diafiltration 
UF processes for concentration are optimised for fold concentration to be achieved without 
causing aggregation of the product. Diafiltration processes are optimised for the number of 
diavolumes (buffer volume normalised to retentate volume) for maximal removal of smaller 
solutes (buffer components or impurities) as well as shear damage to the product. 
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2.4.5 Application of ultrafiltration in viral vector processing 
Using membranes with pore sizes similar to virus particles will result in sharper loss of permeate 
flux and possible entrapment of virus particles in the pores (Grzenia et al., 2008, Czermak et al., 
2008, Grzenia et al., 2006). Impact of the cell growth media component can also influence the 
flux performance of the membranes. It was demonstrated that virus feed with serum-free media 
has a lower flux compared to the virus feed with serum-rich media (Grzenia et al., 2006). This 
effect was attributed to an increase in total host cell proteins secreted in cultures with serum-
free media as opposed to serum containing media.  
High-performance tangential flow filtration (HPTFF) was reported to result in lower but stable 
permeate flux compared to regular tangential flow filtration for small sized viruses, 
densonucleosisvirus (AeDNV) as a model system of adeno-associated viruses (Grzenia et al., 
2006, Grzenia et al., 2008). One study compared 30, 50, 100 and 300 kDa membranes in TFF 
setup for 10 fold concentration of AeDNV (26 nm diameter) and reported loss of virus particles 
in permeate for 300 kDa and lower relative flux (normalized to water flux) for 300 kDa 
membrane compared to 100 kDa membrane (Czermak et al., 2008). HPTFF has also been 
demonstrated to increase recoveries of Adenovirus from 40-60 % to 80 % in hollow fibre based 
module of 0.05 µm pore ratings (Weggeman, 2013). TMP in HPTFF mode was around 0.17 bar, 
and hence low filtrate fluxes of 10-15 LMH were obtained during this ultrafiltration. The author 
also reported higher purity in HPTFF mode. 
A comprehensive study comparing different membranes (materials and format) for Adenovirus 
concentration and diafiltration application has demonstrated 50-90 % host cell protein removal 
while retaining more than 75% infective titre with most of the membranes (Nestola et al., 
2014a). Fluxes for all the membranes, however, remained below 100 LMH for processing of 
approximately 20 L/m
2 
of Adenovirus feed. Authors reported a regenerate cellulose based 
membrane of ~500 kDa MWCO to result in complete recovery of infectious particles. Authors 
showed that PES membranes had lower particle recoveries (23-58%) as opposed to RC based 
membranes where particle recoveries ranged from 69 to 93 % after 10-fold concentration and 
five diavolumes of diafiltration. Losses were attributed to higher MWCO for PES membranes 
(around 1000 kDa). 
Flux values of less than 40 LMH were also reported for Adenovirus concentration for at least 
five-fold using membranes of 0.05 µm, 300 and 400 kDa ratings in hollow fibre modules 
(Subramanian et al., 2005). Constant TMP pressure of 0.5 ± 0.17 bar was used for this study, 
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and more than 80 % infectious virus particles were reported to be recovered. Average flux for 
0.05 µm (50 LMH) was better than 300 and 400 kDa (20 LMH) membranes. Ultrafiltration 
processes for other viruses have also been published. Limited studies have been published for 
ultrafiltration of enveloped viruses. One of the studies compared 100 and 300 kDa rated 
membranes for ultrafiltration of human influenza virus and reported that 300 kDa membrane 
results in 80 % host cell DNA removal along with 90% removal for HCPs. (Wickramasinghe et 
al., 2005) Authors also implied that 300 kDa membrane could remove virus fragments. Fluxes 
for this membrane were reported to be between 40-50 LMH. Peixoto et al.,(2008) have reported 
a loss of Adenovirus yield from 96 % to 42% as membrane rating was increased from 300 to 
750 kDa but at the expense of increased process time. 
Reduced retention of the virus particles at high TMPs have been reported in a number of 
published literature and has been in general attributed to the presence of larger pores in the 
membranes. One study, however, has rejected this explanation and argued that enlargement of 
pores at higher TMPs to be responsible for the leakage of the viruses in permeate 
(Arkhangelsky and Gitis, 2008). However, authors did not give any direct evidence of any pore 
enlargement occurring with TMP increase, though reported an increase in mean pore size of the 
same membrane with an increase in pressure using polymer probe based evaluation and a 
method based on hydraulic permeability of the membranes. Authors also argue that the lack of 
any virus leakage in permeate in a diffusion-driven membrane indirectly supports the hypothesis 
of enlargement of pores with pressure. One study has reported an increase in recovery of 
retrovirus particles with an increase in TMP in an ultrafiltration step using 500 kDa membrane 
(Rodrigues et al., 2007). Authored attributed this observation to the reduced absorbance of virus 
particles to membranes at higher TMP as other proteins will form a thicker layer preventing 
adsorption of virus particles as protein removal decreased with increasing TMP. 
A detailed summary of the above-discussed literature and their key findings are tabulated in 
Table 2-3. Most of these studies have not studied the mechanisms of fouling associated with 
observed losses in the flux. These studies have only used conventional polymeric membranes 
and except a few, were targeted for concentration and buffer exchange application and not for 
the fractionation. Thus studying membrane-based processes for high-resolution separation is 
relatively unexplored especially with respect to membrane morphology.  
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Table 2-3 Summary of the reported literature on application of membrane based processes for separations of viral vectors. NR represents not 
reported.  TFF stands for tangential flow filtration. 
Literature Virus
Virus 
Size 
(nm)
Mode
Module 
used
Membranes 
used
Area 
(m
2
)
Scale 
(L)
Conc. 
Factor
TMP 
(bar)
Flux reported 
(LMH)
Wichramasinghe 
et al, 2005
Human 
Inf. virus
100 TFF Cassettes
PES; 100, 
300 kDa , 
0.1µm 
0.02
0.5- 0.6 
L
~4 0.4 bar
40-50           
(300 kDa)
Negrete et al, 
2014
HIV-gag-
VLPs
100-
300
TFF Hollow fibres PES; 500kDa 0.005  0.2 L ~6 1.25 bar 20-30 
Czermak et al, 
2008
AeDNV 26 TFF Cassettes
PES; 30,50. 
100 and 
300kDa
0.02 0.45 L ~10 NR NR
Grzneia et al, 
2008
AeDNV 26
TFF
1
 and 
HPTFF
2
Cassettes
PES; 30,50. 
100 and 
300kDa
0.02 0.45 L ~10
0.18-0.23
1 
0.09-0.2
2 
bar 
20-30  (300 
kDa); 5 (100 
kDa)
 2
Nestola et al, 
2014
AdV 90-100 TFF
Cassettes, 
Hollow fibres
Different 
polymers; 
300-1000 
kDa
0.02 0.4 L ~10 1.2 bar 20-100 
Subramanian et 
al, 2005
AdV 80 TFF Hollow fibres
300, 400 kDa 
and 0.05 µm
5.6 240 L ~12-20
0.5 ± 0.17 
bar 
20-100 
Weggeman, 
2005
AdV 100 HPTFF Hollow fibres  0.05 µm 5 0.17 bar 10-20
Rodrigues et al, 
2005
RV TFF Hollow fibres  500 kDs 0.003 0.2 L ~11-16 NR NR
Shear induced release of virus from 
cells during TFF with 80 % recovery.
HPTFF results in transmission of viral 
fragment through 100 kDa 
membrane. HPTFF results in more 
stable flux for 300 kDa.
Increased purity and recovery of 
Adenovirus particles in HPTFF 
process
Increase in TMP resulted in improved 
recovery of virus particles.
Remarks
 Membrane with 80 % DNA and 90% 
HCP removal; reported fractionation 
of damaged viruses
Various shear conditions and TMPs 
were screened.
Higher log retention of virus for 100 
kDa (~7) compared to 300 kDa (~2). 
Entrapment of AdV particles in 300 
kDa membrane.
100 % particle recovery using 500 
kDa RC membrane with HCP and HC-
DNA removal of 71 and 57 % 
respectively.
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2.5 Porous anodic alumina (PAA) membranes 
Porous anodic alumina (PAA) membranes are a unique category of porous material which has 
highly ordered porous morphology characterised by self-organised hexagonal cells with 
cylindrical pores and surrounding aluminium oxide material. PAA membranes exhibit narrow 
pore size distribution and straight channels compared to the array of pore sizes and tortuous 
channels in membranes traditionally used in various membrane processes. These traditional 
membranes included ceramic alumina membranes, polymeric ultrafiltration and microfiltration 
membranes. It is worth noting that membranes with narrow and uniform pore size have also 
been produced in the polymeric materials such as polyester and polycarbonates called track-
etched membranes. Figure 2-14 shows the different morphology of top surfaces and pore 
channels of typical polymeric, track-etched and PAA membranes. 
 
 
 
 
 
Figure 2-14 Differences in the porous morphology of a typical track-etched
1
, 
conventional polymeric
2
 membranes and porous anodic alumina
3
 membranes 
visualised using electron microscopy. 
Images were reused with permission from 
1
Xie et al.,
 
(2005), 
2
Mu and Zhao, (2009) and 
3
Lei et 
al., (2007). Notice the highly ordered structure of the anodic alumina membranes with 
seemingly uniform pore diameter for all pores. Track etched membrane have near uniform 
pore sizes but larger pores with two pores merged can also be seen.  
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Porous ordered porous materials with well-arranged pores of uniform size are attractive 
materials to design new tools and techniques for various applications as they offer greater 
control of the transport and optical properties. The ability to control molecular transport at nano-
scale is a characteristic of highly selective systems such as highly ordered natural membranes 
in living systems. Ordered porous materials, thus present an opportunity to design membranes 
with very high selectivity. Conventional polymeric membranes suffer from low selectivity due to 
broad pore size distribution (Urase et al., 1994, Urase et al., 1996). Track-etched membranes 
which have narrow pore size distributions and straight channels have been used for such 
investigations but suffer from low porosity (Ho and Zydney, 1999) and smaller membrane 
thickness (Stroeve and Ileri, 2011). PAA membranes offer higher porosity and improved ordered 
isoporous structure compared to the track-etched membranes (Stroeve and Ileri, 2011). Apart 
from the ordered porous morphology, PAA membranes, upon high-temperature treatment can 
exhibit superior thermal stability and acid/base resistance (pH 2-10) hence are suitable for high-
temperature sterilisation as required in bioprocessing (Lee et al., 2000). Unlike polymeric 
membranes, inorganic PAA membranes are low extractable materials as they are fabricated 
without using any monomers, adhesives or plasticisers (GE Healthcare Life Sciences, 2018). All 
these properties make PAA membranes an interesting material to study for bioseparations. 
 
2.5.1 Fabrication of PAA membranes  
Highly ordered porous anodic alumina is fabricated by electrochemical oxidation of high purity 
aluminium sheets under specific conditions. Electrochemical oxidation of aluminium is also 
known as anodisation as the aluminium metal acts as an anode in the process. Anodisation has 
been known to develop a corrosion resistant oxide layer caller barrier layer under normal 
environmental conditions. This barrier layer is, however, a non-porous layer (Sulka, 2008). 
Under acidic conditions using mild acids as an electrolyte, anodisation of the aluminium metal 
results in a porous oxide layer exhibiting self-assembly behaviour to form a regular array of 
cylindrical pores organised in a honeycomb-like structure. Optimisation of various fabrication 
parameters such as quality of aluminium sheet, the magnitude of the anodising voltage, choice 
of electrolyte and choice of etching method has been extensively studied for fine tuning the 
porous morphology. A typical fabrication process for PAA membranes comprises of three major 
processing steps starting with pre-treatment of aluminium sheet used as substrate followed by 
anodisation of the pre-treated sheet to form porous anodic alumina layer and finally detachment 
of the porous layer from residual sheet to form a free-standing membrane. All three stages are 
thoroughly discussed in following sub-sections: 
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2.5.1.1 Pre-treatment of the aluminium substrate 
Surface roughness, crystalline structure and the purity of aluminium sheet can also impact the 
fabrication process (Sulka, 2008). Aluminium sheets of high purity, usually above 99.90% are 
used for fabrication. Pre-treatment of the aluminium sheet is carried out before the anodisation 
process, which can include various steps such as annealing, ultra-sonicating and polishing of 
the sheet. Annealing is carried out by subjecting the metal sheet to high temperature (usually 
one-third of the melting point of the metal) followed by gradual cooling. Ultra-sonication in 
organic solvents such as acetone and ethanol is carried out to remove the organic 
contaminants. Polishing, primarily by electrochemical methods, is carried out to reduce the 
surface roughness and cavities formed during the mechanical and thermal processing of the 
metal sheets. Electropolishing by application of 30-50 V voltages on the metal sheet for short 
duration (5-30 sec) in a solution of perchloric acid and ethanol has been demonstrated to result 
in remarkably refiner porous structure compared to the non-electropolished samples (Wu et al., 
2002). 
2.5.1.2 Anodisation of the pre-treated substrate  
Anodisation of the aluminium can result in two types of the oxide layers: non-porous barrier-type 
layer and porous layer depending upon the nature of electrolyte used. Porous oxide layers are 
formed if acidic electrolytes such as phosphoric, sulfuric, oxalic, chromic, malic, tartaric and 
citric acids are used. Non-porous layers are formed in neutral electrolytes (pH 5-7).  A two-step 
anodisation process is commonly used for the fabrication of porous anodic alumina membranes 
(Masuda and Fukuda, 1995, Yuan et al., 2004, Choudhary and Szalai, 2016). Figure 2-15 A 
illustrates the two anodisation steps (Lee and Park, 2014) followed by a post-anodisation 
processing.  In the first anodised step, irregular pores are formed (step (i)) on the side of metal 
sheet exposed to the electrolyte solution with gradual reordering of the pores into a self-ordered 
array as the oxidation occurs deeper in the sheet thickness. The disordered layer of the porous 
oxide is then selectively removed by chemical etching (step (ii)) resulting in an aluminium sheet 
with a textured surface in the form of an array of hemispherical pits. A second anodisation (step 
(iii)) is then carried out on this textured aluminium sheet using the same conditions as used for 
the first anodisation step. Pre-texturing creates an array of highly ordered pore nucleation 
centres which grow perpendicularly during the second anodisation step resulting in straight pore 
channels. Each anodisation step can take up to 24 hours if anodisation is carried out at lower 
current density, also known as mild anodisation. Mild anodisation uses lower current densities 
compared to hard anodisation and can result in more ordered porous structure and higher pore 
density but as a cost of lower film growth rate of 2 µm/h compared to 50-60 µm/h for hard 
anodisation (Lee, 2013). 
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Figure 2-15 Diagrams showing the fabrication of porous anodic alumina membranes 
using a two-step anodisation method (A), chemical reactions and ion migration during 
the anodisation process resulting in the formation and dissolution of the oxide layer at 
different interfaces (B) and the relationship of the anodising voltage and the porous 
morphology formed using different electrolytes during anodisation. 
A. Fabrication process of porous anodic alumina membrane using two-step anodisation 
method (Lee and Park, 2014) followed by an etching step to remove residual non-anodised 
metal and barrier oxide layer B. Chemical reactions occurring during anodisation of the 
aluminium sheet at both interfaces (metal/oxide and oxide/electrolyte) resulting in growth and 
simultaneous dissolution of alumina (Thamida and Chang, 2002) C. the graph showing a 
linear relationship between the anodising voltage and the  interpore distance for different 
acidic electrolytes using mild (MA) and hard anodising (HA) condition represented 
respectively by filled and empty symbols. The slope of the plot is displayed as the 
proportionality constant (ζ). Symbol shape: square- sulfuric acid, circles- chromic acid, 
triangle-phosphoric acid and inverted triangles- selenic acid. Images A and C were reprinted 
and adapted with permission from Lee and Park, 2014. Copyright (2014) American Chemical 
Society. 
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The mechanism of the pore formation and growth in the anodisation process is less well 
understood. It has been suggested that a dynamic equilibrium occurs between the formation 
and dissolution of the oxide resulting in a porous oxide layer. Migration of the Al
3+
, OH
-
 and H
+
 
ions under the electrical field across the oxide layer is reported to result in different chemical 
reactions at different interfaces (Thamida and Chang, 2002). Fig. 2-15 B shows an illustration of 
various chemical reactions occurring at metal/oxide and oxide/electrolyte interfaces. Even in 
acidic electrolytes, initially, a barrier- type layer is formed followed by initiation of pores. Pre-
existing ridges on the metal surface and high tensile stress on the initial barrier layer is thought 
to result in the formation of cracks and pits which are accessible to the electrolyte (Shimizu et 
al., 1992). As a result, the oxide layer is thinner on the pit surface. Uneven oxide layer thickness 
results in a local increase in the electrical field on pit surface forming scallop shaped 
metal/oxide interface. Most widely cited model, the field assisted dissolution model advocates 
the enhanced dissolution of the oxide layer at the pore base by increased strength of the local 
electrical field as a result of the concave curvature of pits and high electric field aiding in the 
breakage of Al-O bonds (O'Sullivan and Wood, 1970). The field-assisted dissolution model 
asserts that the rate of formation of the oxide at the electrolyte/metal interface in such pits is 
much lower than the dissolution rate of the oxide resulting in thinning of the oxide layer which is 
compensated by the oxide formation at the metal/oxide interface leading to the pore growth as a 
consequence of maintaining a constant thickness of the initial barrier layer. The alternative 
model, such as flow model proposed by Sheldon et al.(2006) argues that the field-assisted 
dissolution occurs primarily in the initial pore formation stage and the further pore growth is 
mainly driven by the viscous flow of the oxide material from the base of the pores to the pore 
walls due to large compressive stress and to maintain a constant initial barrier layer thickness. 
This model can account for the experimental observations not explained by the field-assisted 
dissolution model such as the presence of electrolyte anions in porous oxide film by predicting 
the mobility of anions in the oxide layer and the volume expansion of the porous anodic oxide 
compared to the oxidised metal. 
The strength and duration of the electrical field, generated by the application of external voltage 
called anodising voltage, is adjusted according to the electrolyte used and the desired pore size, 
pore interval (also referred as interpore distance) and thickness of the film. Figure 2-15 C 
shows the range of anodising voltages used and measured interpore distances in the porous 
anodic alumina fabricated using different acidic electrolytes. The choice of the electrolyte can 
influence the chemical composition of the PAA membranes as the acid anions are known to get 
incorporated into the oxide during the fabrication process (Pedimonte et al., 2014a, O'Sullivan 
and Wood, 1970). Incorporated anions can potentially change the reactivity and surface charge 
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characteristics of the membranes which can be relevant depending upon the intended use of 
the membranes.  
2.5.1.3 Detachment of the porous film from the residual substrate 
Following the pore formation in the anodisation process, the alumina oxide is still covered by a 
barrier oxide layer on the residual aluminium sheet and needs to be detached in order to form a 
free-standing membrane (see step (iv) of Figure 2-15 A). The removal of residual aluminium is 
achieved by electrochemical etching in strong acids such as hydrochloric or perchloric acid 
under an operating voltage in the range of 1-5 V. Electrochemical etching will expose the U-
shaped pore bottoms formed by the barrier oxide layer. A wet chemical method is then used to 
open the pores. The method employs exposure of the bottom side of the anodised sheet in 
solutions of acids such as phosphoric acid, chromic acid and sulfuric acid (Sulka, 2008). The 
time required for opening of the pores can vary with the thickness of the barrier layer which 
depends upon the anodisation conditions (Zaraska et al., 2011). Usually, phosphoric, sulfuric 
and oxalic acids are preferred over malic, citric and tartaric acids as they form thinner barrier 
layers (Lee and Park, 2014).   
Lee and Park (2014) have given a comprehensive review of the anodisation process to 
synthesise porous anodic alumina templates including the chemical processes involved, kinetics 
and mechanisms of the pore formation and the fabrication of various pore geometries.  It should 
be noted that the above-described process for the fabrication of the PAA membranes differs 
significantly from the fabrication process used to prepare the polymeric membranes which 
involves polymerisation of the residue followed by a phase separation to form porous networks. 
 
2.5.2 Biotechnological applications of PAA membranes 
2.5.2.1 Biosensors 
A significant share of the reported literature on the applications of porous anodic alumina 
membranes is in the field of biosensors. Uniform pore size distribution and cylindrical geometry 
of the nanopores of PAA membranes enables accurate quantification of the transport of solutes 
and their interactions in pores. Label-free detection of viruses such as Ebola, Hepatitis B and 
Dengue virus  using specific virus DNA (Tsang et al., 2016, Deng and Toh, 2013, Chen et al., 
2016) and detection of viruses of different sizes through change in electric impedances across 
the pores (Chaturvedi et al., 2016) have been published. Capability to study drug-protein 
interactions by optical reflective spectroscopy (Nemati et al., 2016) and detection of biomarker 
enzymes on modified nanopores using the similar reflective technique (Nemati et al., 2015) 
have also been demonstrated. 
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These studies have stressed on PAA membranes as a template material for low-cost sensors to 
enable faster discovery of drugs by label-free studying drug-protein interactions and to develop 
faster and cheaper point-of-care systems for diagnosis of infections. The goal is to develop 
assays using simple detection methods such as measuring changes in electrical conductivity of 
the pores or optical rather than expensive and sophisticated methods such as ELISA or PCR 
based techniques which need labelling molecules such as antibodies and dyes. 
2.5.2.2 Bio-separations 
Limited applications of PAA membranes have been reported for use as a chromatography 
medium for bind and elute mode of separations. Functionalised PAA membranes have been 
demonstrated to be functionalised and used as affinity membranes for removal of bilirubin and 
haemoglobin from the blood (Shi et al., 2008, Shi et al., 2010). Highly ordered structure of the 
membrane is cited as a reason for the investigation of PAA membranes for affinity 
chromatography to achieve sharper breakthrough curves but these studies do not compare 
other critical performance parameters such as binding capacities with affinity membranes of 
different architecture. Yamashita et al., (2009) have demonstrated the use of unmodified PAA 
membranes for separation of nucleosides and nucleotides by the phosphate group of analytes 
interacting with the membrane material. Such interaction of the phosphate group with anodic 
alumina material has also been utilised to enrich phospho-peptides for mass spectrometry 
analysis (Wang et al., 2007). 
A majority of studies dealing with the application of PAA membranes in bioprocessing have 
dealt with filtration based processes. PAA membranes have been evaluated for haemodialysis 
application and were reported to have 2-3 times larger mass transport of small metabolites like 
urea compared to polymeric membranes and without loss of albumin protein (Attaluri et al., 
2009). Lee and Mattia (2013) had fabricated tubular PAA membranes of sub-20 nm pore 
diameters with asymmetric and symmetric pore geometry and characterised these membranes 
for BSA filtration. These tubular membranes were found to be highly retentive to BSA 
molecules, especially asymmetric membranes.  
Similarly, commercial PAA membranes with pore diameter rating of  20 nm (Anopore, Anotec) 
have been characterised for separations for proteins of different molecular weight (Pradanos et 
al., 1994, Pradanos et al., 1996). These experiments were however conducted at a very low 
transmembrane pressure of 0.05 bar and with cross flow present above the membrane surface. 
Protein with a molecular weight of 270 kDa was reported to be fully retained by the membranes, 
and cake filtration was found to be the mechanism of fouling by this protein. These experiments, 
however, did not explore the separation performance of the membrane, i.e. fractionation of the 
mixture of proteins.  
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Ultrathin anodic alumina membrane with 20 nm pore diameter has also been reported to be 
capable of high-resolution separation (selectivity of ~41) of similarly sized proteins, 
hemoglobulin and serum albumin through charge based mechanism (Osmanbeyoglu et al., 
2009). The experiment was however conducted with custom-made membranes and in the 
diffusion cell. Commercial membrane-based processes, however, are convection based instead 
of purely diffusive.   
Few studies have focused on PAA membranes for virus separations (Moon et al., 2009, Jeon et 
al., 2014). Moon et al., (2009) have reported higher transmission of bacteriophage empty 
capsids compared to mature capsids through a PAA membrane with pore sizes smaller than 
bacteriophage particles under centrifugal filtration setup. Observations were explained by the 
fragility of the empty capsids enabling them to squeeze through smaller nanopores. Authors, 
however, did not study the fouling and capacity of the membranes for such viral feed which will 
be highly relevant for process scale operations. Jeon et al., (2014) have used fabricated 
hierarchical PAA membranes with large support layer pores and smaller pores in the thin active 
layer for the enrichment of Hepatitis C virus (HCV) from cell culture and reported higher 
enrichment of infectious virus particles when compared to ultracentrifugation. Again, this study 
was also not comprehensive enough to investigate the filtration performance of PAA 
membranes. 
There are no reports published so far on the application of PAA membranes for the purification 
of viral vectors. It is clear that these membranes offer significant advantages because of their 
unique morphology. However, a majority of the reported applications of PAA membranes in 
literature did not use the experimental conditions similar to those present in membrane-based 
bioprocessing of protein biologics.   
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2.6 Challenges in studying viral vectors and the need for model systems 
Studying viral vectors for process development can be difficult due to a variety of factors 
 Stringent containment requirements (biosafety level 2 or above) to ensure appropriate 
personnel protection from genetically modified and infectious viral vectors  
 Longer production time (10-15 days) for mammalian cell cultures used to produce viruses 
and requirement of the aseptic environment throughout processing 
 Variable production titres in cell cultures for viruses and subsequent purification requirement 
 Costly raw materials such as serum used for cell culturing 
 Complex analytical requirements (Infectivity assay, TEM, NTA, PCR, ELISA etc.) 
These factors can be prohibitive for studying processes extensively as they tend to take a long 
time and consume a significant amount of the resources. Due to this, only a limited number of 
studies can be conducted in a defined time and space. Further, studies may require purified 
virus material to study the impact of viral particles without risk of the influence of other non-viral 
components originating from complex cell cultures. A model system for viral vector can be 
helpful for some of the studies. An ideal model system shares elemental composition and 
structural complexity of viral vectors, is easy to prepare in short period, Virus-like particles 
usually produced in genetically modified yeast-based expression systems can be used as 
model systems to bypass the requirement of stringent containment as they are not infectious. 
However, VLPs will need to be produced and purified from yeast cell cultures. Similarity, 
bacteriophages produced using bacterial cells also have similar limitations.  
Synthetic polymer nanobeads coated with proteins have also been used as model systems. An 
example of efficient use of protein conjugated latex nanobeads as viral mimic was published to 
assess the impact of protein particle size in binding capacity of monolith based chromatography 
support targetted for virus purification (Kalashnikova et al., 2007). Similar particles but with 
fluorescence tags have been used to study virus retention mechanism of virus removal filters 
used in biopharmaceutical manufacturing (Fallahianbijan et al., 2017). Gold nanoparticles have 
been used as virus mimic to study retention mechanism and pore structure of virus removal 
filters (Kosiol et al., 2017).  Brass et al.,(2000) have used inclusion bodies obtained from E.coli 
as surrogate particles for Adenovirus to explore the utility of aqueous two-phase partitioning in 
viral purifications. These studies show the utility of model particles in studying virus separations 
in various unit operations where particle size has a significant impact on the design and 
outcome of the process. In this study, the use of protein nanoparticles formed from the 
aggregation of protein is proposed as a mimic for virus particles. Further discussion on protein 
nanoparticles is done in the following section. 
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2.7 Protein nanoparticles 
Entities with dimensions in the range of 10 to 1000 nm, usually a complex assembly of 
molecules are classified as nanoparticles. Protein nanoparticles are biodegradable complexes 
synthesised from self-assembly of protein subunits of either single or a combination of multiple 
proteins. Synthesis of such protein nanoparticles involves the creation of conditions conducive 
to the self-assembly process followed by chemical modification to the assembled unit to achieve 
a stable and irreversible unit.  
2.7.1 Applications of protein nanoparticles 
Majority of the reported application of protein nanoparticles are as drug delivery vehicles 
because of their high drug loading capacity due to the high surface area, controlled drug release 
and improved circulation time in the body. Nanoparticles synthesised from human proteins such 
as serum albumin are preferred as drug carriers over conventional non-protein micro-particles 
made from synthetic polymer due to human proteins having low toxicity, low immunogenicity 
and high biodegradability. In fact, a commercial product based on albumin nanoparticles is 
already in the market (See Table 2-4 for more information).  
Other less extensively studied applications of protein nanoparticles are in the field of novel 
vaccines, as gene therapy vectors and for functional food.  Some of the reported studies are 
displayed in the table. For vaccines, protein nanoparticles have been used as antigen 
presenting surfaces to design multi-antigen vaccines. Such vaccines carrying multiple antigens 
offer protection against multiple diseases or multiple strains of a disease-causing pathogen thus 
providing comprehensive protection with a single product. Nanoparticles based vaccines also 
offer an alternative method of vaccine production which is less extensive and laborious than a 
traditional bioprocessing route involving the production of antigens through fermentation and 
subsequent purification.  
Protein nanoparticles have also been used as non-viral vectors for gene therapy but limited by 
lack of specificity and low transfection rates. Surface modification of DNA loaded protein 
nanoparticles has been tried to solve these issues. (Look et al., 2015, Steinhauser et al., 2008) 
Protein nanoparticles have also been used to create functional foods by using them as carrier 
systems for bioactive molecules such as vitamins and other metabolites for nutraceutical 
applications. Specific examples of these applications are outlined in the table. 
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Application area Remarks and examples 
Drug delivery 
vehicles 
 Non-toxic, low immunogenic, biodegradable carriers for small drug 
molecules (especially hydrophobic drugs) 
 Drugs such as paclitaxel (Celgene, 2015), doxorubicin (Dreis et al., 
2007, Thao le et al., 2016), cyclophosphamide (Gulfam et al., 
2012), cis-platin (Zhen et al., 2013) used for cancer treatment have 
been loaded on protein nanoparticles. 
 Specific organ targeting of drug conjugated nanoparticles by 
conjugating cell-penetrating peptides to cross the blood-brain 
barrier (Lin et al., 2016) or other cell-specific proteins (Thao le et 
al., 2016) 
 Marketed chemotherapy product ABRAXANE ®, paclitaxel-loaded 
130 nm albumin nanoparticle (Celgene, 2015) 
Vaccines 
 
 Nanoparticles as highly immunogenic particles due to high antigen 
density 
 Improved antigen response to nanoparticles formed with Thiolated 
protein (Pfs25M) antigen crosslinked to Maleimide modified protein 
(EPA) compared to antigen alone (Jones et al., 2016) 
 Multi-antigen vaccine (matrix proteins and H1 HA2, H3 HA2 
domains) for comprehensive protection from Influenza virus (Deng 
et al., 2017)  
Gene therapy 
vectors  
 Albumin nanoparticles with an antisense oligonucleotide against 
herpes simplex virus conjugated with trastuzumab to target breast 
cancer cells (Steinhauser et al., 2008) 
Functional 
foods/Nutraceuticals 
 Encapsulate hydrophobic metabolites and vitamins to increase their 
bioavailability through foods  
 Protein nanoparticles loaded with metabolites such as curcumin 
(Zou et al., 2016) and cholesterol reducing phytosterols (Cao et al., 
2016) 
 
Table 2-4 Examples of various applications of protein nanoparticles reported in the 
literature 
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2.7.2 Synthesis of protein nanoparticles 
Albumin has been the most common protein used in a number of studies studying the synthesis 
of protein nanoparticles (Galisteo-Gonzalez and Molina-Bolivar, 2014, Langer et al., 2008, Lin et 
al., 2016, Weber et al., 2000, Anhorn et al., 2008). Other proteins such as lactoglobulin (Arroyo-
Maya et al., 2014), casein (Zhen et al., 2013) and zein (Zou et al., 2016) have also been used.  
Most of the literature has used either of two major thermodynamic processes to synthesise the 
protein nanoparticles. These are emulsification and coacervation. Other methods such as 
chemical cross-linking of proteins have also been attempted especially for vaccine applications. 
1. Emulsification process 
Emulsification uses the addition of protein solution to the solution of oil and surfactant to form 
protein nanoparticles at the water-oil interface (Zhang and Zhong, 2009, Muller et al., 1996). A 
significant drawback of this method is the necessity to remove oil and surfactant from the final 
preparation using additional organic compounds. 
2. Coacervation process 
Coacervation employs controlled precipitation of the proteins in a defined aqueous solution by 
addition of a de-solvating agent which is usually a polar organic compound such as acetone and 
alcohol. Coacervation is a more commonly used method and unlike emulsification does not 
require the further addition of organic compounds to remove de-solvating agent.  
A possible mechanism of formation of the nanoparticles is explained on the basis of removal of 
hydration layer around protein upon addition of a de-solvating agent resulting in exposure of 
hydrophobic patches. Hydrophobic interaction among protein molecules in a crowded solution 
results in the formation of aggregates which act as nuclei for further growth. Coalescing of 
aggregated proteins to form large nanoparticle is favoured thermodynamically to reduce the 
high potential energy of the dehydrated protein and aggregates.  
This mechanism suggests a role of macromolecular crowding and the rate of transport of 
proteins to nuclei. Possibly this is the reason that most of the reported protocols have used high 
concentrations of protein in excess of 20 g/L and up to 100 g/L and a minimum of 25 g/L 
suggested by one report (Galisteo-Gonzalez and Molina-Bolivar, 2014). It is unclear if the 
presence of nuclei such protein aggregates in the initial solution has any effect of initiation of the 
process or not. The same report also suggests that nucleation and subsequent growth of the 
nuclei is a delicate balance between various factors. Nucleation rate will increase with an 
increase in supersaturation of the solution but decrease with increased collision rate. High 
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concentration protein solutions have increased viscosity and reduced diffusion which will act to 
reduce collision, but crowded protein solutes due to such a supersaturated solution will have 
increased probability to collide. The growth of nuclei is favoured by increased collision rate thus 
resulting in larger particles. Increasing the temperature from 15 to 35 °C increased the particle 
size which was attributed to increased particle collision due to reduced viscosity and reduced 
supersaturation resulting in growth of nuclei.  
Controlling the rate of addition of de-solvating agent has been emphasised as effective control 
of particle size distribution in final preparations by allowing sufficient time for mixing thus 
preventing high local concentrations of a de-solvating agent, which can result in uncontrolled 
aggregation (Paik et al., 2013). Mixing of de-solvating agent would also be crucial to control 
local concentrations. Effect of stirring rate has been reported insignificant above a minimum 
stirring rate which is essential to decrease local concentration of de-solvating agent and 
possibly fragment large aggregates into smaller nanoparticles (Storp et al., 2012). 
 
 
 
Proteins being charged molecules are affected by the ionic environment around them. The 
magnitude of the charge on protein solute affects their molecular motion and interactions due to 
electrostatic repulsion. Increasing salt concentration and using pH near protein isoelectric points 
Figure 2-16 Pictorial representation of the possible mechanism of formation of 
nanoparticles of proteins using de-solvation method and factor influencing the 
mechanism listed in the boxes below. 
  
 [71]    
have been consistently reported to increase aggregation and result in the larger size of 
nanoparticles (Galisteo-Gonzalez and Molina-Bolivar, 2014). Buffer solutions are usually 
avoided due to interferences of buffer components in the cross-linking process and formation of 
large aggregates (Langer et al., 2003).  
The choice of the de-solvating agent and their composition such as a mixture of acetone and 
ethanol or methanol has been reported to affect the particle size distributions significantly. A 
correlation between the dielectric constant of the de-solvating agent, and final particle size has 
been reported (Storp et al., 2012). Authors advocated the use of de-solvating agents with high 
dielectric constant such as methanol to achieve monodisperse preparations with small 
nanoparticles and attributed it to more controlled and slower dehydration. Nanoparticles formed 
after de-solvation are often cross-linked to form irreversible particles using crosslinker 
molecules such as glutaraldehyde. Crosslinker amount is determined by calculation of the 
number of the binding group present on the total amount of protein used. 
 
2.7.3 Stability of protein nanoparticles 
Stability of protein nanoparticles would influence their utility in a variety of applications. Protein 
nanoparticles because of their high charge density and large surface area are less prone to 
aggregation and sedimentation due to large repulsive forces and thus are reported to form 
stable protein solutions. Albumin nanoparticles have been reported to be stable after two 
months of storage at 4°C (Galisteo-Gonzalez and Molina-Bolivar, 2014) and could also be 
easily re-suspended to a dispersed solution with original particle size distribution from settled 
solution over an extended period of storage (Jun et al., 2011). Use of appropriate storage buffer 
solution should be studied for storage of protein nanoparticles since the surface charge can 
change with the solution pH and ionic strength.  
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CHAPTER 3 PREPARATION AND 
CHARACTERISATION OF BSA PROTEIN 
NANOPARTICLES AS A MIMIC OF VIRUS 
PARTICLES 
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3.1 Objective of the chapter 
Purpose of this chapter is to screen various protocols available in the literature for the 
preparation of protein nanoparticles by desolvation method. The rationale of the work is the 
necessity to establish a repeatable protocol for nanoparticle preparations for various studies for 
objective 2 and 3. A variety of protocols are reported in the literature with different particle size 
and distributions and different proteins used. Since there is no clear understanding or modelling 
of the processes involved in the synthesis of nanoparticles, it is imperative that available 
protocols must be trial tested and appropriately adjusted for a targeted specification of 
nanoparticle solution. Filtrations studies proposed for objective 2 and 3 intend to compare 
different membranes for the separation of viruses like Adenovirus and adeno-associated virus, 
which are sub 100 nm particles. So the target size for the nanoparticle preparation is 100 nm or 
below. Protein nanoparticles preparations also need to be thoroughly characterised for any 
potential differences from the constituent protein which might affect their stability and utility in 
future experiments. 
 
3.2 Introduction 
Virus processing studies require the viral material which is laborious to generate due to the 
requirement of aseptic conditions for mammalian cell culture and subsequent purification 
activity, not to mention a burden of analytical tools (such as electron microscopy, infectivity 
assays, real-time PCR etc.) needed to estimate the amount of virus. Long production times in 
mammalian cell cultures (typically 1-2 weeks) along with variability of final titres present 
additional challenges to process development studies. Testing a new product for virus 
processing, such as new chromatography resins or ultrafiltration membranes, would require a 
significant amount of virus feed to characterise various variants of products as well as a variety 
of the processing conditions. Such testing is carried out to find the best-operating conditions for 
the product and also to draw specifications, guidelines and application notes for end users. 
On the other hand, in a process development program for virus-based therapy, there may be a 
necessity to choose the best suitable commercial product from a range of products available.  In 
such scenarios, usually, the goal is to screen a variety of materials (such as resins or 
membranes) and a variety of process conditions (such as flow rate, flux, transmembrane 
pressure etc.). In such scenario, a material which is a mimic to viral particles in fundamental 
physical and chemical properties could help to achieve these goals in the shortest time frame 
possible and using simplest analytical tools compared to generating and using the viral material. 
This means an ideal mimic would be a nanoparticle with protein surface and nucleic acid core 
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but which can be synthesised in a reasonably good amount, preferably in excess of 10
12
 
particles per mL and in a much smaller time frame than that for virus production. 
Protein nanoparticles are nano-particulate materials in size range of 10 to 1000 nm dimensions, 
synthesised by inducing and controlling the self-assembly phenomenon in proteins molecules. 
Through careful manipulation of the operating conditions nanoparticles as small as 40 nm can 
be synthesised in monodisperse preparations. Viruses range from 20 nm to microns in size; 
however, viruses used gene therapy applications are usually in the range of 20 nm to 400 nm 
depending on the class of virus such as Adeno-associated virus (~ 22 nm), Adenovirus (~90 
nm) and Vaccinia virus (~300 nm). Protein-nanoparticle preparations in these size ranges could 
be used as a mimic for the virus capsids as both structures are proteinaceous in composition 
besides having similar size. Such nanoparticles have been used for various applications 
primarily for drug delivery for hydrophobic drugs (Lin et al., 2016, Thao le et al., 2016), 
functional foods (Zou et al., 2016) and gene therapy vehicles to carry nucleic acids (Steinhauser 
et al., 2008).  
Most commonly these protein nanoparticles have been synthesised using albumin and by 
controlled precipitation of albumin through the addition of a de-solvating agent which dehydrates 
the protein resulting in interactions among protein molecules. Controlling the process conditions 
during the procedure of preparation is very crucial to achieve targeted size characteristics of the 
final preparation. Usually, concentrated protein solutions in water with well-defined pH and salt 
concentration are used as starting material. Choice of the desolvating agent is also crucial for 
desired output. Formed nanoparticles are then cross-linked into irreversible nanoparticles, 
usually using glutaraldehyde. Protein nanoparticles synthesis is a short procedure generally 
lasting no more than a day, and minimum processing is required afterwards as the starting 
material is a purified protein. 
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3.2.1 Methodology used  
 
3.3 Materials and Methods 
3.3.1 Materials used 
Bovine serum albumin manufactured as the heat shock fraction at pH 7 with >98% purity 
(Product no. A706, Sigma-Aldrich, USA) was used for the synthesis of protein nanoparticles. 
HPLC grade ethanol, acetone and methanol (Fisher, UK) were used as de-solvating agents. 
Glutaraldehyde (P/N 340885; Sigma-Aldrich, USA) was used for cross-linking reaction. 
Phosphate buffer saline tablets (Gibco® P/N 18912-014; ThermoFisher Scientific, UK) were 
used to prepare the buffer for protein solutions.  A magnetic stirrer (Starlab, UK) was used for 
stirring during nanoparticle synthesis. A syringe pump (Aladin, World Precision Instruments, 
USA) was used for the controlled addition of de-solvating agents. A stirred cell filtration unit of 
25 mm diameter and 10mL capacity, Amicon 8010 (Millipore EMD, USA) was used for filtration 
studies with 25 mm diameter commercial PAA membrane discs of 0.1 µm rating, AnodiscTM (GE 
Healthcare, UK). For virus related experiments, T75 (75 cm
2
 tissue culture flasks with sterile 
filter caps), HYPERFlask M (1720 cm
2
 tissue culture flasks) and 96 well tissue culture plates 
(Nunc) were obtained from Corning Inc., USA. Fetal bovine serum and Dulbecco’s PBS (without 
Ca and Mg) were obtained from Sigma Aldrich, USA. Dulbecco’s Modified Eagle’s Medium 
(DMEM with Pyruvate and without glutamine), L-glutamine and antibiotics Pen-Strep were 
purchased from Gibco, Thermo-Scientific, UK. 
Figure 3-1 Methodology followed for the preparation of BSA nanoparticles for 
subsequent use as a model solute for adenovirus particles (70-100 nm).  
Protocols reported in literature were screened for reproducibility. The best reproducible 
protocol was studied further for repeatability of the method. Obtained nanoparticle 
preparations were then characterised for size, charge, absorbance, shape and stability. 
Filtration curves obtained for filtration of 80 nm protein nanoparticles solution and 
adenovirus feed, both containing similar number of particles were compared to assess 
suitability of protein nanoparticles as model system. 
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3.3.2 Methods for preparation of protein nanoparticles 
Three protocols were selected from three different literatures describing the preparation of 
serum albumin nanoparticles. Conditions described for a target diameter of 100 nm or below 
were used from respective literature. Details of the three protocols (also summarised in Table 3-
1 are as follows: 
 Method A (adapted from  Jun et al., (2011)) 
BSA solution of 1 % w/v (10 g/L) was prepared in distilled water and pH of the solution was 
adjusted to 9.0 using 1 M NaOH. The solution was stirred overnight at 500 rpm to allow 
complete hydration and was subsequently filtered through a 0.22 µm PES filter. The pure 
acetone solution was added continuously using a syringe pump to 50 mL of the BSA solution 
under stirring speed of 500 rpm until the solution started turning turbid. The flow rate of acetone 
addition was maintained at 1 mL/min. Upon observing the turbidity, 100 µL of 4% (v/v) 
glutaraldehyde solution was added to the protein solution and solution was left under stirring 
conditions for another 3 hours. Preparations were diluted in water and size distribution was 
measured. 
 Method B (adapted from Paik et al., (2013)) 
BSA solution of 1 % w/v (10 g/L) was prepared in distilled water and was allowed to hydrate 
entirely by stirring at 700 rpm for 1hour. The solution was then filtered using 0.22 µm PES filter 
after adjusting the pH to 9.0 using 1M NaOH. For de-solvating, ethanol (98%) solution was 
added intermittently at 1 mL/min flow rate to 50 mL of BSA solution under stirring conditions 
(500 rpm). Each 1 mL addition of ethanol was followed by 5 minutes of stirring without any 
ethanol addition. The intermittent addition was repeated until protein solution became turbid. 
The turbidity of the protein solution was tracked by measuring absorbance at 545 nm, after the 
end of each 1 mL addition of ethanol to be able to correlate the outcomes with what was 
reported in the original method. At the appearance of turbidity 200 µL of 4 % (v/v) 
glutaraldehyde solution was added to the solution and solution was stirred for another 2 hours. 
 Method C (adapted from Storp et al. (2012)) 
BSA solution of 10 % w/v (100 g/L) was prepared in 10 mM NaCl solution, and pH of the 
solution was adjusted to 8.0. The solution was then filtered through a 0.22 µm PES filter. 
Precipitation was carried out by addition of a mixture of methanol and ethanol (70:30 in %v/v) at 
1 mL/min flow rate to 1 mL of concentrated protein solution. The solution was stirred at 500 rpm 
through the procedure. Glass beaker of defined dimension (diameter 25 mm; height 60 mm) 
was used along with a magnetic stirrer bar (diameter of 6 mm; length 20 mm) as similar 
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dimensions were described in the referenced literature. After observing turbidity, 60 µL of 8 % 
(v/v) glutaraldehyde solution was added to the solution and solution was stirred for a minimum 
of 2 hours or overnight. Targeted size in this protocol was 60 nm as per the referenced 
literature. Since method A and B used BSA solutions without any NaCl in them, method C was 
further modified and repeated without NaCl in the protein solution. 
 
Method A Method B Method C 
Initial BSA 
concentration.  (g/L) 
10 100 
Volume of protein 
solution (mL) 
Unspecified (50 mL) 1 mL 
Solvent Deionized water, pH 9.0 
10mM NaCl, 
pH 8.0 
De-solvating agent Acetone Ethanol Methanol + Ethanol 
Rate of addition 1 mL/min 
Mode of addition Continuous Intermittent Continuous 
Stirring speed 500 rpm 700 rpm 500 rpm 
Temperature Room temperature 
Vessel 250 mL beaker 250 mL beaker 50 mL beaker 
 
Table 3-1 Process conditions for various methods screened for albumin nanoparticles 
preparation.  Method A, B and C were adopted from Jun et al., (2011), Paik et al., (2013) 
and Storp et al., (2012) respectively. 
3.3.3 Particle size characterisation using Dynamic light scattering (DLS) and 
Nanoparticle tracking analysis (NTA) 
For DLS, protein nanoparticles were appropriately diluted (usually 30-40 times diluted to a 
concentration of 1 mg/mL) in phosphate buffer saline, pH 7.0 and were analysed using 
Zetasizer NS (Malvern, UK) for estimation of particle size distribution. Disposable polystyrene 
cuvettes (1.5 mL) were used.  Preparations were equilibrated at 22°C for 90 seconds and light 
scattering data was collected using a laser of 633 nm wavelength at backscattering angle (173°) 
with auto settings for optimum location and attenuation. Usually, the attenuation factor of 6 to 10 
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and photon scattering rate of 150 kcps and above was considered as reliable for analysis. 
Instrument calibration was tested using 50 nm polystyrene nano-spheres (3050A, 
ThermoScientific, USA) NIST standards. Three runs were performed on each sample.   
 DLS measures the fluctuation of the scattered light over time and correlates the decay rate of 
initial scattering intensity to the Brownian motion of the particles by calculating the diffusivity 
(Carvalho et al., 2018). Size of the particles is obtained from the estimated diffusivity values 
using the Stokes-Einstein equation assuming a spherical shape for the particles and using 
viscosity values for the solvent used (Kato, 2018). This analysis is automatically performed by 
the Zetasizer software and presented in form of a size distribution plot, mean particle diameter 
value and poly-dispersity index (PDI). Size distribution plot is usually presented in form of 
particle size as x-axis and % relative intensity of scattered light as the y-axis. The plot can also 
be transformed into % relative volume by converting the intensity distribution into volume 
distribution for spherical particles. The mean particle diameter is measured in form of intensity-
weighted value, also known as Z-avg value and can also be measured in form volume weighted 
mean. The polydispersity index (PDI), which is an indication of the spread of the distribution of 
the particle size, is calculated from cumulant analysis by a standard method and can range from 
0 to 1 for a sample. Samples with a PDI value below 0.2 are considered to be monodisperse i.e. 
with a narrow particle size distribution.    
Nanoparticle tracking analysis (NTA) was also carried on protein nanoparticles and Adenovirus 
rich preparations using PBS buffer as diluent. Nanosight LM10 (Malvern, UK) with 532 nm laser 
was used for NTA measurements. A minimum of 3 and maximum of 5 measurements, each of 
60 seconds was obtained for each sample, and proper detection limits were applied to analyse 
the raw data using the software provided with the machine. NTA also utilises light scattering by 
suspended particles but measures the Brownian motion i.e. mean free path by tracking the 
movement of scattering centre of each particle in the solution by analysing the video recordings 
of the illuminated sample obtained using a digital optical microscope. In this way, NTA can 
measure the number of particles in the sample along with particle size distribution, which is an 
advantage over DLS (Malloy, 2011). 
 
3.3.4 Estimation of the yield of nanoparticles 
The yield of nanoparticles was indirectly determined by measuring the amount of residual 
unmodified BSA in the final nanoparticle preparation.  Protein-nanoparticle preparation was 
diluted using PBS, and 100 µL of diluted preparation was manually injected on to size exclusion 
column, Superose 6/12 300 (24 mL column volume). The column was pre-equilibrated using 
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PBS for 4-5 column volumes at 0.5 mL/min flow rate. BSA solutions of various concentrations 
were also injected into the column to obtain a standard calibration curve for BSA by measuring 
peak area at elution volume characteristic to BSA size. Amount of residual protein in diluted 
nanoparticle preparations was calculated from peak area at an elution volume of corresponding 
to BSA standard and calibration plot obtained for BSA solution (see Appendix A2). Net residual 
amount of BSA was calculated by considering the dilution factor and the total volume of 
nanoparticle preparation obtained. The yield of the nanoparticles was created using formula as 
below: 
BSA nanoparticles yield(%) = 100 ∗  (
Total BSA used(mg) − Residual BSA (mg)
Total BSA used(mg)
) 
 
3.3.5 Zeta potential measurements 
Zeta potential of nanoparticle preparation was measured using Zetasizer NS (Malvern, UK).  
Nanoparticle preparations were diluted in 10 mM NaCl, and pH of the solution was adjusted 
using 1M solutions of HCl and NaOH. pH values in the range of 3-10 were tested. Preparations 
were carefully loaded onto disposable polystyrene cells with electrodes, avoiding any air 
bubbles. Loaded cells were then equilibrated at 22°C for two minutes before measurements 
were started. Quality parameters such as conductivity (less than 5 mS/cm) and attenuation 
(between 5 and 10) were monitored to ensure the accuracy of measurements obtained. Three 
measurements were obtained for each sample. Scattering data was processed using software, 
Zetasizer. Calibration of the instrument was tested using zeta potential standard (47mV rating) 
supplied by the instrument manufacturer. 
 
3.3.6 Analysis of the protein nanoparticles using Transmission Electron 
Microscopy (TEM) 
Preparation of the protein nanoparticles was diluted 100-fold using 20mM Tris buffer (pH 7.5) 
and was negatively stained using uranyl acetate solution.  The stained sample was spread onto 
a carbon grid with a mesh rating of 400 and was air-dried. The sample was then observed using 
a JEOL 1010 Transmission Electron Microscope (Jeol, MA, USA). Negative staining means that 
the sample or part of the sample would not be stained so would appear as a white feature in 
contrast to the surrounding black background.  
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3.3.7 Filtration studies to compare the filterability of protein-nanoparticle feed 
and Adenovirus feed  
Filtration study comparing flux decline of BSA nanoparticles feed and Adenovirus feed was 
carried out in a stirred cell filtration set up using 100 nm rated commercial PAA membranes. 
Monodisperse preparation of 80 nm BSA nanoparticles was used and Adenovirus rich feed was 
obtained from mammalian cell culture and further processing.   
 
3.3.7.1 Filtration set up 
A cylindrical stirred cell device (Millipore, Amicon 8010) with a maximum working capacity of 10 
mL and filter support area of 25 mm (as shown in Figure 3- 2) was used for this study. The 
device is equipped with a magnetic stirrer bar to provide tangential flow to the feed above the 
membrane surface. Filter support plate has distribution channels embedded in the plate and 
leading to the filtrate output with elastomeric tubing. Tubing volume was determined to be 0.3 
mL. Membranes were wetted in water and mounted on to the filter support plate. The stirred cell 
was assembled as instructed by the manufacturer and filled with solution to be filtered with 
valve V2 closed (See Figure 3-3). The stirrer bar was carefully lowered into the cell by 
positioning the stirrer shaft in the centre and ensuring the stirrer bar is not pressed upon the 
membrane. The top plate of the stirred cell, connected to nitrogen supply was mounted on 
assembled stirred cell. Gas supply was turned on slowly by controlling gas flow using pressure 
regulator valve (V1) while gas relief valve (V3) on top plate kept open. After saturating the 
stirred cell with nitrogen gas relief valve on the top plate is closed.   
Stirring rate is adjusted followed by adjustment of the feed pressure through valve V1 to the 
desired pressure. The collection vessel is kept on weighing balance and balance is blanked to 
zero. Valve V2 on filtrate tubing is then opened, and the filtrate is collected into 20 mL 
polystyrene tubes kept on weighing balance. To ensure that set up is leak proof, connections 
were routinely checked for gas leakage using leak detection liquids. Trans-membrane pressure 
is calculated as the difference of the applied feed side pressure and pressure in the filtrate 
tubing. In the case of the stirred cell, the applied gas pressure measured at valve V1 is 
considered equal to the effective transmembrane pressure as filtrate side is at atmospheric 
pressure.  Pressure drop in the short filtrate line is assumed to be insignificant.  
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Stirred 
cell 
Stirrer 
Filtrate tubing 
Figure 3- 2 Amicon stirred cell (8010, 10 mL) used in this study. 
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Magnetic stirrer 
(0-1500 rpm) 
Nitrogen 
C
y
lin
d
e
r 
P 
V1 
V2 
V3 
Top plate 
Support 
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Figure 3-3 Illustration of the experimental setup for filtration studies using Amicon 
stirred cell device (8010, 10 mL). 
V and P denote valves and pressure readout respectively. Nitrogen gas is used to create 
positive pressure in the stirred cell after closing valve V2 and V3. Valve V2 is opened after 
auto-zeroing the weighting balance and measurements are manually entered from the readout. 
Filtrate line is primed with buffer before addition of feed to the stirred cell so that immediate 
readings can be noted down. 
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3.3.8 Adenovirus production and filtration   
Recombinant Adenovirus particles carrying the heterologous gene for enzyme ß-galactosidase 
were produced using adherent mammalian cell culture of Human Embryonic Kidney (HEK 293) 
cell line.  All experiments related to viruses were performed in a biosafety level-2 chamber.  
3.3.8.1 Mammalian cell culture 
Fetal bovine serum (FBS) was heat inactivated at 56°C for no more than 30 minutes. Growth 
media was prepared by addition of 50 mL of heat-inactivated FBS, 5 mL of L-glutamine and 5.5 
mL of antibiotic, Pen-Strep to 500 mL of DMEM media. HEK 293 cells were obtained from the 
European cell bank. Cells were cultured in tissue culture flasks with the treated surface. 
Cultures were incubated at 37°C at 5 % CO2 incubator and routinely passaged after 80-90% 
confluency is achieved. During passages, cells were washed with PBS and treated with trypsin 
solution for 2-3 minutes to allow detachment. Trypsin was inactivated by addition of growth 
media and cells were centrifuged down at 100x g for 5 minutes. The cell pellet was re-
suspended in fresh growth media and seeded in 75 cm
2  
tissue culture flasks. Cells were used 
for Adenovirus production in HYPERFlask culture vessels or infectivity assay after 5
th
 passage 
and no more than 20
th
 passage. 
3.3.8.2 Recombinant Adenovirus production using HEK293 cell lines 
Recombinant Adenovirus, serotype 5, genetically engineered to contain genes for enzyme ß-
galactosidase was produced using Human Embryonic Kidney cell line, HEK293. Cells were 
infected using a virus stock (10
9
 virus particles/mL) to a final concentration of ~3 x 10
5
 virus 
particles/mL in an HYPERFlask culture vessel. Cells were then incubated at 37°C at 5 % CO2 
incubator for five days. Cells were attached to a 500 mL capacity stacked tissue culture vessel, 
HYPERFlask with the treated surface. At the end of incubation, cells were observed to show the 
cytopathic effect (loosely bound to the vessel surface, round in the shape and smaller). 
3.3.8.3 Preparation of Adenovirus feed for filtration studies 
Infected cells loosely attached on the flask surface of HYPERFlask were detached by tapping 
the flask. Cells were then collected in 50 mL centrifugation tubes and centrifuges at 100xg for 5 
minutes. The supernatant was discarded and cells were re-suspended in fresh growth media 
(DMEM + FBS). Cells were then exposed to one freeze-thaw cycle and stored at -70°C until 
further use. Growth media was added to enhance the stability of the virus particles during the 
long-term storage and shield the virus from stresses in freeze-thaw cycles. Frozen cells/ cell 
debris were further treated to two more freeze-thaw cycles, and subsequently, a suspension 
containing cell debris was filtered through 0.45 µm PVDF filter. The filtrate was collected and 
stored at -70°C.  
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3.4 Results and Discussion 
3.4.1 Screening of the methods for synthesis of BSA nanoparticles 
Three protocols from different literature (for details refer to Table 3-1) were selected for 
screening under local laboratory conditions. Operating conditions used were similar to those 
described for the synthesis of 100 nm nanoparticles in the original literature except for method 
C where the target size of 60 nm was cited. 
Compared to target size, larger particle diameters were measured for preparations obtained 
through all the methods tested along with higher polydispersity (shown as polydispersity index, 
PDI) except for method C as displayed in Figure 3-5.  Preparations with a polydispersity index 
of 0.2 and above are considered to be polydisperse solutions signifying that diverse class of 
sizes are present in the samples. However, the difference between target and measured 
particle diameter was smallest for method C. Particle size distribution plot of these preparations 
show clear differences in mean size and polydispersity of preparations (See Figure 3-4).  
Method A, de-solvation using acetone, shows a variable particle size distribution even among 
repeat measurement of the same solution.  Method A was thus found to be not suitable for the 
intended application considering highly poly-disperse preparation and high particle size along 
with the requirement of removal of acetone which will otherwise interfere with protein 
measurements using 280 nm absorbance assays.  
Method B resulted in particles larger than targeted 100 nm particles and improved PDI over 
method A.  However repetition of this method performed differently with large aggregates 
formed. It was also observed that ethanol consumption was much lower than what was reported 
by the reference literature (Paik et al., 2013) possibly because of the differences in protein 
batches used in this study and authors.  
Method C was found to result in monodisperse preparation with mean particle size at 82 nm 
compared to 60 nm targeted as per reference. Method C resulted in highly monodisperse 
preparation (PDI < 0.1) and particle size distribution was highly consistent with repeated 
measurement. Large standard deviations in PDI and intensity weighted particle diameter were 
observed for method A and B as shown above in Table 3-2. Thus method C was selected for 
further studies. 
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Figure 3-4 Particle size distributions for BSA nanoparticle preparations 
synthesised using three different methods A, B and C.  
Samples were diluted with water to minimise interference due to de-solvating 
agents. Method A, B and C were adopted from Jun et al. (2011),Paik et al. (2013) 
and Storp et al. (2012) respectively. Triplicate measurements of each sample were 
carried out. 
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Figure 3-5 Nanoparticle diameter (bars) and polydispersity index, PDI (▲) of nanoparticle 
suspension prepared through three methods screened; Targeted size (○) is the diameter 
value published in the referenced literature.  
Bars and symbols represent the average value of the measured diameter and PDI for three 
consecutive measurements of the nanoparticle solution. Error bars represent one standard 
deviation obtained for three measurements.  
 
 
Method 
Target size 
(nm) 
Measured diameter 
(Intensity weighted) 
(nm) 
PDI 
A 100 219 ± 21 0.36 ± 0.03 
B 100 137 ± 5 0.25 ± 0.02 
C 60 83 ± 0.3 0.04  ± 0.004 
 
Table 3-2 Particle size distribution obtained through three methods of nanoparticles 
synthesis, i.e. Method A  (Jun et al., 2011), Method B (Paik et al., 2013) and Method C 
(Storp et al., 2012).   
Data displayed as average value ± one standard deviation for three measurements of the 
sample. 
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3.4.2 Manipulating nanoparticle size by varying the salt concentration in method 
C 
Use of salt and pH to control particle size has been well established (Paik et al., 2013, Langer et 
al., 2008, Galisteo-Gonzalez and Molina-Bolivar, 2014) and trends are consistent in most of the 
reported literature. A variation of method C where the protein was dissolved in plain distilled 
water without any salt addition instead of 10 mM NaCl solution resulted in significantly lower 
particle size as shown in Figure 3-6. 
 Use of salt concentration to control the size was selected over the use of pH as it provided a 
more reliable parameter to adjust compared to pH where variability between electrode to 
electrode and effect of ageing of pH electrodes could affect the repeatability of preparation. 
Using salt as ’size controlling agent’ does not have instrumentation risk except for the weighing 
of the salt and volume measurements. Salt helps to screen some of the charged groups on 
protein molecules thus reducing repulsion between molecules. Reduced repulsion increases the 
aggregation of protein molecules resulting in the formation of larger nuclei and hence larger 
nanoparticles. 
 
 
Figure 3-6 Volume based particle size distribution of  BSA solution and nanoparticle (NP) 
preparation obtained using method C (Storp et al., 2012) with varying concentration of 
NaCl (0 and 10 mM) in initial BSA solution.  
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3.4.3 Sources of variability in various methods screened 
All three methods screened used different operating conditions for multiple parameters as 
detailed in Table 3-1. Thus a direct correlation with differences in protocols to the differences 
observed for particle size distributions of final nanoparticle preparation is not possible this 
experiment. However potential sources of variation could be speculated on the basis of 
differences in methods.  A significant difference between the three methods was the de-
solvating agent used. Storp et al, (2012) have observed smaller particle size and monodisperse 
preparations with methanol as compared to ethanol and acetone. Methanol having higher 
dielectric constant (polarity) results in slower and more controlled de-solvation of protein 
molecules thus resulting in smaller nano-particulates of uniform sizes. Method C utilised a 
mixture of methanol and ethanol in the ratio of 70:30 and resulted in smaller and more 
monodisperse preparations than method A and B where acetone and ethanol were used 
respectively.  Nanoparticle size and polydispersity decreased in the order of method A > method 
B > method C whereas the polarity of solvent used in corresponding methods followed reverse 
trend i.e. highest polarity for methanol used in method C and lowest for acetone used in method 
A. High polarity of desolvating agent results in slower aggregation of protein thus minimising 
uncontrolled aggregation. This, however, does not explain why methods A and B could not be 
reproduced, unlike method C.  
Another critical distinction between method C and other two methods was the explicit detail of 
the vessel and stirrer dimensions provided by the referenced literature for method C. Original 
authors did not publish such details for method A and B. For method C, though the original 
literature (Storp et al., 2012) has reported no significant effect of the stirring rate above 500 rpm, 
it was suspected that mixing also plays  a role in particle size distribution of final preparations. 
To test this, method B was performed with three different vessel dimensions with rest of the 
conditions being constant; it was found that volume of ethanol required for the onset of turbidity 
increased for the vessel with broader diameter along with foaming observed in stirred protein 
solution (For details refer to Appendix B).  Vessel with dimension described by Storp et al., 
(2012) was found to result in a lower polydispersity of preparation compared to other two 
vessels. Vessel with broader base was found to result in preparation with a high polydispersity 
(> 0.3). It appears that choice of the vessel could significantly alter size characteristics of 
nanoparticle preparation which suggests a strong influence of mixing characteristics of setup. 
Poorly defined mixing conditions for a simple beaker and stirrer system limit the study into the 
role of mixing in nanoparticle formation. A detailed study based on fluid dynamics to 
characterise shear zones and dead volumes and the effect of shear on protein molecules could 
help explain these observations. However, such study is beyond the scope of this research 
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work. Other significant differences such as protein concentration, 100 g/L for method C 
compared to 10 g/L for the other two methods could also be influencing. 
The protein used itself could also be the source of variation. The protein used in these methods 
is bovine serum albumin. However, the commercial product used in this study and referenced 
literature are different. Manufacturing conditions, as well as final purity of lyophilised protein, 
may be different. In the case of method C, authors used human serum albumin, which though 
represents proteins with the same functionality but different sources and slightly different 
primary structure than bovine serum albumin. It is difficult to say how much of these changes 
impact toward non-reproducibility of these methods. BSA used in this study has been found to 
contain smaller protein aggregates (dimers and oligomers) when analysed using size exclusion 
chromatography (see Figure 3-9). It is possible that dimers and oligomers act as nucleation 
centres resulting in higher particle sizes than targeted. The composition of lyophilised protein 
material (such as impurity content, salt content and aggregates) has not been studied for its 
effect on protein nanoparticle synthesis.  
 
 
3.4.4 Effect of cross-linking duration on particle size 
Referred literature (Storp et al., 2012) for method C used overnight incubation during cross-
linking reaction. If a large amount of nanoparticles is to be generated, multiple reactions need to 
be set up thus smaller preparation time is strongly desired. Thus the minimum time required for 
cross-linking was investigated after which particle size distribution remains unchanged. With 
protocol C, particle size and PDI was tracked for 6 hours. Samples of 15 µL were taken 
immediately after addition of the crosslinker and then at 0.5, 2, 4 and 6 hours since the addition 
of the crosslinker. Samples were analysed using DLS within 15 minutes of collection time. 
Nanoparticle preparation was stirred at room temperature throughout the cross-linking process. 
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Figure 3-7 Effect of the cross-linking duration on particle size distribution (mean values 
of the particle diameter (▲) and PDI (∆)) of nanoparticles preparation obtained using 
method C. 
Error bars on particle diameter represent one standard deviation of the size distribution curve 
and one standard deviation of three measurements of the sample for PDI.   
It was found that particle size distribution parameters (mean diameter and PDI) did not change 
significantly beyond 0.5 hours (as seen in Figure 3-7). Cross-linking time of 0.5 hours was thus 
sufficient for cross-linking. Conservatively, cross-linking duration of 2 hours was selected for 
future experiments. Two hours was selected to allow sufficient time for all of BSA to be 
converted to nanoparticles, and this was confirmed by yield calculated using size exclusion 
chromatography as shown in Section 3.4.6. Cross-linking time has been reported to have no 
significant effect on nanoparticle size distribution (Galisteo-Gonzalez and Molina-Bolivar,2014). 
On the other hand, the amount of glutaraldehyde added does influence particle size if used in 
smaller quantities. However, the amount of glutaraldehyde used in this method was higher and 
sufficient enough for cross-linking of all amino groups available on total protein used. 
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3.4.5 Repeatability of the selected method 
It is essential that if method C is selected as a preferable method for generating nanoparticle 
material for filtration studies, it should be able to do so consistently. Thus, protocols for both 
preparations (for 50 and ~80 nm nanoparticles) were repeated four times to assess consistent 
performance. 
Figure 3-8 shows mean particle diameter and polydispersity index for four different batches 
both two variations of method C targeting final particle size of 50 and 80 nm indicated by 
legends A and B respectively. For a targeted particle size of 50 nm, particle diameter ranged 
between 50 to 60 nm, and polydispersity was also below 0.1 for all of the batches. A similar 
trend was observed for a target size of 80 nm, except for batch 3, all other batches yielded 
nanoparticles with a diameter in the range of 80 to 90 nm and polydispersity index below 0.1. 
Batch 3 for both sub-methods showed higher particle sizes than particles sizes observed for 
other batches. This could be the result of an unknown contaminant as batch 3 for both 
preparations were synthesised on the same day using same protein stock. Overall, method C 
could be used consistently for nanoparticles synthesis.  
 
Repeatability was not discussed in the original reference (Storp et al., 2012) and since the 
method used the continuous addition of the de-solvating agent, these results were contrary to 
observations made by other authors (Paik et al., 2013) where the continuous addition was 
reported to have poor repeatability. These authors, however, used ethanol or acetone as de-
solvating agents contrary to the mixture of ethanol and methanol used in method C. Lower 
polarity of the de-solvating mixture would mean slower dehydration of protein molecules by a 
de-solvating agent. Slower dehydration should result in the formation of smaller nuclei despite 
higher local concentrations of de-solvating agents upon continuous addition. Thus the use of 
methanol appears to be a significant factor in controlling the size distribution of nanoparticles by 
reducing undesired precipitation 
  
 [91]    
 
 
Figure 3-8 Repeatability of method C for the synthesis of BSA nanoparticles for 
consistent particle diameter (▲) and polydispersity index, PDI (∆) studied using four 
batches of nanoparticles prepared with the target sizes of 50 nm (A) and 80 nm (B) with 0 
and 10 mM NaCl in BSA solution respectively.  
Symbols represent the average value of the particle diameter and PDI and error bars represent 
one standard deviation for triplicate measurements of the samples. 
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3.4.6 Nanoparticle yield for the selected method 
An ideal method of synthesis is not only repeatable for consistent nanoparticle size distribution 
but also for its efficiency of converting BSA protein molecules into the nanoparticles. Method C 
was checked for the yield of nanoparticles by measuring the amount of residual unmodified BSA 
in final preparation using size exclusion chromatography (SEC) as described in the Section 
3.3.4 of the chapter. Three batches of protein nanoparticles for both 50 and 80 nm preparations 
were tested with SEC. SEC is the method of choice for such quantitation due to its ability to 
resolve between larger nanoparticles and smaller unmodified protein molecules. Due to large 
size, nanoparticles were expected to elute earlier near void volumes as opposed to unmodified 
protein eluting later. As shown in Figure 3-9, nanoparticles were found to elute at an elution 
volume of 5-7 mL irrespective of size and unmodified BSA eluted later between 11 to 17 mL. 
Gel filtration protein standard with thyroglobulin eluting at 11 mL further confirmed that 
nanoparticles eluted in the void volume of the column implying large size of the particles (refer 
to the chromatogram in Appendix A1). 
 
Chromatograms for these preparations (Figure 3-9, B and C) also show very small peak 
observed at retention time corresponding to unmodified BSA preparation indicating that most of 
the BSA molecules are aggregated into larger particles. Conversion percentage or yield of 
nanoparticles was calculated using the formula described in Section 3.3.4. Average yields of 
99.4 ± 0.8 % and 97.5 ± 1.8 % were calculated for 50 nm and 80 nm nanoparticles preparations 
respectively. These values are average of three batches for each size.  Results also validate 
that cross-linking duration of 2 hours is sufficient to achieve high conversion of protein into 
nanoparticles. It is important to recognise that conditions such as pH, salt concentrations as well 
as the amount of crosslinker added do influence the yield of nanoparticles (Galisteo-Gonzalez 
and Molina-Bolivar, 2014). These results could not be tallied with original reference as authors 
have not provided yield data. 
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Figure 3-9 Size exclusion chromatograms for unmodified BSA solution (A) and BSA 
nanoparticle preparations, (50 nm (B) and 80 nm (C)) obtained using method C (Storp et 
al., 2012)  
Superose 6 10/300 column (CV 25 mL, 13 µm average particle size) was equilibrated and 
injected with 100 µL of samples. Isocratic elution was carried out with PBS (~10mM phosphate 
buffer with 143 mM NaCl and pH 7.4). The overlay shows chromatograms obtained for three 
nanoparticle batches of similar size. Consistent chromatograms were obtained for three repeats 
for BSA nanoparticle synthesis using the selected method C. 
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3.4.7 Characterisation of BSA nanoparticle preparation 
It is essential to establish the means of measuring concentrations of the nanoparticles so that 
reproducible feeds could be prepared for future filtration experiments. Also, it should be ensured 
if such preparations are stable in the buffers used during filtrations along with long-term storage 
of nanoparticle samples.  
For measuring the concentration, particle detection techniques such as dynamic light scattering 
or nanoparticle tracking analysis could be used. Dynamic light scattering (DLS) is a qualitative 
technique as it can only give information about particle size distribution of a bulk sample by 
analysis of change in intensity of backscattering from the sample. Nanoparticle tracking analysis 
(NTA) is another scattering based technique which uses a high-performance camera to observe 
the random motion of particle by tracking the scattering on individual particles. NTA is 
quantitative techniques and counts the number of particles in a defined sample volume along 
with size distributions.  
However, NTA is a laborious technique as a single analysis cycle is around 10 minutes, and the 
sample chamber needs to be manually flushed after each repeat. Further, samples need to be 
diluted many folds before they can be analysed with NTA. A more convenient approach would 
be to use commonly used light absorption based protein quantification techniques for measuring 
nanoparticle concentrations in a sample as they are easier to perform and do not depend on 
sophisticated instrumentations unlike like DLS and NTA.  
3.4.7.1 Absorbance characterisation of BSA nanoparticle preparations 
Protein quantification for purified protein preparations is usually done by measuring absorbance 
at 280 nm where some amino acids are known to absorb light. BSA nanoparticles preparations 
in phosphate buffer saline were observed to have higher absorbance compared to BSA 
preparations of similar concentrations under similar conditions. Since most of the BSA was 
shown to get converted into nanoparticles, a nanoparticle preparation equivalent to 1 mg/mL of 
BSA was prepared by appropriately diluting nanoparticle preparation using mass balance 
calculations. Higher absorbance for nanoparticle preparation is the result of increased scattering 
by larger protein nanoparticles compared to much smaller BSA molecules. A visual inspection 
of nanoparticle preparation after synthesis against unmodified protein solution also shows high 
turbidity of the nanoparticle solution as can be seen in Figure 3-10. 
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Figure 3-10 Turbid BSA nanoparticles preparation (labelled NP) obtained after 
precipitation of 1 mL of 100 g/L unmodified BSA solution (labelled BSA) using a mixture 
of methanol and ethanol as de-solvating agent (prepared using method C).  
The mean particle size of the preparation was measured to be ~80 nm using DLS in contrast to 
~8 nm measured for BSA solution. The yellow colour of the preparation is the result of cross-
linking reaction using glutaraldehyde. 
The turbidity was quantified by measuring the absorbance of these preparations at 330 nm and 
545 nm where proteins do not absorb light. Nanoparticles preparations showed higher 
absorbance than BSA solution even at these wavelengths. Increase in absorbance compared to 
BSA solution was more pronounced with an increase in the size of nanoparticles (see in Figure 
3-11). The increase in absorbance at higher wavelengths is attributed to the dependence of 
scattering intensity on particle diameter by a power of 6 and increased ratio of the particle size 
particle and illuminating wavelength (Kato, 2018). Large particles would tend to scatter more 
and forward scattering is highly disproportional to size as particle size approaches light 
wavelength by the Mie theory (Tilley, 2011). The contribution of scattering in absorbance at 280 
nm is difficult to predict as there is a possibility of change in the local environment around amino 
acids groups when protein is de-solvated and converted into nanoparticles. It has been shown 
that protein secondary structure is significantly altered in protein nanoparticles (Arroyo-Maya et 
al., 2014).  
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Figure 3-11 Light absorption characteristics at 280, 330 and 545 nm wavelengths for 1 g/L 
preparations of protein-nanoparticle (NP) preparations obtained through method C and 
unmodified BSA preparation in PBS, pH 7.0.  
Error bars represent one standard deviation of absorbance measured for four protein 
preparations. Absorbance was measured using a quartz cuvette with 0.3 cm path length and 
Biomate 3S (ThermoScientific) spectrophotometer. High 330 nm absorbance for protein 
nanoparticles is likely due to increased scattering by the nanoparticles which also contributes to 
the net absorbance at 280nm. 
Solute 
Extinction coefficients at 280 nm  
(mL mg
-1
 cm
-1
) 
BSA 0.62 
BSA NP (50nm) 1.23 
BSA NP (80nm) 2.12 
Table 3-3 Extinction coefficients for BSA and BSA nanoparticles calculated from 
dilutions of 1 g/L solutions of respective solutes.  
Extinction coefficients (280 nm) for BSA and BSA nanoparticles preparation were calculated by 
measuring the absorbance of carefully diluted solutions of BSA nanoparticles. A strong 
dependence of the size of solute was observed with extinction coefficient for 50 nm preparation 
being ~1.7 times smaller than that of 80 nm preparation (See Table 3-3). 
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In some preparations, larger aggregates were formed and were eventually filtered out. Under 
such scenario, the mass balance equation could not be closed due to loss of the protein in large 
aggregates. This necessitated benchmarking filtered nanoparticle preparations against BSA 
solution based on a reliable criterion so that consistent feed of nanoparticles could be prepared. 
This was done by appropriately diluting the nanoparticles preparation to achieve a final 
absorbance at 280 nm equal to that of a solution of 1 g/L solution of unmodified BSA in the 
same buffer. This procedure avoids error-prone mass balance calculations against the use of a 
reliable spectrophotometer based reading to prepare appropriate dilutions. In similar particle 
size preparations, this method would likely result in feeds of similar particle titres if absorbance 
of 280 nm is similar. 
It is easier to prepare a BSA solution of 1 mg/mL due to the availability of commercial 
lyophilised BSA powder. However, BSA nanoparticles are in suspension after their synthesis, 
and there is no direct method of quantification of nanoparticles except particle titre using NTA. 
Protein quantification using BCA based colourimetric assay resulted in lower absorbance for 
BSA nanoparticles solutions than that for an unmodified BSA solution of similar concentration 
prepared by mass balance. BCA assay detects protein by binding of the reagents to specific 
groups on the protein. Assay signal depends on the presence and density of these dye binding 
groups on the protein surface.  Accessibility of these binding groups would decrease with a 
decrease in the total surface area of all protein molecules. Nanoparticle synthesis results in a 
decrease in this surface area as protein molecules aggregate to form larger particles. Reagent 
binding groups inside protein nanoparticles become inaccessible to the reagents thus resulting 
in lower signal output. 
 
3.4.7.2 Surface charge characterisation of BSA nanoparticles 
Proteins are charged molecules with multiple charge groups having different charge and 
valences. A sum of total surface charge results in a net charge on protein molecules which is 
affected by the ionic environment around proteins. The large size of protein nanoparticles 
increases their potential energy. Thermodynamically, such a system would attempt to reduce 
the surface area by collapsing into aggregates. However, the presence of charge on 
nanoparticles would result in a repulsive force to counterbalance aggregation. Thus aggregation 
of protein nanoparticles could be avoided by increasing repulsive forces among particles. This 
could be achieved by changing the pH of the solution.  
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Figure 3-12 Zeta potentials of protein nanoparticles (50 and 80 nm NP) and unmodified 
BSA measured at various solution pH in 10 mM NaCl solution showing a shift of 
isoelectric point  (pH where zeta potential = 0) of BSA nanoparticles to 5.2 from 4.8 for 
unmodified BSA.  Both protein nanoparticles were prepared using method C. 
Symbols and error bars represent mean values and one standard deviation respectively for 
three consecutive measurements of the sample at each pH value. 
It has been reported that secondary and tertiary structure of protein undergoes drastic changes 
during the de-solvation process for nanoparticle synthesis. Thus surface charge distribution of 
the protein nanoparticles can be different from constituent proteins. This implies that protein 
nanoparticles could have different isoelectric points compared to their protein subunits. 
Nanoparticle preparations were tested for zeta potential at different pH from pH 3 to 10 and 
were found to have higher zeta potential compared to BSA solution. Isoelectric point (pI) was 
observed to be shifted from ~4.8 for BSA to ~5.2 for BSA nanoparticles (See Figure 3-12). This 
shift is likely due to cross-linking of terminal amino groups by the glutaraldehyde. Size of 
protein-nanoparticle did not have a significant effect on zeta potential values at different pH and 
isoelectric point. The difference in isoelectric point is significant but is inconsequential for 
storage of the protein nanoparticles. Both BSA and BSA nanoparticles should not be stored 
within 0.5 pH unit above or below the isoelectric points.  Protein nanoparticles also showed 
higher zeta potentials than those of BSA at pH values away from isoelectric points. This could 
be attributed to the higher charge density of compact protein nanoparticles. 
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3.4.7.3 Stability of BSA nanoparticle preparation concerning storage temperature 
It is essential to further studies that a nanoparticle preparation should be stable in the buffer 
used for a longer period. Most of the filtration experiments will be done at room temperature 
with nanoparticle preparations exposed to room temperature for at least a few hours. Further 
nanoparticle preparations are intended to be stable in the buffer for a few days at 4-8 °C to 
allow further analysis. Figure 3-13 shows the change in particle diameter and polydispersity 
over the course of 72 hours (3 days) for storage at two temperature ranges. Intensity-weighted 
particle diameter, Z- avg was tracked as this parameter is highly sensitive to larger particles 
which may result from the aggregation of protein nanoparticles. Particle diameter and 
polydispersity index of preparation did not change significantly until 48 hours for preparations 
stored at 4-8°C. Compared to low temperature, particle size and polydispersity of preparations 
increased significantly after 24 hours of storage at room temperature. These changes, however, 
did not result from the aggregation of particles as the particle diameters increased by 
approximately 5 nm suggesting a change in nanoparticle density upon extended exposure to 
room temperature.  
 
 
Figure 3-13 Stability of BSA nanoparticles preparations (obtained through method C) for 
storage at 4-8°C (—) and room temperature, 20-22°C (----) represented as time profile of 
particle diameter (●) and polydispersity index, PDI (▲).  
Error bars represent one standard deviation around the average value for three measurements 
on the sample. 
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Presence of any significant fragmentation can also be ruled out from the observation of the 
polydispersity index in Figure 3-13 as PDI remained below 0.1 which is expected to increase as 
partial fragmentation would make the solution more polydisperse. Further other parameters 
such as derived count rate, which is the total number of scattered photons collected from 
samples, remained constant throughout the storage duration. Numbers of photons scattered are 
sensitive to the composition of the sample.  
Particle suspensions were also found to be stable for three months when stored at 4 °C   in a 
mixture of ethanol and methanol as obtained after de-solvation. Particle size distribution did not 
change significantly after such prolonged storage despite the presence of glutaraldehyde 
indicating a complete cross-linking during preparation as also indicated by high yields. Galisteo-
Gonzalez and Molina-Bolivar, (2014) have also reported no significant change in particle size 
distribution of preparations stored at 4 °C for as long as two months presumably after 
resuspension in water. 
 
3.4.7.4 Particle titre measurement using NTA and TEM analysis of BSA nanoparticles 
Particle size distributions and titres for nanoparticle preparation were measured by nanoparticle 
tracking analysis (NTA). A comparison of size distribution plots obtained through NTA and DLS, 
as shown in Figure 3-14, confirms similar size distribution for the nanoparticle preparations. 
NTA, however, shows a broader particle size distribution as it can track individual particles in 
real time while DLS deduces the particle size distribution from the bulk back-scattering 
characteristic of the solution. 
No large aggregates beyond 200 nm were detected by any of these two techniques confirming 
that the sample is monodisperse. Particle titre for the nanoparticle solution was measured in the 
range of 1.4 – 2.1 x 10
11 
particles/ mL of 1 g/L (BSA absorbance equivalent) nanoparticle 
solutions in PBS when three different nanoparticle preparations were tested. This confirms that 
benchmarking nanoparticle solutions against 280 nm absorbance (equivalent to BSA 
absorbance) for denoting concentration is a reliable method to prepare a nanoparticle solution 
of particle titre of the defined range. This range, however, will be applicable for fixed particle 
size as particle titres would increase for lower particle size and vice versa assuming that 
packing density of nanoparticles does not change with particle size. 
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Figure 3-14 Comparison of particle size distribution of an 80 nm nanoparticle preparation 
prepared using method C using two orthogonal techniques DLS and NTA.  
Both techniques showed similar particle size distributions and did not reveal any large 
aggregates.  
 
 
Figure 3-15 Analysis of 80 nm BSA nanoparticle preparation using Transmission Electron 
Microscopy after negative staining of nanoparticles indicated by white arrow.  
Scale bar represents 100 nm and images were obtained at ~200,000x magnification factors. 
Non-spherical but globular nanoparticles were obtained using the method used.  
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Both DLS and NTA do not offer any insights into particle shape so nanoparticles were visualised 
using transmission electron microscope (TEM). Nanoparticle preparation, diluted in water and 
stained using uranyl acetate solution, was imaged under transmission electron microscope. 
Figure 3-15 shows negatively stained nanoparticles. These nanoparticles are not perfectly 
spherical but rather a collection of smaller spherical nano-particulates which have dimensions 
around 20-50 nm. White spots are the grid artefacts.   
 
 
3.4.8 Filtration: comparison of Adenovirus and 80 nm BSA nanoparticles 
To investigate if nanoparticles could be used as a mimic for virus particles in purification 
studies, filterability of protein nanoparticles of 80 nm hydrodynamic diameter was performed 
using anodic alumina filters rated 100 nm for average pore size and compared with a similar 
experiment using partially purified Adenovirus feed. Similar stirring conditions were used using a 
stirred cell at 1000 rpm along with the same transmembrane pressure of 1 bar for both filtration 
experiments. Approximately similar filtrate volumes (7.5 - 8 mL) were collected for both 
nanoparticles as well as Adenovirus feed. Adenovirus feed showed lower filterability than 
nanoparticles which is likely due to the complex composition of Adenovirus feed.   
 
Adenovirus feed showed slower filtration as the average cumulative flux of ~37 LMH was 
observed for filtration of ~7.5 mL feed as compared to ~80 LMH observed for filtration of ~8 mL 
of nanoparticles solution. However, the flux decline for both feed showed similar decay curve as 
shown in Figure 3-16. Adenovirus feed was found to have 4.9 ± 0.22 x 10
10
 particles/mL as 
compared to 2.1 ± 0.1 x 10
11
 particles/mL in BSA nanoparticles feed. Transmission of BSA 
nanoparticles was slightly higher 3.1 ± 1.9 % (n=3) compared to that of Adenovirus particles 
1.5-2.2 ± 1.03 % (n=2). Lower flux for the Adenovirus feed could likely due to the fouling caused 
by particles with larger particle size as observed in the particle size distribution of the 
Adenovirus feed. 
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Figure 3-16 Comparison of filtrate flux (LMH) decline with filtrate volume (V) for 
Adenovirus feed (▲) and BSA nanoparticles feed (●) filtered through 2.83 cm
2
 of 100 nm 
rated commercial PAA membrane (Anodisc) in stirred cell filtration.  
Particle concentration of 10
10
-10
11
 per mL was used for both feeds. Similar processing 
conditions (feed volume of 10 mL, transmembrane pressure of 1 bar and stirring rate of 1000 
rpm) were used for both feeds. Error bars represent one standard deviation about the mean 
value of flux for triplicate filtration runs. 
 
Figure 3-17 Comparison of particle size distribution of diluted protein nanoparticles feed 
(A), and Adenovirus feed (B) measured using NTA shows complex nature of Adenovirus 
feed with a major peak at 100 nm (similar to BSA nanoparticle preparation).  
Both feeds were measured at 22-23°C and similar instrument setting. Grey bars represent one 
standard error about the mean (line) for 5 measurements of each sample. 
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Adenovirus feed is clarified supernatant obtained after cell disruption to release viruses. A 
centrifugation based clarification was used to remove debris. However, particles as large as 
300-500 nm were still present in the feed (see Figure 3-17). They could be aggregates of virus 
itself as well as finner cell debris.  Nanoparticles feed, however, showed narrower particle size 
distribution. 
Adenovirus feed also shows particle sizes smaller than 100 nm likely which could be other 
protein aggregates, fragments of virus particles or exosomes. As far as transmission is 
concerned, transmission of particles from Adenovirus feed was lower compared to 
nanoparticles likely due to higher fouling by Adenovirus feed. However, in the case of 
Adenovirus feed, total particle count was used for transmission calculations. A fairer comparison 
would be to use highly purified Adenovirus particles with a titre equal to nanoparticles. Thus 
nanoparticles should be used cautiously as virus mimics and for only studying trends such as 
transmission or flux decline not for predicting absolute values of parameters. 
 
3.4.9 Scale-up of BSA nanoparticle synthesis 
In order to produce large amounts of protein nanoparticles, increasing volume of BSA solution 
from 1 to 2-3 mL was investigated for method C. Simply increasing volume, however, was found 
to alter size distribution characteristics of the final preparation. Preparations were found to have 
a significant amount of large aggregates and bimodal distributions in some cases (for PSD 
plots refer to Appendix C).  In this study, synthesis was carried out at a smaller scale (1mL 
solution containing 100 mg BSA) with two preparations carried out simultaneously.  
Since preparation time is ~3 hours and each preparation can usually be diluted to approximately 
200 mL of the feed material with a titre of ~10
11
 particles/mL, sufficient nanoparticle preparation 
could be easily generated for small-scale experiments that were carried out in this research 
work. However, scale-up experiments do suggest that a simple volumetric scale up does not 
result in same particle size distributions as observed at smaller scales most likely due to altered 
mixing conditions. Thus, scale-up of nanoparticle synthesis needs to be studied in detail as it 
would be of crucial interest in various applications of protein nanoparticles such as therapeutics 
and food additives. Such a study, however, is not in the scope of this research work. 
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3.5 Conclusion 
The objective of the chapter was to synthesise albumin nanoparticles and characterise them for 
the use as a mimic of virus particles for further filtration studies. A method was developed to 
synthesise albumin nanoparticles from bovine serum albumin under local laboratory conditions 
by controlled precipitation of the protein using organic solvents followed by cross-linking using 
glutaraldehyde. It was found that by altering the salt concentration in the initial protein solution 
the mean particle diameter can be tuned. Mixing in the vessel appears to be crucial in 
determining the particle size distribution and polydispersity of the nanoparticle preparations as 
the same protocol yielded different particle size distribution in vessels of different dimensions. 
Duration of the cross-linking step beyond 0.5 hours did not have any significant effect on the 
particle size distribution of the nanoparticle preparations (Section 3.4.4). Cross-linking duration 
of the method was optimised and was reduced to 2 hours compared to 12 hours as mentioned 
in the original literature.  This resulted in a reduction of total preparation time to 3-4 hours 
without affecting the desired particle size distribution. Shorter preparation time is essential to 
generate a large amount of nanoparticle feed given that protocol was not found reproducible in 
a simple volumetric scale up (Section 3.4.9). The selected method was demonstrated to be 
repeatable by obtaining consistent particle size distribution and above 97% yield in four batches 
(Section 3.4.5). 
High scattering due to the large size of nanoparticles was found to artificially increase the 
absorbance at 280 nm wavelength which is commonly used for protein concentration 
measurement. A benchmarking approach was thus devised to prepare the nanoparticle solution 
by diluting to a final absorbance equivalent to the BSA solution of 1 g/L. Benchmarking with the 
absorbance of BSA solution was useful in accurate quantification of protein nanoparticles and in 
preparation of consistent feeds for a particular particle size (Section 3.4.7.1). Nanoparticle 
preparations were found to be stable in buffer solutions for up to a day in room temperature and 
2 days at 4°C to allow sufficient time for further analysis during filtration studies. Filterability of 
the nanoparticle preparation and Adenovirus feed was compared under similar processing 
conditions. Similar shape of flux decline curve was observed for both preparation, but 
membrane fouling was higher for Adenovirus feed possibly because of the polydisperse nature 
of the feed when compared to protein nanoparticles. The study shows the limitation of protein 
nanoparticles as a model mimic for viruses (Section 3.4.8). However, easy and economical 
production of protein nanoparticles makes them attractive models for preliminary experiments 
for a variety of studies targeted toward processing of large biomolecules such as viruses where 
morphology and biochemical characteristics of viruses could be ignored for initial developments 
such as screening of membranes for processing viral material. 
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CHAPTER 4 CHARACTERISATION OF POROUS 
ANODIC ALUMINA (PAA) MEMBRANES FOR 
FILTERABILITY OF PROTEIN SOLUTIONS OF 
SINGLE MODEL SOLUTES 
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4.1 Introduction and objective of the chapter 
Polymeric membranes dominate ultrafiltration unit operations in biopharmaceutical processing 
(van Reis and Zydney, 2007). There have been significant improvements in the membrane as 
well module design for these applications. Primarily these membranes have been employed for 
concentration and buffer exchange rather than high-resolution separations unlike other DSP unit 
operations such as chromatography. This is due to the low selectivity of the membranes likely 
because of the presence of larger pores as defects (Urase et al., 1994, Urase et al., 1996). 
Thus membranes with uniform pore size distributions such as track etched membrane and 
anodised alumina membrane are attractive candidates for high-resolution separations of 
biologicals. Further, polymeric membranes have one drawback that they have limited solvent 
resistance especially to cleaning agents such as acids and bases and cannot be autoclaved. 
Ceramic membranes such as metal oxide membranes have better acid/base resistance and 
heat resistance. Porous anodic alumina (PAA) membranes are ceramic and offer quasi-uniform 
pore size distributions thus present an opportunity to design a new generation of ultrafiltration 
processes. However, little is known about their MWCO ratings, their filtration performance and 
fouling characteristics with a biological feed especially in comparison to the polymeric 
membranes. 
The objective of this chapter is to screen commercial anodic alumina membranes of three 
different pore ratings for nanoparticles retention and subsequently compare selected 
membranes with commercial polymeric ultrafiltration membranes. PAA membranes are rated on 
the basis of pore size of the active side while polymeric UF membranes are usually rated by the 
molecular weight cut off (MWCO). The methodology used in this chapter is shown in Figure 4-1 
in the form of a flowchart. 
This chapter will attempt to answer the following questions: 
1. What is the pore size of the porous anodic alumina membrane potentially suitable for viral 
ultrafiltration? 
2. How do porous anodic alumina membranes compare to polymeric UF membranes when 
rated using a standard dextran retention test for ratings? 
3. How and if anodic alumina membranes differ in filtration performance and fouling 
susceptibility when compared to polymeric UF membranes? 
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4.1.1 Methodology used 
 
Figure 4-1 Schematics showing the methodology used and expected outcomes for 
objective 2 of the present work 
PAA membranes of three ratings (20,100 and 200 nm) were screened for filterability and 
retention of 80nm protein nanoparticles. The membrane with the highest normalised process 
flux for nanoparticle solution and highest retention was selected for further experiments 
including dextran sieving and filtration studies with model protein solutes. Selected PAA 
membrane was compared with polymeric ultrafiltration membranes of three different MWCO 
ratings on the basis of hydraulic permeability, dextran sieving curves and membrane 
morphology using electron microscopy. Selected PAA membrane and a polymeric membrane 
with similar permeability and dextran sieving characteristics were then compared for filterability 
of protein solutions of single model solutes. Three model solutes were selected by the size of 
impurity and viral vectors. Transmission of the model solutes and fouling mechanisms were 
compared for the two membrane types. 
Filtration studies with single component feeds of model protein 
solutes (Bovine serum albumin (BSA), Thyroglobulin (TG) and 
BSA nanoparticles (BSA NP))  
Transmission and fouling 
analysis 
Comparison of PAA and 
polymeric PES membrane 
Comparison of membrane architeture, hydraulic permeability 
and standard dextran sieving characterstics of the selected PAA 
membrane with different polymeric (PES) ultrafiltration 
membranes  
Selection of a comparable polymeric ultrafiltration membrane for 
protein filtration studies 
Screening of three pore ratings of PAA membrane (20, 100 and 
200 nm) for BSA nanoparticles retention 
Selection of a pore rating for further studies with maximum 
nanoparticles retention 
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4.1.2 Selection of the model protein solutes for filtration studies 
A viral feed is a complex mixture of solutes containing virus particles as product and impurities 
such as host cell proteins, fragments of virus capsids as well as viral and host cell nucleic acids. 
All solutes except nucleic acids are proteinaceous. Nucleic acids can be ignored for the 
simplification of the present filtration studies as nucleic acids are usually degraded into smaller 
fragments (<100 base pairs) using commercial nucleases added after clarification of viral feed. 
Thus, a viral feed can be simplified to contain proteinaceous viral particles and protein 
impurities such as host cell proteins. Adeno-associated virus (AAV) and Adenovirus (AdV) are 
the most commonly used viral vectors, and their hydrodynamic sizes are reported to be 20-26 
nm and 70-90 nm respectively (Burova and Loffe, 2005). Virus-like particles (VLPs) is another 
form of viral vectors and is reported to have dimensions in the range of 20 to 100 nm depending 
upon their composition. Thus, evaluation of ultrafiltration membranes for purification of AAV and 
AdV would necessitate two proteinaceous model solutes of two different sizes and another 
smaller proteinaceous solute to model as impurities or host cell proteins. For filtration studies, 
bovine serum albumin (BSA), bovine thyroglobulin (TG) and BSA nanoparticles were selected 
as model solutes representing smaller protein impurities or host cell proteins, AAV particles and 
AdV particles respectively. The basis of selection was average size either in terms of molecular 
weight or hydrodynamic size. Table 4-1 summarises the three model solutes used and the 
species of viral feed material they are intended to represent. The comparison is based on the 
size measurement of model solutes using DLS and the reported size of the major species 
encountered in the viral feed. BSA, to be used as model host cell impurity, is a monomeric 
protein of 67 kDa molecular weight. It has been reported that approximately 40 % of the host 
cell proteins produced in mammalian cell culture are in the range of 50-75 kDa molecular weight 
and more than 90% of all host cell proteins are within 25 to 100 kDa range with few proteins 
above 150 kDa (Jin et al., 2010). Given that BSA monomer has a molecular weight of 67 kDa 
and BSA preparation used was found to have a significant amount of high molecular weight 
components (possible dimers and trimers), BSA can be used as a model impurity solute. 
Further, mammalian cell cultures also utilise serum-based media where albumin is the most 
abundant protein. Also, BSA is available in large quantities in lyophilised form at relatively lower 
costs compared to other proteins such as antibodies. 
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Thyroglobulin, a 660 kDa protein, was measured to have a hydrodynamic diameter of ~21 nm, 
similar to smaller viral particles such as AAVs. Protein nanoparticles of hydrodynamic diameter 
of 75-90 nm were selected to represent larger virus particles such as Adenovirus which are 
reported to have similar hydrodynamic size. BSA preparation, on the other hand, was measured 
to have an average hydrodynamic diameter of 8.1 nm, much smaller than both thyroglobulin 
and nanoparticles. Another variable in selection was availability and cost of the model solute. 
Larger proteins such as IgM (~900 kDa) can also be used, but limited availability and the high 
cost of these antibodies can be prohibitive for their use in experiments consuming large 
quantities of the protein.  
Model solute for 
Reported particle 
diameter (nm) or 
molecular weight 
Model solute 
used 
Measured 
molecular weight 
or hydrodynamic 
diameter (nm) 
Impurities (HCP) 
(40% of HCPs) 
25-75 kDa 
 
(Jin et al., 2010) 
Bovine serum 
albumin (BSA) 
67kDa, ~8.1 nm 
Adeno associated 
virus (AAV) 
20-26 nm 
(Burova and Loffe, 
2005) 
Bovine  
thyroglobulin 
(TG) 
21 nm 
Adenovirus (AdV) 
70-90 nm 
(Burova and Loffe, 
2005) 
BSA  
nanoparticles 
(NP) 
74-90 nm 
Table 4-1 Comparison of the reported solute size for common viral vectors and host cell 
proteins with measured hydrodynamic size of the model solutes used for filtrations 
studies. Particle size distribution measured for three solutes are included in Appendix D. 
As all three model solutes have very close isoelectric points (in range of 4.6 to 5.1) the net 
surface charge (i.e. positive or negative) of the solutes at any given value of pH outside the 
above range will be same. Thus any effect of the surface charge could be ignored when 
comparing the filterability of different model solutes at a given pH value. Further, isoelectric 
points for Adenovirus and BSA protein nanoparticles were also closer at 4.7 and 5.0 
respectively thus making BSA nanoparticles a reliable model solute. A limitation for the use of 
these model solutes is that they are intended to be physical mimics of viral particles and do not 
imitate the structural complexity and shape of the virus capsid. Thus these solutes can only be 
used for preliminary studies where the mechanism of separation is dominated by the size 
exclusion and to a limited extent electrostatic but not due to bio-specificity. Thus, the use of 
these model solutes cannot be extended to chromatography except size exclusion.  
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4.2 Materials and methods 
4.2.1 Materials used 
Bovine serum albumin, BSA (heat shock fraction, pH 7, > 98% purity, (A706)) and Bovine 
thyroglobulin, TG (> 90% purity, (T1001)) were purchased from Sigma-Aldrich, USA. PAA 
membrane discs of 25 mm diameter, Anodisc
TM
 of three pore ratings, 20 (6809-6002), 100 
(6809-6012) and 200 nm (6809-6022) were procured from GE Healthcare, UK. Membrane discs 
of polymeric commercial ultrafiltration membranes, Biomax
®
 of 100(PBHK02510), 300 
(PBMK02510) and 500 kDa (PBVK02510) were obtained from EMD Millipore, MA, USA. Gel 
filtration protein standard (151-1901) from Biorad, CA, USA; Dextran from Leuconostoc sp, Mr 
1500,000 -2800,000 (D5376), Dextran Mr 450,000 -650,000 (31392) and Dextran Mr 40,000 
(31389) were procured from Sigma-Aldrich, Denmark while Dextran Mr 6,000 (31388) was 
obtained from Sigma-Aldrich, China. Gel permeation chromatography (GPC) grade dextran 
standards were purchased from Sigma-Aldrich, USA. Size exclusion columns (SEC), 
TSKgel3000SWXL (08541) and TSKgel5000PWXL (08023) were purchased from Tosho 
Biosciences GmBH, Germany. Size exclusion column, Bio SEC-5 (5190-2536) was obtained 
from Agilent, USA. 
4.2.2 Filtration runs with solutions of model protein solutes 
Filtration of the model protein solutes, BSA, TG and BSA nanoparticles was carried out in a 25 
mm stirred cell module. Filtration set up used in the study is thoroughly described in materials 
and method of Chapter 3 (Section 3.3.7.1). All solutions, including buffers and protein solutions, 
were prepared using deionised water obtained from MilliQ water purification systems (Millipore) 
and the solutions were also subsequently filtered using 0.22 µm rated low protein binding PES 
filters. Only BSA nanoparticle solutions were filtered using 0.45 µm rated PES filters. All protein 
solutions were prepared in phosphate buffer saline (PBS, pH 7.4). Protein solutions with solute 
concentrations of 1.0 mg/mL were prepared for BSA and BSA nanoparticles. For TG solution, 
the concentration of 0.2 mg/mL was used. All solutions were prepared at room temperature 
conditions (21-23°C). Filtration was carried out using 25 mm membrane discs for both PAA 
(Anodisc) and polymeric PES membranes (Biomax). Available membrane diameter for discs 
was, however, smaller than 25 mm due to the presence of an impermeable seal (1 mm 
thickness) to be placed on top of the membrane while assembling the stirred cell. PAA 
membrane disc also had a 3 mm wide circular polypropylene support ring thermally bonded to 
the active side of the membrane, thus reducing effective membrane diameter to 19 mm. Thus 
the active filtration area for PAA membranes was 2.83 cm
2
 compared to 4.15 cm
2
 for a 
polymeric membrane like Biomax. 
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Both membranes were rinsed before assembling into the stirred cell. PAA membranes were 
washed with 20% ethanol solution for 3-5 minutes. Polymeric membranes were rinsed as per 
manufacturer's instructions, for 1 hour using pre-filtered, deionised water to remove any 
preservatives used for dry storage of the membranes. After assembling into the stirred cell 
membranes were first flushed with 20 L/m
2
 of MilliQ water at different transmembrane pressures 
(in increasing order) to assess the hydraulic permeability. Subsequently, membranes were 
flushed with 20 L/m
2
 of the buffer solution at similar transmembrane pressure as to be used for 
protein filtration. Time taken for filtration of 20 L/m
2
 buffer was noted using a stopwatch and 
used to calculate the pre-filtration flux or initial buffer flux (Jo) for the clean membrane. While 
comparing two membrane types (PAA and PES), equal loading of protein solution (the volume 
of feed added per active filtration area, L/m
2
) were applied, and similar filtrate outputs (the 
volume of the filtrate collected per active filtration area, L/m
2
) were collected. Before loading 
protein solution into the stirred cell, any residual buffer solution was removed to avoid dilution of 
the protein solution. However, the buffer solution in the filtrate line was not removed to enable 
measurement of the filtration force (flow rate) for the initial period of the filtration. After filtration, 
the retentate solution was carefully aspirated out, stirred cell with the membrane and stirrer bar 
were rinsed with successive washes of 2, 5 and 5 mL of the buffer solution. Membranes were 
then flushed with the buffer solution as done before the protein filtration to measure the buffer 
fluxes after filtration. Recovery of the buffer permeability was calculated as a percentage of the 
initial buffer flux measured as post-filtration buffer flux at same transmembrane pressure. 
For most of the experiments, a pressure of 0.6 bar is used with a stirring rate of 1500 rpm 
unless stated otherwise. The filtrate was collected in tubes kept on weighing balance. Readings 
from weighing balance were manually noted down at regular intervals (30 seconds) during the 
filtration runs. Filtration volumes were deduced from weighting balance reading by the 
assumption of the uniform fluid density of 1 g/mL for all solutions. This assumption is valid 
considering the low concentration of proteins in solution. Filtrate, retentate and feed samples 
were analysed for protein concentrations.  
4.2.3 Dextran sieving characterisation of membranes 
Dextran feed solution was prepared from a mixture of four dextrans (6, 40, 450 and 2000 kDa) 
with each dextran at 1 g/L final concentration except 0.5 g/L for 2000 kDa dextran. The solution 
was prepared in 20mM phosphate buffer (pH 7.0). Approximately 20 L/m
2
 dextran feed solution 
was added to the stirred cell (10 mL capacity) with membranes mounted on the base of the 
stirred cell. This loading corresponded to 5.6 mL and 8.3 mL of feed solution for PAA and PES 
membranes respectively. The filtrate was recirculated to stirred cell through a tubing (Master 
flex, 1.6 x 500 mm) using a peristaltic pump (Watson Marlow 120U) as illustrated in Figure 4-2. 
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Figure 4-2 Illustration of the filtration set up for dextran sieving experiments. 
Stirring speed is set at maximum of 1500 rpm after addition of the dextran and then pump is 
switched on. Recirculation is carried out for 2 recycles of total feed volume. At the end of 
recirculation, pump is stopped and samples from both stirred cell (feed) and filtrate line were 
collected and injected onto to size exclusion column. Sample is collected from this end of the 
filtrate line. 
Filtrate flow rate was kept at 1.5-1.6 µm/s (5.5-5.8 LMH) by adjusting the pump rotation speed 
at 0.2 and 0.3 rpm for PAA (Anodisc) and PES (Biomax) membranes respectively. This was the 
minimum rotational speed for the pump. The filtrate was recirculated for 2 cycles (i.e. a total of 
40 L/m
2
 filtered through membranes) to ensure well steady state. This corresponded to 7.2 and 
6.8 hours of total filtration time for PAA and PES membranes respectively.  
Samples were collected from stirred cell and filtrate tubing at the end of 2 recirculation cycles. 
Samples were analysed using high-pressure size exclusion chromatography (HP-SEC) using 
TSKgelPW5000XL column (7.8 x 300 mm) operated at 0.3 mL/min in isocratic conditions using 
20 mM phosphate buffer at pH 7.0. Injection volume for both filtrate and feed sample was 100 
µL (<1 % of column volume). Since dextrans do not absorb any particular wavelength, diode 
array detector could not be used. Instead, refractive index detector (RID-20A, Shimadzu) was 
used to detect the dextrans. The column was well equilibrated using the same buffer for at least 
10 column volumes. Calibration was carried out by injecting solutions of monodisperse gel 
permeation chromatography or GPC grade dextran standard (T5, T12, T25, T50, T80, T120, 
T250, T450 and T660) prepared at 1 g/L concentration in the same buffer as mobile phase. The 
calibration plot was obtained by plotting peak retention times against specified peak molecular 
weight for the GPC grade dextran standards. The calibration plot was used to transform the 
time axis of chromatograms for samples into molecular weight. Sieving curves are then 
obtained by normalising chromatograms for the filtrate samples with that of the feed sample as 
shown in Figure 4-3 and the formula below the figure. 
 
Dextran 
feed 
Membrane 
Magnetic stirrer 
P 
Recirculation 
Peristaltic pump  
(0.2 -0.3 RPM) 
~ 5.5 LMH 
Filtrate 
  
 [114]    
 
Figure 4-3 Schematic for analysis of the chromatograms of the dextran feed and the 
filtrate obtained using size exclusion chromatography to calculate sieving values 
Sieving coefficient for a given molecular weight (MW) value of 𝑥 was calculated using the 
following formula 
𝑆𝑖𝑒𝑣𝑖𝑛𝑔 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡𝑥  =  
𝑆𝑖𝑔𝑛𝑎𝑙 𝑎𝑚𝑝𝑙𝑖𝑡𝑢𝑑𝑒 𝑓𝑜𝑟 𝐹𝑖𝑙𝑡𝑟𝑎𝑡𝑒 𝑎𝑡 𝑥 𝑀𝑊
𝑆𝑖𝑔𝑛𝑎𝑙 𝑎𝑚𝑝𝑙𝑖𝑡𝑢𝑑𝑒 𝑓𝑜𝑟 𝐹𝑒𝑒𝑑 𝑎𝑡 𝑥 𝑀𝑊
 
 
4.2.4 Scanning electron microscopy (SEM) of membranes 
Membranes were fixed on aluminium stubs (13 mm diameter) using adhesive carbon discs and 
sealed on edge with conductive silver paint. Samples were then dried overnight in a closed 
chamber with moisture absorber pellets. Both alumina and PES being non-conducting materials 
could not be observed directly under electron microscope due to strong charging effects. 
Hence, samples were sputter coated with Platinum using sputter coater (Cressington 108auto) 
for a coating cycle of 24 seconds under helium. The coating thickness of 0.4 nm was achieved 
in this cycle. Platinum coated samples were then mounted on the stage and observed under 
field emission SEM (Zeiss Gemini, Sigma) using a secondary electron detector (InLens 
detector) in vacuum conditions. Low gun voltages of 3-5 kV were used at working distances 
between 3-7 mm with an aperture size of 30 µm.  
4.2.5 Image analysis of SEM images for pore size distribution 
Images acquired using SEM were analysed using software Image J (NIH, USA).  Scale settings 
were fed into software by manually selecting the scale bar dimensions from raw images. 
Usually, 1.4 nanometres per pixel resolution was obtained for images of anodic alumina 
membranes obtained at 100,000-magnification factor. Images were then cropped to remove 
portions other than membrane features and normalised for enhanced contrast between pores 
and membrane wall.  Images are smoothened to remove any noise or blur and then segmented. 
Segmentation of image refers to identifying a feature of the image by locating pixels of that 
feature in grey scale histogram. Greyscale value is representative of the light intensity stored in 
a pixel from 0 (black) to 255 (white). Threshold adjustment is made to segregate pore spaces 
from pore walls as former were usually black while latter brighter in intensity. Segmented 
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images only have information about pore space and are represented as two-dimensional 
particles. These particles are then counted, annotated with a number and area of the particle is 
measured. The equivalent circular diameter of the pore is obtained from the area of the particle 
in the segmented image.  Debris (bright) on the membrane is recognised as the wall material 
and is not thus included as particles. Figure 4-4 illustrates the various steps used in the image 
analysis with an example of the steps performed on a PAA membrane. 
  
Figure 4-4 SEM image processing using Image J (NIH) software for evaluation of pore 
size distribution of membranes. 
Step A. Original image with scale bar, B. Image with threshold adjusted to identify pore walls 
C. Image with threshold adjusted to include pore area D. Segmented image showing only 
pores as 2D particles, E. Pores annotated by software after identification of boundaries and 
subsequently analysed for area of pores. F. Pore size distribution obtained post-processing G. 
Process flow diagram for image processing. 
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4.2.6 Curve fitting for identification of the fouling mechanisms 
Fouling mechanism for various protein filtrations runs was identified by fitting the experimental 
filtration data (initial buffer flux, filtrate volume and time) with well-established mathematical 
models (Bolton et al., 2006) for four fundamental mechanisms (standard blocking, complete 
blocking, intermediate blocking and cake filtrations). These models are discussed in detail along 
with their mathematical expressions in Chapter 2 (see Section 2.4.2.1.1 and Table 2-3). For 
analysis of the fits, curve fitting tool of software, OriginPro (OriginLab Corp, USA) was used. 
Curve fitting tool is supplied with the mathematical expression and experimental filtration data to 
perform iterative fitting by assessing the goodness of the fit. Curve fitting tool initialised the 
value of the output parameter (blocking constant, kx) and then predicts the values of volumes 
based on experimental time data. Residuals (the difference between predicted and 
experimental values of volume at same time point) of the volume-time curve are then squared 
and added to calculate the sum of the square of residuals (SSR). A least square algorithm 
known as chi-square minimisation is used to minimise the value of the chi-square (χ
2
). The 
value of the output parameter is iteratively adjusted using Levenberg-Marquardt (LM) algorithm. 
Experimental volume data was normalised with filtration area and converted to SI unit (m
3
/m
2
) 
for curve fitting. Initial buffer flux values in m/s units were used for input values of initial flux. 
Outputs from non-linear fittings were SSR, the adjusted regression coefficient (R
2
) and blocking 
constant. R
2
 and SSR values were used to compare fits with different mechanisms.  The ideal fit 
would have SSR value of 0 and an R
2 
value of 1. A mechanism where the best fit had highest 
R
2 
and lowest SSR values were considered as dominant mechanism. 
 
4.2.7 Estimation of protein transmission 
Protein transmission in the filtrate samples was estimated by analysing filtrate and feed samples 
using size exclusion chromatography. For BSA and TG, 50 µL of sample was injected onto a 
7.8 mm x 300 mm SEC column, TSKgel3000SWXL (Tosoh Biosciences GmBH) at 0.6 mL/min 
under isocratic conditions with PBS with Agilent 1260 Infinity HPLC system. For BSA 
nanoparticles, a 7.8 mm x 300 mm SEC column with larger pore sizes of 100 nm, BioSEC-5 
(Agilent, UK) was used with 20 µL sample injection and 0.6 mL/min flow rate under isocratic 
conditions with PBS. Protein transmission and recoveries were calculated by using peak areas 
per injected volume of the sample as equivalent concentrations.  Protein peaks were detected 
by measuring absorbance at 280 nm (characteristic absorption wavelength of some amino 
acids) or 214 nm (characteristic absorption wavelength of peptide bonds) using an inline UV 
detector. 
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4.3 Results and Discussion 
4.3.1 Screening of various pore ratings of commercial PAA membrane for 
filterability of BSA nanoparticle preparation 
Commercial PAA membrane, Anodisc is offered in three pore ratings viz. 20, 100 and 200 nm. 
These ratings refer to the nominal pore size of the thinner (<1 µm) active layer of the membrane 
supported by a thicker (~59 µm) layer of straight channel pores of larger diameter (~200 nm). 
These membranes would obviously have different filtration and retention properties for solutes. 
Three pore ratings were screened for filterability and retention of protein nanoparticles of ~90 
nm diameter. Selection of BSA nanoparticles, a model system for Adenovirus particles, to 
screen three pore ratings is appropriate as the goal of the present work is to evaluate PAA 
membranes for viral separations. Equal volume (8 mL) of 1 g/L protein nanoparticles (of ~ 90 
nm diameters) solution in PBS was filtered through membranes of three pore ratings at a trans-
membrane pressure of 1 bar (±0.1 bar assuming 10% error in the analogue readout) and stirring 
rate of 1000 rpm. TMP of 1 bar selected on the basis of values reported in literature relevant to 
virus ultrafiltration. Nanoparticle concentration in the feed, filtrate and retentate were measured 
using nanoparticles tracking analysis. Log removal values were then calculated for 
nanoparticles removal in the filtrate solutions. 
PAA membrane with 20 nm pore rating operated at higher steady-state flux percentage of 5% 
(process flux normalised to initial buffer flux through the membrane), compared to 100 and 200 
nm membranes where process fluxes declined to less than 1% of the respective initial buffer 
fluxes. The flux decline was not as prominent for the membrane with 20 nm pore rating as seen 
in Figure 4-5. This was likely due to the lower accessibility of pores in 20 nm rated membrane 
where the majority of pores will be much smaller than the dimension of nanoparticles (80-90 
nm). On the other hand, majority of pores in 100 and 200 nm membranes are likely to be in 
similar or larger size range as of nanoparticles size distribution thus increasing the chances of 
pore blockage by protein nanoparticles. Fouling susceptibility was also confirmed by 
comparison of recovery of buffer permeability (measured before and after the filtration) of the 
membrane for different pore ratings (Table 4-2). It was found that for 20 nm membrane 
approximately 22% of the permeability of the clean membrane could be recovered after the 
filtration of BSA nanoparticles. Recovery of the buffer permeability decreased with increase in 
the pore rating of the membrane with the 200 nm membrane being most fouled. The actual 
value of the average process flux was lower for 20 and 100 nm membrane compared to the 
200nm membrane. The high value of the process flux for 200 nm is due to the high porosity of 
the membrane and high permeability value resulting in very high initial flux. 
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Figure 4-5 Flux decline for the filtration of 80 nm BSA nanoparticles solutions through 
different pore ratings (20,100 and 200nm) of the PAA membranes. 
Fluxes were normalised by the initial buffer flux (Jo) for the respective membranes. BSA 
nanoparticles solutions (1 mg/mL) were filtered through membranes at 1 bar transmembrane 
pressure and stirring speed of 1000 rpm. Error bars represent one SD for three filtration runs 
using fresh membranes. 
Pore 
rating 
Process flux 
Permeability 
(before 
filtration) 
Permeability (after 
filtration) 
Recovered 
permeability 
 
LMH LMH/bar LMH/bar % 
20 nm 81 ± 0 2003 ± 18 430 ± 29 22 ± 2 
100 nm 81 ± 0 4897 ± 188 601 ± 144 12 ± 3 
200 nm 94 ± 1 6583 ± 193 512 ± 124 8 ± 2 
 
Table 4-2 Process flux, membrane permeability before and after filtrations and recovered 
permeability for different pore ratings after protein nanoparticle filtration (~28 L/m
2
) at 1 
bar pressure and 1000 rpm stirring (average values ± one SD for three filtration runs 
using fresh membranes) 
As shown in Table 4-2, average process flux for ~28 L/m
2
 filtrate output was highest for 200 nm 
rated membrane at ~94 LMH compared to ~80 LMH observed for both 20 and 100 nm rated 
membranes. Flux decay profiles were very similar for all three pore ratings. However, since the 
hydraulic permeability of different pore ratings is significantly different, it is more sensible to 
study normalised flux decay than absolute flux decay.  
0 5 10 15 20 25 30
0.00
0.05
0.10
0.15
0.20
0.25
0.30
0.35
N
o
rm
a
lis
e
d
 f
lu
x
 (
J
/J
o
)
Filtrate output (L/m
2
)
  PAA ratings
  20 nm
100 nm
200 nm
  
 [119]    
Transmission of the protein nanoparticles was also compared for different pore ratings. For virus 
filtrations, log removal values are often used to assess the ability of the membranes to remove 
virus particles from a virus-rich feed. Log removal values (LRVs) were obtained by negative log 
value of the ratio of BSA nanoparticles concentration in the filtrate to that in the feed solution as 
measured using nanoparticle tracking analysis. As expected, transmission of nanoparticles 
increased with pore ratings with 20 nm membrane capable of ~3 log removal as shown in 
Figure 4-6. Total protein recovery measured using 280 nm absorbance assay also showed the 
lowest transmission loss of protein nanoparticles with 20 nm rated PAA membranes. 
 
Figure 4-6 Log removal values (LRV, ▲)  for BSA nanoparticles in the filtrate collected 
through different pore ratings of PAA membranes and nanoparticles recovery (% of feed)  
in the retentate and filtrate at different pore ratings. 
Log removal values were calculated from particle titre values in the filtrates and feed solution as 
obtained using nanoparticle tracking analysis (NTA) and protein recovery was calculated on the 
basis of absorbance at 280 nm. Lot 1 of 20 nm rated PAA membrane (Anodisc) was used in this 
experiment. 
Analysis of protein recovery in the retentate (using A280 absorbance assay) showed 90 ± 2.5 % 
of the protein retained by 20 nm pore ratings as opposed to 87± 6 % for 100 nm and 86 ± 1 % 
for 200 nm membranes. Net recoveries for all three membranes were between 90 to 95 %.  
PAA membrane with 20 nm pore rating was thus selected for further experiments as it showed 
better filterability, low fouling susceptibility and highest retention among three pore ratings of 
PAA membranes.  
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4.3.2 Comparison of membrane morphology of 20 nm rated PAA membranes and 
polymeric PES ultrafiltration membranes of various MWCO ratings 
4.3.2.1 Comparison of the active layer surface of the membranes and pore size   
distribution obtained from image analysis 
Commercial PAA membrane (Anodisc, 20 nm rating) and commercial polymeric PES 
ultrafiltration membranes (Biomax, 100, 300 and 500 kDa) were compared using scanning 
electron microscopy. Surface images of the active layer side of the membranes show non-
uniform pore diameters, especially for 300 and 500 kDa polymeric membranes. Except for the 
100 kDa PES membrane, all of the membranes were found to be highly porous. PAA 
membrane exhibited smaller pores and more uniform pore sizes across the membrane surface 
(See Figure 4-7) 
 
Figure 4-7 SEM images of the active side surface of a PAA membrane rated 20 nm (A) 
and PES membranes rated 100 kDa (B), 300 kDa (C) and 500 kDa (D) obtained at a 
magnification factor of 50,000X using FE-SEM (Leica Sigma). Scale bar corresponds to 1 
µm distance.  
All the images were obtained using InLens detector (secondary electron detector) with 30 µm 
aperture, the gun voltage of 4-5 kV and a working distance of 3-7 mm. Commercial PAA 
membrane, PAA (Lot 1) and PES membrane (Biomax) were used. 
A B 
D C 
50,000X   50,000X 
50,000X 50,000X 
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Figure 4-8 Surface pore size distribution for the active layer of PAA membrane rated 20 
nm, and PES membranes rated 300 kDa and 500 kDa obtained by analysing SEM images. 
Histograms are plotted for the equivalent pore diameters obtained using bin size of 5, and best 
fitting distribution curve (black line) was applied. The plot on the lower right side shows the 
mean pore size and distribution standard deviation as obtained from descriptive statistical 
analysis of the histograms. 
Though the mean pore size for the 20 nm PAA and 300 kDa PES membranes were similar, the 
pore size distribution was narrower for 20 nm PAA membranes as highlighted by the lower 
value of the distribution standard deviation. However, distribution standard deviation, which is 
an indicator of the spread of the pore size values, was lowest for 20 nm rated PAA membrane 
with a value of 16.5 while values for 300 kDa and 500 kDa were calculated to be 28.8 and 71 
respectively (shown in Figure 4-8). Pore size distribution of 100 kDa membrane could not be 
determined due to the poor quality of SEM scan for this membrane as well as the presence of a 
very low number of pores.   
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4.3.2.1.1 Comparison of commercial PAA membrane with custom fabricated PAA 
membranes reported for virus separation studies 
It is apparent from Figure 4-9 that such custom-made membranes have different pore shape 
and narrower pore size distributions compared to the commercial product used in the present 
study. This could be because of the differences in fabrication method employed by the 
manufacturer and by research groups fabricating in-house. Apart from pore size distribution, 
pore morphology is also different. Membranes used in a majority of the reported literature have 
circular, or near circular pores, however, commercial PAA membranes show a variety of pore 
geometries with most of the pores being polygonal. 
 
 
 
  
  
  
B A 
C 
Figure 4-9 Comparison of the commercial PAA membrane used in the present study with 
reported in-house fabricated PAA membranes used in other viral separation studies.  
A. AAM (pore size ~23±2 nm) used by Jeon et al,(2014 ) for enrichment of HCV , B. AAM (pore 
size ~25±3 nm) used by Moon et al,(2009) for separation of empty and filled capsids of 
bacteriophages and C. commercial PAA (Anodisc) membranes rated 20 nm by manufacturer 
(used in this study). Figure A and B reprinted with permissions. 
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4.3.2.2 Comparison of membrane architecture across the membrane thickness 
Figure 4-10 SEM images of the membrane cross-sections of the PAA membrane rated 20 
nm (A, B), and PES membrane rated 300 kDa (C, D). 
The white arrow indicates the active side of the membrane. Different magnifications were used 
for the two different types of membranes. Magnified sections of membranes are represented in 
red boxes. 
Membrane morphology for polymeric ultrafiltration membrane and PAA membrane differs 
significantly across the membrane thickness. Both membranes are asymmetrical but different in 
tortuosity. Polymeric membranes show three distinct zones across the thickness exhibiting 
different porous structure as visible in Figure 4-10 (C and D). The thickness of the active layer 
is very small (<1 µm) for PAA membrane compared to 18 µm for the polymeric membrane. 
Interconnectivity of the pores is also higher for the polymeric membrane. Low interconnectivity 
of the PAA membrane makes them more susceptible to fouling by pore plugging. Loss of 
membrane permeability could be correlated to the extent of surface pore plugging for such 
membrane. The tortuous channel along with interconnected channels may likely foul internally. 
A B 
C D 
2,000X 25,000X 
600X 1,500X 
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Debris 
Defect 
4.3.2.3 Membrane defects and debris observed on 20 nm rated PAA membranes 
White amorphous structures were observed on top of the membrane surface for commercial 
PAA membranes (see Figure 4-11). This debris was confirmed to be aluminium oxide when 
observed for elemental analysis using energy dispersive X-ray spectroscopy (see Appendix E 
for the spectrum) and is likely the residual material left after chemical etching of oxidised porous 
structure from un-oxidised aluminium substrate. Distribution of debris across the membrane was 
uneven with some areas without any debris and some areas with abundant debris material.  
PAA membranes were found to have a large number of structural defects on the active side of 
the membrane. Defects can be as large as 2-3 μm in dimension can be observed as shown in 
Figure 4-11. In all of the defects observed the active layer of the membrane was absent, 
exposing the support layer of larger pore diameter but no through holes were ever observed. 
The frequency of these defects could not be observed with electron microscopy, which is only 
useful to observe smaller areas at sufficient resolutions. Further, these defects appear to be 
randomly distributed hence require scanning a large membrane area to calculate the accurate 
frequency of these defects and their contribution to membrane permeability. 
 
 
No such debris or defect was found to be on the surface of polymeric membranes thus 
confirming debris to be related to membranes. 
Figure 4-11 SEM image of the active surface of a PAA membrane showing defect (large 
area of peeled active layer exposing support layer of larger pores) and debris particles 
sitting on membrane surface. 
20,000X 
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4.3.3 Comparison of the hydraulic permeability of 20 nm rated PAA membrane 
and polymeric UF membranes of various MWCO ratings 
Hydraulic permeability of the membrane is strongly affected by pore size, bulk porosity, 
tortuosity and thickness of the membrane which is different for all the membranes.  
 
Figure 4-12 Comparison of the hydraulic permeability (LMH/bar) of 20 nm PAA 
membranes (Anodisc), and PES membranes (Biomax) of three MWCO ratings. 
Water (deionised, pre-filtered) flux data obtained at 22°C were obtained at different 
transmembrane pressures (TMP) for multiple membranes (n=3 for 100 and 500 kDa Biomax; 
n=9 for 20 nm PAA and 300 kDa PES). Linear fitting of the water flux and TMP data resulted in 
a regression coefficient of 0.99 and above. The slope of the data (in the table on the right) 
represents average hydraulic permeability. Error bars represent one standard deviation for 
multiple membrane discs. Lot#5 of PAA membrane was used for testing. 
The variability in hydraulic permeability within the membrane lot is very high for polymeric 
membranes as compared to PAA membrane even within the same lot of the membranes tested. 
This is evident from large standard deviation (36.5% relative to the average value of 
permeability) observed for 300 kDa PES membrane as opposed to smaller (5%) standard 
deviation calculated for the 20 nm PAA membrane. The variability was also lower for 100 kDa 
and 500 kDa membranes with %RSD value of 3 and 10 % respectively. However, compared to 
PAA and 300 kDa PES membranes average values were calculated with only three membrane 
samples for each of 100 and 300 kDa membranes. Thus variation values could be 
underrepresented by the data collected for these membranes.  
Hydraulic permeability of the PAA membrane (20 nm) was found to be higher than 100 and 300 
kDa rated PES membranes but lower than that of 500 kDa PES membrane. Hydraulic 
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permeability of 2045 ± 93 LMH/bar was observed for 20 nm PAA membranes while for 300 kDa 
PES membranes value was estimated to be 1752 ± 640 LMH/bar.  By hydraulic permeability, 20 
nm PAA membrane was found to be similar in performance to 300 kDa PES membranes. Thus 
300 kDa PES membranes were selected for comparison with 20 nm PAA membranes for 
filtration studies using protein solutes. Since PES membranes are marketed as high flux 
membranes, other commercial membranes were not considered.  
 
 
4.3.3.1 Lot-to-lot variations in 20 nm rated PAA membranes: Correlating hydraulic 
permeability and mean pore sizes for various membrane lots 
Since 20 nm rated PAA membranes were selected for further filtration studies, which resulted in 
the use of a large number of these membranes in this study. Ensuring the use of the same lot of 
the PAA membrane for all of the experiments done in this study was not feasible as often the 
same lot of membrane was not available from the suppliers on subsequent orders. Thus, six lots 
of PAA membranes used in this study were retroactively compared for their hydraulic 
permeability and pore size distributions. 
Surface images of the active layer of PAA membranes were obtained using SEM and analysed 
to measure the pore size distributions. Lot variations observed in the membrane morphology 
are significant as shown in the comparison of the pore size distributions obtained after analysis 
of the images of the active layer surface of the membranes. Only lot #1 was found to be closer 
to manufacturer-specified pore ratings for this product. Since lot#1 was used for initial screening 
experiment and resulted in 3-log removal value for BSA nanoparticle removal in the filtrate. It is 
expected that similar experiment with lots such as lot#6 would result in lower log values. Hence 
achieving high viral retention or removal using these PAA membranes would depend upon the 
lot characteristics. 
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Figure 4-13 Lot variations observed in the pore size distribution of the commercial 20 nm 
rated PAA membrane shown in histogram overlays of pore size distribution of different 
lots as observed by SEM image analysis and SEM images (right side) of two lots of the 
membranes obtained at same magnification factor (100,000X) showing different pore 
sizes. 
Mean pore size of these lots ranged from 26 to 60 nm along with variation in hydraulic 
permeability as shown in Table 4-3. Plotting mean pore diameter and hydraulic permeability 
suggested a linear correlation between the two parameters, though with a regression coefficient 
(R
2
) of 0.84 only. A strong correlation is indicated by a higher value of correlation usually above 
0.95. It is possible that accounting for the defect density (holes in the active layer) as shown 
previously, along with mean pore size could be used for a complete correlation. Calculation of 
such defect density is hindered by low scanning area of the electron microscopy. 
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 Nonetheless, a significant change in mean pore size can impact the sieving of solutes 
especially with size in the range of 10 to 100 nm.  
 
Lot 
No 
Hydraulic permeability 
(LMH/bar) 
Mean pore 
diameter (nm) 
Pore size 
Distribution SD 
(nm) 
#1 1540  ± 50 27  ± 2 10  ± 1 
#2   1820  ± 150 45  ± 5 15  ± 3 
#3 1570  ± 80 32  ± 4 14  ± 5 
#4  1930  ±100 55  ± 7 19  ± 6 
#5    2070  ± 100 49  ± 4 20  ± 2 
#6  2250  ± 50 60  ± 4 19  ± 6 
 
Table 4-3 Lot-to-lot variability in hydraulic permeability, mean pore diameter and pore 
size distribution standard deviation for 20 nm rated PAA membranes. 
Mean pore diameter represents the mean equivalent circular diameter of pores size distribution 
when a normal distribution is applied to the pore size histogram. Distribution SD represents 
standard deviation or spread of the applied normal distribution. (Values ± one SD, n=3). 
 
 
Figure 4-14 Linear correlation of the mean pore diameter measured using image analysis 
of SEM images and measured average hydraulic permeability of six different lots of the 
20 nm rated PAA membranes.  
Error bars represent standard deviations for measurements of three membrane samples for 
each lot. 
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4.3.4 Comparison of 20 nm rated PAA membranes and polymeric PES 
membranes of various MWCO ratings for dextran sieving characteristics 
Dextran sieving analysis has been commercially used as a reliable test for rating membranes on 
the basis of molecular weight cut off (MWCO) or normal molecular weight limit (NMWL). Both 
MWCO and NMWL are used alternatively to specify the molecular weight of solutes rejected by 
membranes at a defined level or above. However, commercially available PAA membranes 
such as PAA are not rated on the basis of dextran sieving properties. Comparing PAA 
membranes with conventional polymeric membranes is thus necessary to answer the following 
questions : 
1. Does the membrane architecture of PAA membranes have any impact on sieving 
characteristic of the membrane? 
2. Which polymeric membrane rating should be used for comparison with 20 nm rated PAA for 
fouling and separation studies? 
Hence, dextran sieving analysis of both PAA and PES membranes was carried out using a 
mixture of dextran with molecular weights ranging from 5 kDa to 2500 kDa. These experiments 
were performed at a very low flux rate (approximately 5 LMH) across the membrane and at a 
high stirring rate to avoid concentration polarisation at the membrane surface. Concentration 
polarisation of large solutes can form a layer on membrane surface which can reduce 
transmission of otherwise permeable smaller solutes. Thus the dextran sieving characteristics 
are near to the intrinsic sieving characteristics of the membranes and are not affected by any 
external phenomenon. Use of the dextran mixture instead of single dextran solution was 
favoured due to the similarity in the complexity of such a mixture with actual biological feeds 
used in fractionation applications. A detailed description of the method used is available in the 
section 4.2.3 of this chapter. 
Analysis of the samples is crucial to study the dextran sieving characteristics for the membranes 
and compare different membranes. Chromatograms of feed and final filtrate samples were 
obtained using high-performance size exclusion chromatography (HP-SEC) with refractive index 
detector for detection of the dextrans. It is crucial the size exclusion chromatography is properly 
calibrated before the application of the samples. Calibration plot obtained using nine GPC-grade 
standard dextrans with molecular weights ranging from 5 to 670 kDa (T5-T670) is shown in 
graph B in Figure 4-15. A linear correlation was obtained between the log value of the 
molecular weight of the dextrans and peak elution volume as signified by a high value of the 
regression coefficient. Graph B in the same figure shows the peaks obtained with single 
dextrans solutions. Peak molecular weight specified by the manufacturer was used for the 
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calibration plot, though calibration plot with number average or weight averaged molecular 
weight also showed similar linear plot. 
 
 
Figure 4-15 SEC chromatograms of various GPC grade dextran standards, 5 to 670 kDa 
(Top) on GPC column and semi-log calibration plot for dextran molecular weight and 
peak elution volume showing linear fit for the data. 
Dextran standards in PBS were injected (100 µL) onto the GPC column TSKgel5000PWXL (7.8 
X 300 mm) at 0.3 mL/min with PBS as mobile phase and detected using refractive index 
detector. The linear relationship shown in the calibration plot is described by the equation, log10 
(M.W.) = (0.7 x Ve) + 10.7, which is used to transform the chromatograms obtained for samples 
obtained after dextran sieving experiments. 
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Figure 4-16 Transformed chromatograms for the dextran feed (solid line) and filtrate 
(dotted lines) samples obtained in the dextran sieving experiments using PAA membrane 
rated 20 nm and PES membranes rated 100,300 and 500 kDa. 
Chromatograms were obtained by injection of 100 µL of the samples onto the GPC column, at 
conditions similar to those used to obtain the calibration plot. The x-axis (elution volume) of the 
initial chromatograms was transformed to molecular weight using the calibration equation. 
Figure 4-16 shows gel permeation chromatograms of the polymeric membranes of three 
molecular weight cut-offs (100, 300 and 500 kDa) and 20 nm PAA membranes as selected 
during screening experiments. The feed was found to be highly polydisperse in composition with 
dextrans of molecular weights ranging from 3 kDa to approximately 6 MDa. However, a majority 
of the dextrans were in the range of 10 to 1000 kDa. It should be noted that since calibration 
plot was obtained in a range of 5 to 670 kDa and the linear range specified by the manufacturer 
for the elution of linear polymers such as polyethylene glycol and polyethylene oxide through 
the GPC column was in 10 to 800 kDa. Hence any significant extrapolation of the linear 
relationship of the calibration plot, especially above 1000 kDa should be used cautiously to 
make any experimental inference. 
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Feed solution curve was identical for all of the membranes as solutions of the same composition 
were used in all of the experiments. The additional peak observed at approximately 3 kDa 
molecular weight in the chromatogram of 20 nm rated PAA membranes. No such peak was 
observed with polymeric membranes. Since anodic alumina membrane does not have any 
leachates this is likely due to leachates from thermally bonded polypropylene support ring 
around the anodic alumina membranes. This was confirmed by analysing samples obtained 
after incubating a detached support ring (membrane removed except on bonded area) in buffer 
solution for a day. A similar spike was observed. Leachate was however found to be less than 
5kDa and would be effectively removed during the filtration by the membrane.  
Sieving curves for different membranes were calculated by normalising the filtrate signals with 
the feed signals as shown in the transformed chromatograms. Except for 100 kDa PES 
membranes, all of the membranes showed similar signals for both filtrate and feed solution for 
dextran molecules smaller than 20 kDa. As shown in Figure 4-17, PAA membrane exhibits a 
sharper sieving curve compared to PES membranes of all ratings. Among polymeric 
membranes, only 100 kDa membranes coincided with manufacturer specified ratings (~100 
kDa) for 90% rejection (or 0.1 value of observed sieving coefficient). Both 300 and 500 kDa 
were found to have much higher MWCO compared to their original ratings from the 
manufacturer. Manufacturer’s (Millipore) website appears to indicate that ratings for PES 
membranes are on the basis of proteins rather than dextrans. As proteins are charged 
molecules and globular in shape, their sieving across the membrane is likely to be influenced by 
a variety of factors other than the solute size such as protein-protein and protein-membrane 
interactions. 
A rationale for using dextrans for sieving analysis is that these molecules are neutral, inert to 
the solvent environment to some degree and can be synthesised easily for a specified 
molecular weight, thus minimising the interference for solute-solute and solute-membrane 
interactions. However, there is no standard sieving test format for either dextran or protein-
based testing.  For dextran-based sieving analysis also it has been reported that factors such as 
the format of filtration i.e. stirred cell or cross-flow module, stirred cell diameter and composition 
of the dextran feed can strongly influence the retention ratings (Zydney and Xenopoulos, 2007, 
Bakhshayeshi et al., 2011a). Thus dextran-based nominal molecular weight limits (NMWL) 
rating can vary for same membrane depending upon the procedure used. However, comparison 
of the membranes using same format or procedure can still be valid. 
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Figure 4-17 Dextran sieving curves for PAA membrane rated 20 nm and PES membranes 
rated 100,300 and 500 kDa. 
Sieving coefficients were obtained by normalising signal obtained for filtrate to that obtained for 
feed solution at a particular elution volume, which represents a particular molecular weight of 
dextran as per calibration curve obtained using GPC grade standard dextrans. Sobs of 0.1 
correspond to 90 % rejection of a dextran molecule of corresponding molecular weight. Lot 5 of 
PAA (Anodisc) membranes was used for this study. 
Nominal molecular weight limits (NMWL) at 90% rejection were estimated to be 800-900kDa for 
PAA membrane. NMWL for 300 and 500 kDa PES membranes could not be accurately 
determined using the sieving curve obtained as the curve extended beyond the calibration limit 
and linear range of the size exclusion column. However, NMWL at 90% rejection can be 
speculated approximately 2000kDa for 300 kDa rated PES membrane. Zydney and 
Xenopolous, (2007) have reported 385 kDa value for 90 % rejection for 300 kDa rated PES 
membranes (same product) in a stirred cell experiment using a dextran solution. Authors 
favoured using 76 mm stirred cell diameter as they found smaller stirred cells to be very 
sensitive to operating conditions such as stirring speed as used in this study. A larger stirred cell 
could not be used in this study as the PAA membranes are not available at sizes larger than 43 
mm.  Use of similar format and size of the stirred cell was necessary to avoid the influence of 
different mass transfer of solutes with different stirred cell sizes. Nonetheless, out of three 
ratings of PES membranes, only 300 kDa membrane showed closest dextran sieving 
characteristics along with similarity in the mean pore size and hydraulic permeability established 
previously. Thus, 300 kDa PES membrane was selected for studying filterability of solutions of 
various proteins for comparison with PAA membrane. 
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4.3.5 Filterability of single solute solutions of selected protein model solutes 
through 20 nm rated PAA and 300 kDa PES membranes 
Selected PAA membranes (Anodisc 20 nm rating) and PES membranes (Biomax 300 kDa) 
were compared for filterability of dilute feeds of single model solutes. BSA, Thyroglobulin and 90 
nm BSA nanoparticles were filtered through both membranes are compared for transmission, 
average flux and fouling potential. Mechanisms of the fouling are deduced by statistically fitting 
the experimental data for filtration with the mathematical expressions for well-established 
mechanisms of fouling. Selection of these two membranes for comparison was by similar 
hydrodynamic permeability and dextran sieving characteristics as demonstrated in previous 
sections (4.3.3 and 4.3.4). 
 
4.3.5.1 Flux decline for filtration of single model solute solutions  
Equal feed volumes per unit membrane area were loaded (~26 L/m
2
) and filtered (~20 L/m
2
) 
through the two membranes to compare the performance for equal filtration output. Stirring 
conditions and pressure were the same for all filtration runs irrespective of solute and 
membrane. Figure 4-18 shows the average (or cumulative) filtrate flux values for both 
membranes with three different model solutes.  
For both membranes, average flux for 20 L/m
2
 filtrate output decreases as solute size 
increases. Higher filtrate fluxes were observed for PAA membrane compared to PES membrane 
for each solute. However for BSA nanoparticles filtration difference of average process fluxes 
for two different membranes was marginal though still significant. Flux through PAA membrane 
was 20 LMH higher than that for PES membrane.  Lot 5 of PAA membrane of 20 nm pore rating 
was used for these studies. Surprisingly, filtration of BSA through 300 kDa polymeric membrane 
(Biomax 300) resulted in lower process flux of ~500 LMH compared to that for PAA membranes. 
This could be due to lower mean pore size in 300 kDa PES membranes, i.e. 34 nm, compared 
to ~48 nm observed for the used lot of PAA membranes (lot 5). 
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Figure 4-18 Filtrate fluxes through 20 nm rated PAA and 300 kDa PES membranes for 
solutions of model solutes (BSA, TG and BSA nanoparticles)  
Solutions of all solutes were filtered for similar filtrate output (~20L/m
2
) at a transmembrane 
pressure of 0.6 bar and a stirring rate of 1500 rpm was used in stirred cell-based filtration.  BSA 
and BSA nanoparticles (90 nm) solutions were 1mg/mL and TG solution was 0.2 mg/mL, all 
prepared in PBS, pH 7.0 Lot 5 of PAA membranes was used for all filtration runs. 
Filtrate fluxes normalised to the initial buffer flux (see Figure 4-19) highlight the differences for 
both membranes. A sharper flux decline was observed for PES membrane with BSA filtration 
resulting in membrane operating at ~60% of initial buffer flux instantaneously as filtration is 
started. PAA membranes however operated at ~90% value of the initial flux. Size exclusion 
chromatogram for BSA solution (see Appendix A1) used in this study shows that around 20 % 
of the total peak area is composed of dimers or trimers which would likely block some of the 
pores in 300 kDa rated PES membrane. Flux decline curves for TG were significantly different in 
shape for the two membranes which steeper decline observed for PES membranes indicating 
likely different mechanisms of fouling. For BSA nanoparticles, both membranes exhibited 
sharpest flux decline as filtration is started with membranes operating at ~20% of the initial 
buffer flux and the steady state is established very early in the filtration. This suggests 
immediate fouling or polarisation at the membrane surface. For all three solutes of different 
hydrodynamic sizes, PAA membranes operated at higher normalised flux rates throughout the 
course of the filtration indicating lower fouling. Large error bars for filtration runs with PES 
membranes show significant variation in filtration through membrane discs of the same lot as 
noted previously. Impacts of these variations were not though not significant for nanoparticle 
filtration. 
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Figure 4-19 Flux decline for filtration of solutions of BSA, TG and BSA nanoparticles through 20 nm PAA and 300 kDa PES membranes. 
Graphs on the left side show flux values normalised by the respective initial buffer flux (Jo) through the respective membranes. Error bars represent one standard 
deviation for flux data for triplicate filtration runs using fresh membranes discs. 
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4.3.5.2 Transmission of model solutes through membranes 
 
Figure 4-20 Observed sieving coefficients for three model protein solutes (BSA, TG and 
BSA NPs) of various hydrodynamic sizes filtered through 20 nm PAA and 300 kDa PES 
membranes. 
Similar operating conditions (TMP, feed volume, stirring speed and filtrate output) were used for 
all filtration runs. The solute size was obtained from dynamic light scattering measurements for 
protein solutions. Error bars represent one standard deviation for triplicate filtration runs. 
Figure 4-20 displays transmissions of the individual solutes through two membranes for equal 
filtrate output in the form of a ratio of final permeate concentration to the initial feed 
concentration denoted by observed sieving coefficient. Protein transmission for BSA was similar 
for both membranes. A remarkable difference is seen for TG transmission through two 
membranes. PAA membranes are partially retentive for the TG. Value of the observed sieving 
coefficient for PAA membrane was 3.6 times larger than that for the 300 kDa PES membrane. 
Overall both membranes were highly retentive for the nanoparticles of 80-90nm size as sieving 
coefficient was below 0.05 signifying less than 5% transmission for both membranes.  
Sieving values for single solute filtration can be used to calculate selectivity or separation factor 
of the membrane for that particular solute. A selectivity permeability trade-off has been 
suggested and demonstrated for a variety of membrane ratings from 30 to 1000 kDa using BSA 
as model solute including a theoretical relationship between intrinsic selectivity and permeability 
estimated using applying some assumptions to the hydrodynamic model of sieving and stagnant 
film theory (Mehta and Zydney, 2005).  
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For BSA filtration in this study, the polarisation index (ratio of cumulative average flux and mass 
transfer coefficient for solute) was very high >100 for both membranes thus resulting in 
erroneously low values of actual sieving coefficient hence this analysis was not used. For TG 
and BSA nanoparticles, polarisation index was less than 15 for PAA membranes and less than 
10 for PES membranes, so selectivity permeability analysis was conducted for these two 
solutes (Calculations for mass transfer coefficients and polarisation index are shown in 
Appendix F and G). Theoretical curves for selectivity-permeability trade-off were generated for 
two solutes by using same assumptions as used by Mehta and Zydney (2005), i.e. log normal 
pore distribution is assumed with a value of 0.2 for the ratio of the standard deviation of pore 
size distribution to mean value of pore radius (σ/µ).  For thyroglobulin, PES membranes show 
lower selectivity and very close to the theoretical curve. PAA membranes exhibited higher 
selectivity and above the theoretical curve as displayed in Figure 4-21. 
 
Figure 4-21 Comparison of 20 nm PAA and 300 kDa PES membranes for separation 
factors for Thyroglobulin and BSA nanoparticles under the theoretical selectivity-
permeability framework (Mehta and Zydney, 2005). 
Since the effect of fouling or concentration polarisation has not been factored in the theoretical 
calculation of selectivity.  Nonetheless, such a framework is useful as in the actual application of 
the membranes non-ideal conditions such as high polarisation as well as fouling are very likely. 
Thyroglobulin can be used to compare the performance of two different membranes targeted for 
filtration of large molecules such as viral vectors. However, a thorough evaluation of fouling and 
other phenomenon is necessary to correlate such analysis with actual performance.  
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4.3.5.3 Mechanism of fouling 
4.3.5.3.1 Thyroglobulin filtration 
Fouling by thyroglobulin feed was more prominently due to intermediate blocking in PAA 
membranes while cake filtration mode was dominant for the PES membranes. Figure 4-22 
shows these two mechanisms being the best fit for the respective membranes. Regression 
coefficients of all of the model-fits for PAA membranes were above 0.95 with the intermediate 
model above 0.99 as shown in Table 4-4. Such high values for all the models make it difficult to 
identify a dominant mechanism of fouling. Thus, the values of the sum of squares of residuals 
(SSR) were compared and the intermediate blocking model was found to has the minimum 
value for SSR, 1/3
rd
 of the value obtained for the standard blocking model, the next best fit. 
Short filtration window and a low number of data points collected is likely the reason for a good 
fit for all of the fouling models in PAA membranes. Short filtration time was unavoidable as 
membranes needed to be compared for similar filtrate output or capacity to compare the impact 
of fouling, process flux and transmission. For PES membrane, regression coefficients were 
above 0.9 only for cake filtration and intermediate blocking. Cake filtration was identified as the 
dominant mechanism as the regression coefficient was 0.99 and minimum SSR value that was 
1/5
th
 of SSR value for intermediate fouling.  
For thyroglobulin, the initial period of the filtration ( < 60 seconds) appear to fit standard blocking 
or complete blocking models for PAA membranes and intermediate blocking for the PES 
membranes indicating the presence of a different fouling mechanism in the initial window of 
filtration. A combined model approach was attempted to fit the filtration data with the reported 
combined models, but fitting was inconclusive due to over-parametrisation of the fits. Best fits 
for such combined models resulted in negative values of the kinetic parameters with large 
standard errors thus such fits were not considered valid. Likely reason could be the short time 
frame of initial mechanisms and very low number of data points captured in such a short period. 
Another possibility is that two participating mechanisms are consecutive and not concurrent and 
the combined models applied was developed assuming simultaneous fouling by two 
mechanisms. Initial pore blocking in the PAA membranes could be because of the thyroglobulin 
and aggregates blocking the pores similar to the size of solute (~20 nm) and as these pores are 
blocked, the more particles deposit on the blocked pores manifesting into intermediate blocking. 
Cake filtration in the polymeric membrane, however, indicates the inability of the particles to 
enter more in-depth into the membrane bed and deposition in the top active layer of the 
membrane could result in a cake-like layer. Such cake is likely to block large channels near 
membrane surface and result in lower transmission. 
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Figure 4-22 Fitting the experimental filtration data (triangles) obtained for filtration of thyroglobulin (TG) and 90nm BSA nanoparticles (NP) solutions 
through PAA and PES membranes using the well-established mathematical models for the fundamental mechanisms of fouling (predicted as solid 
curves). 
Goodness of the fits were analysed and compared for the four mechanisms on the basis of adjusted R
2
 and sum of square of residuals.  
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Fouling 
mechanism 
BSA nanoparticles Thyroglobulin 
2
0
 n
m
 P
A
A
  
SSR (x 10
-3
) R
2
 Parameter SSR (x 10
-4
) R
2
 Parameter 
Standard 1.24 ± 0.06 0.49 ks = 137 ± 1 0.07 ± 0.04 0.99 ks = 78 ± 2 
Complete 1.78 ± 0.78 0.27 kb = 0.03 0.30 ± 0.11 0.95 kb = 0.02 
Intermediate 0.65 ± 0.02 0.73 ki = 278 ± 5 0.02 ± 0.00 1.00 ki = 112 ± 4 
Cake 0.13 ± 0.00 0.94 kc = 4.4 ± 0.2 0.15 ± 0.03 0.98 
kc = 0.64 ± 
0.1 
        
3
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SSR (x 10
-3
) R
2
 Parameter SSR (x 10
-3
) R
2
 Parameter 
Standard 1.83 ± 0.14 0.40 ks = 145 ± 1 0.17 ± 0.05 0.85 ks = 100 ± 7 
Complete 2.45 ± 0.16 0.20 kb = 0.03 0.33 ± 0.07 0.71 kb = 0.02 
Intermediate 0.95 ± 0.08 0.70 ki = 321 ± 4 0.08 ± 0.03 0.94 ki = 160 ± 20 
Cake 0.17 ± 0.02 0.94 kc = 5.8 ± 0.3 0.01 ± 0.01 0.99 kc = 1.7 ± 0.3 
 
Table 4-4 Results of the curve fitting of experimental filtration data with well-established 
mathematical models for fundamental mechanisms of fouling for PAA and PES 
membranes   
Parameters represent kinetic constants of the respective mechanisms, ks (m
-1
), kb (s
-1
), ki (m
-1
) 
and kc (sm
-2
 x 10
-6
). Mathematical expressions of the fouling mechanisms are tabulated in 
Chapter 2 (Section 2.4.2.1.1). 
 
4.3.5.3.2 BSA nanoparticles filtration 
The goodness of fits for filtration data obtained for BSA nanoparticles solution was not as robust 
as observed for the thyroglobulin filtration. This was the case for both PAA as well as PES 
membrane. It could be argued that better goodness of fits observed for thyroglobulin solution is 
a result of shorter filtration time (200-500 sec) compared to filtration time observed for filtration 
of BSA nanoparticles. However, as fits show, even the best-fitted curves diverge from 
experimental data points in case of BSA nanoparticles. Hence it is likely that better goodness of 
fits in case of thyroglobulin is not because of the shorter filtration windows. The fundamental 
mechanism of fouling differs for two solutes. For both membranes, cake filtration model was 
observed to be the best-fitted model to experimental data collected for protein nanoparticles. 
Comparison of fitting for various models regarding R
2
 and SSR is detailed in Table 4-4.  
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4.3.5.4 Recovery of the membrane permeability 
Figure 4-23 shows the percentage of initial membrane permeability that could be recovered 
after a simple rinse of the fouled membranes. Interestingly, PAA membranes showed higher 
recovery for all three solutes compared to polymeric PES membranes.  Higher recovery of the 
buffer permeability implies lower irreversible fouling, which can only be removed using chemical 
treatment and not using simple rinse or washing of the membranes with the buffer solution. 
 
Figure 4-23 Recovered membrane permeability for 20 nm PAA and 300 kDa PES 
membranes after filtration of single solute solutions of three model solutes (BSA, TG and 
BSA nanoparticles). 
Recovered membrane permeability is calculated as the buffer flux through the fouled membrane 
(Jfoul) as a percentage of initial buffer flux (Jo) measured before protein filtration. Membranes 
along with stirred cells were gently rinsed three times before measuring the buffer flux through 
the fouled membranes. Measurement of buffer fluxes before and after the protein filtration was 
performed at similar operating conditions (0.6 bar TMP and 1500 rpm stirring rate). Error bars 
represent one standard deviation for triplicate filtration runs. 
The difference is significant for BSA nanoparticles where more than 95 % of initial buffer 
permeability was restored for PAA membrane as opposed to only 40% for PES membranes. 
Recovery of the initial buffer permeability was lowest in case of TG for both membranes.  For 
BSA solutions, PES membranes showed unexpectedly low recovery of the buffer permeability. 
This was likely due to the presence of dimers and oligomers of BSA proteins which would have 
molecular weights closer to the MWCO of the membrane.  
TG can foul larger pores in the PES membranes and similarly sized pores available on PAA 
membrane. For protein nanoparticles, it appears that most of the particles are sieved on the 
membrane surface and did not plug a significant number of the membrane pores in PAA 
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membranes. Low transmission of nanoparticles (<0.1%) also concurs with this. Easy restoration 
of the initial membrane permeability is a known characteristic of concentration polarisation, 
which is known to be a pressure-dependent and reversible phenomenon (Porter, 1972). Loss of 
the hydraulic permeability of the membrane is typically a consequence of fouling of the 
membrane especially internal fouling or pore blockage which is usually an irreversible 
phenomenon. It can be argued that compression of the membranes during long filtration cycle 
could also be responsible for the reduced buffer permeability, especially in the case of 
polymeric membranes. However, the role of the compression can be ruled out as trend appears 
to be by the solute size and membranes were operated at lower transmembrane pressures than 
the maximum operating pressure specified by the manufacturers. PAA membranes being 
ceramic are not easily compressible. 
 
Trends observed for the recovery of buffer permeability concerning different model solutes, and 
two different membranes were also visually verified using scanning electron microscopy of the 
active layer surface of the fouled membranes after rinsing. Figure 4- 24 and Figure 4-25 show 
the surface images for unused membranes as well as fouled membranes for PAA and PES 
membranes respectively. Comparing two different membranes for the extent of the fouling 
caused by the same solute is difficult due to different mechanisms of fouling observed. A visual 
comparison of the membrane fouling on the surface of the PES membrane appears to suggest 
lower surface fouling if correlated with corresponding recovery data, thus suggesting the 
possibility of internal fouling which was not identified by curve fitting of the filtration data. Such 
fouling may be present on the thin active layer as well as thicker intermediate layer observed for 
the polymeric membranes. Imaging of the membrane cross-section using SEM was tried after 
cutting the membrane; however, images were inconclusive due to the damage caused to the 
layers during the cutting procedure.  
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On a visual comparison of the membrane surfaces fouled with different protein solutions, 
membranes appear to be fouled maximal with TG and least with BSA solution, confirming the 
recovery data obtained for buffer permeability through membranes. BSA nanoparticles appear 
to be deposited on the membrane surface as opposed to the TG molecules which appear to be 
embedded into the membrane bed. This cannot be ascertained with SEM, and other techniques 
such as atomic force microscopy need to be used which can give detailed information about the 
texture or surface roughness of the sample being investigated. 
A 
C 
B 
D 
100,000X 100,000X 
100,000X 100,000X 
Figure 4- 24 SEM images showing fouling by different model solutes on the active layer 
surface of 20 nm rated PAA membranes. A- Unused membrane, B- BSA fouled, C- TG 
fouled and D- BSA nanoparticles fouled membrane.  
Scale bar represents 0.2 µm and images were taken at a magnification of 100,000 for all of 
the samples. Images were obtained after drying and coating the membranes with ultrathin (<1 
nm) and uniform layer of platinum using sputter coater and analysed using InLens detector 
with less than 5kV gun voltage. 
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From SEM images of the active layer surface of the PES membranes, the trend observed in the 
recovery of buffer permeability concerning three model solutes is apparent. Darker non-porous 
solid mass characterises fouling or deposition of the protein in contrast to the lighter and porous 
membrane material. Fouling on the surface, however, did not seem to reflect the values of 
recovery of the buffer permeability when compared to PAA membranes. This suggests that 
internal fouling may also have played some role in fouling of the polymeric membranes. 
Gelatinous masses of protein observed on the surfaces of the membrane fouled by TG suggest 
cake formation on the membrane surface. 
Figure 4-25 SEM images showing fouling by different model solutes on the active layer 
surface of 300 kDa PES membranes.  A- Unused membrane, B- BSA fouled, C- TG fouled 
and D- BSA nanoparticles fouled membrane. 
Scale bar represents 5 µm (except A) and images were taken at a magnification of 10,000 
(except 20,000X for A) for all of the samples. Images were obtained after drying the 
membranes and coating with ultrathin (<1 nm) and uniform layer of platinum using sputters 
coater and analysed using InLens detector with less than 5kV gun voltage. 
 
A B 
D C 
20,000X 10,000X 
10,000X 10,000X 
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4.3.5.5 Confirming concentration polarisation for BSA nanoparticles filtration through 20 
nm PAA membranes: effect of stirring speed on flux and transmission 
High reversibility of membrane permeability with a simple rinse of membrane surface after BSA 
nanoparticle filtration and flux decline mechanism resembling to cake filtration and high 
retention of protein nanoparticles appear to suggest the presence of significant concentration 
polarisation in PAA membranes. Concentration polarisation is also known to increase 
transmission of polarising solute (Zydney, 1997, Narsaiah and Agarwal, 2007). This is likely due 
to diffusion of solute due to a high solute concentration above large membrane pores and 
defects. On the other hand in fouling, foulant solute molecules are trapped in membrane pores 
and are less likely to be transmitted to permeate side. Concentration polarisation can be 
confirmed by comparing different operational conditions where concentration polarisation is 
known to vary. Tangential flow across the membrane surface is known to reduce the 
polarisation by aiding in back-transport of the polarising solute from membrane surface to bulk 
solution. For stirred cells, tangential flow is controlled using the stirring rate. An experiment was 
designed to investigate the impact of stirring speed on the filtration performance of PAA 
membranes for BSA nanoparticle feed with all the other parameters (TMP, feed volume, filtrate 
output) kept constant.  
Varying the stirring speed from 0 to 1500 rpm significantly increased the average filtrate flux 
from 59 to 87 LMH across the membrane for same filtrate output (as shown in Table 4-5). 
Changes in the clean membrane permeability were observed but were estimated to be 
statistically insignificant using ANOVA.  Flux decline across the filtrate output as shown in 
Figure 4-26 shows similar initial flux decline irrespective of the stirring speed. The steady-state 
region of the flux (beyond 10 L/m
2
) however indicates improved steady state flux for 1500 rpm. 
As shown in the figure, the normalised steady state flux for 1500 rpm ranges from 0.075 to 0.1 
of the initial buffer flux. 
Analysing the flux decline for the mechanism of fouling; only cake filtration mechanism shows 
better fits out of four fundamental mechanisms of fouling with above 0.95 regression coefficient 
for all of the stirring speeds. As shown in Table 4-6, the cake filtration model showed better fits 
(low SSR and high regression coefficients) at lower stirring speeds (0 and 500 rpm) compared 
to 1000 and 1500 rpm. This is also reflected in the reduced value of the cake fouling constant at 
higher stirring speeds. Lower stirring speeds were expected to increase the concentration 
polarisation. It is also clear that 500 rpm is insufficient to create any significant improvement in 
flux as compared to unstirred filtration. Some improvement is seen for stirring speed of 1000 
rpm and above. It is likely that the transition point is located somewhere between 500 and 1000 
rpm.  
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Figure 4-26 Effect of stirring rate on the flux decline for filtration of BSA nanoparticles 
through 20 nm PAA membrane (lot#6) at a constant transmembrane pressure of 0.6 bar. 
Stirring speed 
(rpm) 
Recovered 
membrane 
permeability % 
Clean membrane 
permeability 
(LMH/bar) 
Protein flux 
(LMH) 
0 93 ± 1 2022 ± 87 59 ± 5 
500 95 ± 1 1873 ± 74 57 ± 6 
1000 96 ± 1 1938 ± 34 71 ± 3 
1500 98 ± 1 1941 ± 105 87 ± 4 
P-value (ANOVA) 0.001 0.22 0.0001 
Table 4-5 Membrane permeability, protein flux and recovered membrane permeability for 
filtration of BSA nanoparticles at various stirring rates. 
P-value (ANOVA) indicates the probability of error assuming the differences to be significant 
when they are not. A p-value less than 0.05 is assumed to indicate statistical significance. 
(Data: Average value ± one SD) 
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) 
0 0.98 ± 0.01 4.13 ± 4.03 6.14 ± 0.65 
500 0.98 ± 0.00 4.37 ± 1.47 7.02 ± 0.82 
1000 0.96 ± 0.00 10.9 ± 0.75 5.91 ± 0.29 
1500 0.96 ± 0.01 10.1 ± 1.96 4.54 ± 0.17 
P-value (ANOVA) 0.001 
 
0.004 
Table 4-6 Fit parameters (Adjusted R
2
, SSR and cake constant) for the model fit of cake 
filtration model to experimental filtration data for various stirring rates.  
(Data : Average value ± one SD) 
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Additionally, more than 90% of the initial membrane permeability was recovered after rinsing the 
surface of the membranes post filtration of the feed. High reversibility of the membrane 
permeability is an indicator of concentration polarisation phenomena. Retentate solutions 
collected from stirred and unstirred runs were compared for particle size distribution using DLS 
to ensure if any aggregation of the nanoparticles is responsible for the different performance at 
extremes of the stirring rate. Particle size distributions of retentates were found similar to the 
initial feed solution. 
Another characteristic associated with concentration polarisation is increased transmission of 
the polarising solute. Figure 4-27 shows a decline in the sieving coefficient of BSA 
nanoparticles with an increase in the stirring rate. Filtration without stirring resulted in very high 
sieving coefficients of 0.13 compared to 0.04 observed for 1500 rpm. The lowest transmission 
was however observed at 1000 rpm instead of 1500 rpm. This could be due to reversible 
structural changes induced to nanoparticles at higher shears of 1500 rpm resulting in increased 
transmission through defects or could merely be due to higher defect density of the membranes 
used in 1500 rpm runs. 
Figure 4-27 Effect of the stirring rate on observed transmission or sieving coefficients for 
BSA nanoparticle filtration through PAA membranes.  
Solid symbols denote average values of the observed sieving coefficients for triplicate runs with 
error bars representing one standard deviation across the average and open symbols represent 
individual values for triplicate runs.  
Trends observed for protein transmission, filtrate flux and consistently high reversibility of the 
membrane permeability upon withdrawal of transmembrane pressure for all stirring rate confirm 
that concentration polarisation is the dominant mechanism for flux decline in BSA nanoparticles 
filtration through PAA membranes.  
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An analysis of the variation of the momentum boundary layer above the membrane surface 
explains the effect of the stirring speed. The momentum boundary layer is a hypothetical zone 
above the membrane surface where the velocity of the fluid is less than the mean fluid velocity 
of the bulk liquid with the fluid velocity approaching zero near the membrane surface. The solute 
transport within the boundary layer region is dominantly diffusive. Diffusion is the primary mode 
of the back-transport of the polarised solutes which are pushed towards the membrane surface 
by strong convection of the pressure applied to the solvent. Diffusion is small for large 
macromolecules and significantly smaller for macromolecular assemblies such as nanoparticles 
and viruses. The boundary layer thickness is a characteristic of the bulk properties of the liquid 
(viscosity and density) and the bulk fluid velocity. 
 
Figure 4-28 Boundary layer thickness and Reynold’s number over a range of stirring rate 
in 25 mm stirred cell. Calculated using the equations described by Becht et al., (2008). 
The polarising solute needs to overcome significant boundary layer thickness to come back to 
the bulk solution. Calculation of the boundary layer thickness suggests a non-linear relationship 
with the stirring speed as shown in Figure 4-28. Stirring aids in the back transport of solutes 
from the membrane surface to the bulk solution. It was also found that the tangential flow of the 
liquid in the stirred cell under the stirring rates used is laminar as the Reynolds’ number at 1500 
rpm is calculated to be 22,800 while the transitional Reynold’s number for stirred cells is 
determined to be 32,000 by Smith and Colton, (1972). Operating at a higher stirring rate (above 
2000 rpm) approaching the transitional or turbulent flow regimen will likely improve the filtration 
performance and will further reduce the transmission. The higher stirring rate was not possible 
due to the instrumentation limitation. A characterisation study using cross-flow filtration could be 
helpful to reduce the concentration polarisation.  
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4.3.6 Proposed sieving mechanisms in PAA and PES membranes   
PAA (20 nm rating) and PES (300 kDa rating) membranes tested in this study show different 
fouling resistances and different protein transmissions for same model solutes despite having 
similar hydraulic permeability and closer dextran sieving curves. Higher transmission of 80 nm 
BSA nanoparticles through PAA membrane and almost complete recovery (>90%) of the initial 
membrane permeability is in stark contrast with the PES membrane indicating lower retention 
for BSA nanoparticles but higher fouling resistance (Section 4.3.5.1 and 4.3.5.2). Data shows 
that PES membranes are more susceptible to fouling by large protein solutes. Since analysis of 
fouled membrane surfaces showed low coverage of surface fouling on PAA membrane and 
PES membrane, along with data on recovery of membrane permeability, it can be concluded 
that PES membranes have a significant internal fouling. Since identical feed and filtration 
conditions were used for testing of both membranes, the different performance of the two 
membranes can be attributed to the differences in the membranes themselves. As discussed 
earlier (Section 4.3.2), the two membranes have radically different porous architectures. This 
section attempts to explain the difference in solute transmission and fouling resistance of PAA 
and PES membranes on the basis of their morphology resulting in different solute transport 
mechanisms for the two membranes.  
Large solutes such as BSA nanoparticles are excluded from the smaller pores on the 
membrane surface. Pores larger than the solutes are however accessible to the nanoparticles. 
Once particles enter pores, solute transport within the pores is dominated by diffusion, given 
that the particle diameter is close to the pore diameter. Diffusive transport is affected by the 
pore length and tortuosity.  Effective diffusion length is increased with the membrane thickness 
and tortuosity of the pore channels. BSA nanoparticles are able to penetrate the large pores 
observed on the surface of the PES membranes but the transport is hindered by tortuous pore 
channels in the interconnected porous membrane bed. Particles are thus entrapped in the 
inside the membrane bed. Since used PES membranes are asymmetric membranes, it is likely 
that entrapment occurs in active or intermediate layer zone. Thus particles are effectively 
screened inside the membrane bed preventing them to be transverse membrane bed into the 
filtrate resulting in lower sieving coefficients and low recovery of the membrane permeability 
after a surface wash with the buffer solution. Smaller pores of the active layer of the PAA 
membrane along with narrow pore size distribution are not penetrated and plugged by the BSA 
nanoparticles thus avoiding any internal fouling and screening solutes above the membrane 
surface. Such a mechanism is expected to also result in completely which was not observed in 
the experiments. Higher transmission is likely due to diffusion of the BSA nanoparticles through 
large support layer pores exposed by the surface defects. Since PAA membranes have thinner 
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membrane bed (by a factor of 2 compared to the PES membranes) and have straight pore 
channels (very low tortuosity), the effective diffusional path length for the solute to sieve through 
the PAA membranes would be significantly smaller than that in thicker and tortuous channels of 
PES membranes. Since surface defects offer low hindrance to the solute transport they are 
unlikely to be plugged. The presence of small number of surface defects thus explains the 
higher sieving coefficients for BSA nanoparticles along with the high recovery of the membrane 
permeability in PAA membranes. 
 
Figure 4-29 Illustration of the proposed mechanisms of fouling and screening/retention 
of BSA nanoparticles through 20 nm rated PAA, and 300 kDa rated polymeric 
ultrafiltration membranes.  
Differences in the extent of internal fouling and NP transmission between the two membranes 
are attributed to the differences in the pore size distribution of the active layers, the presence of 
the surface defects, tortuosity and length of the pore channels in two membranes. SEM images 
of the active layer surface of the membrane show the differences in pore size distribution of the 
two membranes. Surface defect exposing the support layer of large pores in the PAA 
membrane is shown in the inset.  
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4.4 Conclusion 
The objective of this chapter was to characterise the porous anodic alumina membranes for its 
filtration performance using model protein solutes, primarily 20 nm thyroglobulin and BSA 
nanoparticles used as mimics of virus particles, compare the performance with traditionally used 
polymeric ultrafiltration membranes and understand the role of membrane architecture in the 
filtration performance of the membranes.  
Suitability of the 20 nm rated PAA membranes among three available ratings (20, 100 and 
200nm) was demonstrated for highest retention of 80 nm BSA nanoparticle and lowest fouling 
among all ratings (Section 4.3.1). Different methods and units of ratings used for PAA (pore 
diameter using electron microscopy or porosimetry) and the polymeric membranes (molecular 
weight cut off using tracer molecules of different molecular weight) presented a challenge to 
select the polymeric membrane with an appropriate rating to compare with the selected 
membrane. Comparisons on the basis of hydraulic permeability and dextran sieving 
characteristics were utilised for the selection of the polymeric membrane rating and among 
three available ratings for polymeric membranes, 300 kDa rated PES membrane was shown to 
exhibit hydraulic permeability and dextran sieving curves closest to those of the 20 nm PAA 
membranes (Section 4.3.3 and 4.3.4). 
A structural characterisation of the two different membrane types was also performed using 
scanning electron microscopy and image analysis highlighting a porous morphology with narrow 
pore size distribution, straight pore channels and surface defects in PAA membranes as 
opposed to wider pore size distribution and interconnected tortuous bed with thicker membrane 
bed in the polymeric membrane (Section 4.3.2). The presence of the surface defects and 
straight pore channels in PAA membranes was found to make PAA membranes susceptible to 
leaky transmission of solutes as higher transmission of large model solutes (thyroglobulin and 
BSA nanoparticles) were observed compared to the polymeric membranes. Higher solute 
transmission along with lower irreversible membrane fouling was observed in PAA membranes, 
especially for BSA nanoparticles. Overall, the filterability of protein-nanoparticle solutions was 
found to be superior for 20 nm rated PAA membranes and was dominated by concentration 
polarisation of the nanoparticles above the membrane surface. Superior fouling resistance (1.5-
2.5 folds higher) of PAA membranes for protein-nanoparticles makes them attractive membrane 
material for concentration and buffer exchange applications of larger viral vectors such as 
Adenovirus. The impact of concentration polarisation and other fouling mechanisms observed in 
this chapter on protein fractionation needs to be examined.   
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CHAPTER 5 SEPARATION PERFORMANCE OF 
POROUS ANODIC ALUMINA (PAA) MEMBRANES 
FOR BINARY MIXTURES OF THE MODEL 
SOLUTES 
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5.1 Introduction and objective of the chapter 
In bioprocessing, membranes are mainly used in concentration and diafiltration of protein 
solutions and for fractionation of a protein mixture of various sizes of proteins. So far 
bioseparation properties of anodic alumina membranes have been studied using diffusion cells 
where solute transport is diffusion dominated (Osmanbeyoglu et al., 2009) or lab-scale 
centrifugation filtration (Jeon et al., 2014, Moon et al., 2009) which is not easily scalable to pilot 
or manufacturing scales. These studies involved the separation of bovine serum albumin and 
haemoglobin through an ultrathin anodic alumina membrane by alteration of buffer pH and 
separation of hepatitis C virus using anodic alumina membranes in centrifugal filter format. 
These membranes were custom made and did not represent the commercially available 
membranes used in this study. Ultrafiltration operations at lab, pilot or manufacturing scales are 
pressure driven processes, and solute transport is mainly convective. Thus to utilise the 
potential advantages of anodic alumina membranes evaluation of their separation performance 
should be carried out at conditions similar to industrial format.  
 
In chapter 4, anodic alumina membranes were compared with commercial polymeric 
ultrafiltration membranes for MWCO ratings, hydraulic permeability and transport of model 
protein solutes in pressure driven filtrations. These studies, however, did not include the 
investigation of the separation ability of the membranes. What happens if a mixture of these 
model solutes is filtered through membranes instead of solutions of single model solute? How 
can separation performances of anodic alumina membranes be affected by process conditions 
such as pH and salt concentrations? Are these commercial anodic alumina membranes capable 
of separating virus particles without loss of infectivity? These are some of the questions that will 
be addressed in this chapter. Separation performance of the PAA membranes was studied 
using mixtures of model solutes in two combinations 1.) TG + BSA and 2.) BSA NP + BSA. BSA 
used as a model impurity or host cell protein and TG and BSA nanoparticles used as model 
mimics for virus particles of Adeno associated virus and Adenovirus, two most commonly used 
viral vectors in gene therapy. 
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5.1.1 Methodology used 
 
Figure 5-1 Illustration of the methodology followed and various experiments conducted 
to study separation performance of commercial PAA membrane (20 nm rating). 
Various experiments are grouped into three major groups. Initial studies involved evaluating the 
filterability of binary mixtures of three model solutes (BSA, TG and BSA NP) through PAA and 
PES membranes and comparison with single solute filtrations as discussed in Chapter 4. Impact 
of fouling on the transmission of two solutes was assessed.  A diafiltration based fractionation 
process was studied to increase separation of model solutes. TG/BSA system was used for the 
majority of separation studies for studying the impact of process parameters during diafiltration 
based fractionation process.  Improvement in separation factor was studied by utilising 
electrostatic interactions of the solutes and membranes. Optimised processing parameters and 
conditions were applied to the separation of BSA and BSA nanoparticles mixtures. Finally, 
filterability of Adenovirus rich clarified cell culture filtrate was studied and performance of two 
membrane types was compared for impact on infectivity. Arrows show a sequence of studies 
conducted.  
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5.2 Materials and Methods 
5.2.1 Materials used 
All the materials used for experiments using model solutes (BSA and TG) reported in this 
chapter are described in detail in Section 4.2.1 of Chapter 4. Materials used for the production 
of Adenovirus feed are described in detail in Section 3.3.1 of Chapter 3.  Infectivity assay for the 
Adenovirus was performed using ß-galactosidase reporter cell staining kit from Sigma Aldrich, 
USA and flat bottom Costar® 96-wells cell culture plates obtained from Corning Inc., USA. Poly-
L-lysine (0.01% solution) was also obtained from Sigma Aldrich, USA. 
 
5.2.2  Filtration setup and experiment 
All of the filtration experiments reported in this chapter are carried out using 25 mm stirred cell 
module. Except few, most of the experiments were conducted in a UF/DF format in 
discontinuous diafiltration mode. Discontinuous diafiltration is discussed in detail in the section 
below (5.2.3). A detailed protocol for assembly of the stirred cell and filtration runs are 
discussed in Section 3.3.7.1 and Section 4.2.2 of Chapter 3 and 4 respectively. 
 
5.2.3 Discontinuous/Sequential diafiltration 
Fractionation/separation experiments were carried out in UF/DF format. A fixed volume of feed 
was loaded into the assembled stirred cell with the membrane. Feed conversion ratio (ratio of 
collected filtrate volume to feed volume) of 0.75 was used for all steps including an initial 
concentration step and diafiltration steps. After concentration to a volumetric concentration 
factor (VCF) of 4, permeate was removed and retentate was diluted back to original feed 
volume using PBS. The final retentate (obtained at the end of the final diafiltration cycle) was 
not diluted. Permeates collected for the different steps (initial concentration and DF cycles) and 
final retentate sample was analysed for protein concentration. Figure 5-2 shows an illustration 
of a discontinuous diafiltration process after an initial concentration step. 
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Figure 5-2  Illustration of a discontinuous ultrafiltration/diafiltration (UF/DF) process.  
The discontiounous diafitration process is a series of alternating concentration and dilution 
steps. The retentate is diluted back to the original feed volume using diafiltration buffer after 
each concentration step. One diafiltration cycle involves dilution of the retentate obtained after 
previous step/cycle to original feed volume and subsequent 4 fold concentration of the diluted 
retentate. Impurity (low MW solute) will pass through membranes and product (larger solute) will 
be retained through all of the steps. 
 
5.2.4 Calculation of yields and purification factors for protein model solutes 
Yields or recoveries of model solutes in permeate, retentate, rinse or wash samples were 
estimated by quantification of the peak area of the solute in HP-SEC chromatograms. A detailed 
description of the HP-SEC methods used for separation of protein solutes and estimation of 
peak areas is discussed in Section 4.2.7 of Chapter 4. The purity of the samples is interpreted 
from the relative peak area % for the desired solute (product) in a given sample. 
Yield or recovery of any solute 𝑠 in a filtration fraction (permeate or retentate) 
% 𝑌𝑠 = (
𝐶 ∗ 𝑉
𝐶𝑓 ∗ 𝑉𝑓
) ∗ 100 
𝐶 and 𝑉, represent concentration (peak area per injection volume) of the solute and total 
volume of the sample (retentate or permeate) respectively. 𝐶𝑓 and 𝑉𝑓, represent concentration 
(peak area per injection volume) of the solute in the feed and total volume of the feed 
respectively. 
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The yield of impurity is also referred to as % removal in permeate and residual % in the 
retentate. The yield of the product to be retained is referred as % retained in retentate and % 
loss in permeates. 
Purification factor (PF) is calculated for the retained product as the ration of the yield of product 
to the yield of impurity in retentate (since model solutes for viruses, TG and BSA NP are 
completely or partially retained by the membranes). 
𝑃𝐹 = [
𝑌𝑝𝑟𝑜𝑑𝑢𝑐𝑡
𝑌𝑖𝑚𝑝𝑢𝑟𝑖𝑡𝑦
] 
 
5.2.5 Filtration experiments to investigate electrostatic effects on the separation 
performance of PAA membranes for fractionation of a mixture of protein solutes. 
All initial filtration studies were performed using PBS buffer which can have a high salt 
concentration (~150 mM) hence high conductivity (~18 mS/cm as measured from the 
conductivity detector of FPLC). The first experiment was to measure the impact of salt 
concentration on the fractionation of BSA and TG from a binary mixture. Hence phosphate 
buffer solution (10 mM Na2HPO4, 2.3 mM KH2PO4 and  2.7 mM KCl) were prepared with varying 
NaCl concentrations (0, 50, 100, 150 and 300 mM). Final pH of every buffer preparation was 
adjusted to 7.4, and final pH did not change after protein addition to the buffer. Solutions were 
then filtered through 20 nm PAA membranes in a discontinuous diafiltration mode with one 
diafiltration cycle (3 diavolumes filtered after the initial concentration step). The transmembrane 
pressure of 0.5 bar and a stirring speed of 1500 rpm was used throughout the filtration.  
Impact of pH was studied in a similar manner with protein solutions prepared using the 
phosphate buffer system (10 mM) and final pH adjusted to 3.5, 4.6, 6.5, 7.4 and 9.0.  Phosphate 
buffer system of H3PO4, NaH2PO4, Na2HPO4 and Na3PO4 was used. For example pH 3.4 and 
4.6 solutions were obtained by addition of 10mM of H3PO4 to 10mM solution of NaH2PO4. 
Buffer solutions of pH 6.5 and 7.4 were obtained by mixing defined volumes of 10mM solutions 
of NaH2PO4 and Na2HPO4. A buffer solution of pH 9.0 was obtained by addition of 10mM 
Na3PO4 to 10 mM solution of Na2HPO4. Final solution pH of the protein solutions was adjusted 
to the required pH levels (3.5, 4.6, 6.5, 7.4 and 9.0) using either H3PO4 or Na3PO4. Similar 
buffer system was required for all pH to eliminate the effect of different ion species (citrate, 
acetate, tris etc.) which may manifest from the use of different buffer systems for different pH 
levels. Filtration of protein solutions was carried out at a transmembrane pressure of 0.5 bar, 
stirring speed of 1500 rpm and for one diafiltration cycles using corresponding buffers. 
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5.2.5.1 Batch adsorption of protein solutes on PAA membranes 
Protein solutions of BSA and TG at 1.0 and 0.2 mg/mL concentrations respectively were 
prepared in phosphate buffer system (10 mM) for two final pH values of 5.2 and 8.4. The low 
ionic strength of buffer components, as well as lack of any salt, was to avoid charge screening 
effect of salts. Fresh, unused anodic alumina membranes (20 nm Anodisc) were wrapped in 
clean aluminium foil and crushed to small pieces (< 3 mm). Pieces of crushed membranes were 
added to 2 mL polypropylene centrifugal tubes. Tubes with membrane pieces (referred to as 
treatment) and tubes without membranes (referred to as control) were washed with 1 mL of pre-
filtered buffer to remove any dust and buffer solution was aspirated out. Following washing, 0.5 
mL of protein solution was added to both control and treatment tubes. Samples were incubated 
at room temperature for 1.5 hours. After incubation, protein solutions were carefully aspirated 
out of both control and treatment tubes and the absorbance of the solutions was measured. The 
absorbance of protein solutions was measured at 280 nm using 100 µL of the sample in a 
quartz cuvette and UV-Vis spectrophotometer (Biomate 3S). The same procedure was repeated 
for all four protein solute-solution pH combinations. An equal amount of anodic alumina material 
was used for all experiments.  
 
5.2.6 Virus UF/DF  
5.2.6.1 Preparation of Adenovirus feed for Ultrafiltration/Diafiltration experiments 
Adenovirus particles were produced in mammalian cell culture and subsequent processing of 
the cell culture as described earlier in Section 3.3.8 of Chapter 3. 
5.2.6.2 Filtration of clarified Adenovirus feed 
Feed material diluted in PBS (clarified Adenovirus -rich supernatant) was filtered through the 
PAA membranes. To compare these two membranes with different filtration areas, the load on 
the membrane was adjusted accordingly to keep the constant load per unit area (L/m
2
). Similar 
conversion ratio hence similar filtrate output per unit area (~20 L/m
2
) was used for filtration 
experiments with both membranes. Three diafiltration cycles (each of 3 diavolumes) were 
applied to the retentate obtained after the initial concentration step. Each diafiltration cycle 
consisted of 20 L/m
2
 of filtrate collected. PBS was used as the diafiltration buffer. 
5.2.6.3 Infectivity assay for Adenovirus 
Infectivity assay for the recombinant Adenovirus (with ß-gal gene) was based on observing the 
number of HEK293 cells infected by the virus and thus transformed to produce ß-galactosidase 
enzyme intracellularly. The assay was composed of following three major steps: 
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Step 1: Preparation of samples and tissue culture plates 
Tissue culture plates with 96 wells were coated with 30 µL of 0.01% poly-L-lysine solution in 
each well and incubated for 10 minutes at room temperature. The solution was aspirated out 
and discarded. Wells were then subsequently washed twice with 50 µL of Dulbecco’s PBS 
solution for each well per wash. PBS solution was aspirated out and discarded. Wells were then 
seeded with 100 µL HEK293 cell suspension at a seeding density of 4 x 10
4
 viable cells per 
well. The cell suspension was repeatedly mixed by inverting to ensure uniform seeding in each 
well and all the plates. Plates were incubated overnight at 37°C until 70 % confluency is 
observed. Dilutions of samples containing virus particles were prepared on the same day in 
growth media and stored at 4°C. It was ensured that all the samples are stored for an 
approximately equal amount of time in similar buffer conditions. For each sample, four dilutions 
were prepared with dilution factors ranging from 100 to 1 x 10
6
 depending upon the nature of 
the sample. 
Step 2: Infecting cells   
Following day, plates were seeded with 100 µL of samples at various dilutions and incubated at 
for 1 hour. At the end of incubation, wells were carefully aspirated and 100 µL of fresh growth 
media was added. Plates were then incubated overnight at 37°C. Each sample was seeded in 
four dilutions with triplicates per dilutions. As a negative control, 100 µL of growth media was 
also plated in triplicate wells in each plate. As a positive control, similar dilutions of feed material 
were plated in each plate.  
Step 3: Staining and counting  
Following overnight incubation, the growth medium is carefully aspirated out of the wells. Cells 
are washed twice with 50 µL of 1X PBS per well in each wash. Cells were then fixed using 50 
µL of 1x fixation buffer (2% formaldehyde + 0.2% glutaraldehyde in PBS) per well for 10 minutes 
at room temperature. Following fixation, cells were further washed twice with PBS as described 
above. 30 µL of staining solution containing MgCl2, Potassium ferricyanide, Potassium 
ferrocyanide and substrate, X-gal was added to each well. Plates were sealed with parafilm and 
covered with aluminium foil before incubating for 24 hours at 37°C. Cells infected and 
transformed by recombinant Adenovirus would produce the recombinant ß-galactosidase 
enzyme. This enzyme can aid in the hydrolysis of glycosidic bonds in carbohydrate like ß-
galactosides into monosaccharides. Staining kit uses X-gal (5-bromo-4-chloro-3-indolyl ß-D-
galactopyranoside) as a substrate, an organic compound with indole group attached to 
galactose through the glycosidic bond. The substrate can penetrate the cells. Bond cleavage 
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catalysed by recombinant ß-galactosidase in infected cells results in the release of indole group 
which results in indigo-blue colour. Infectivity was measured by counting the number of blue 
formation unit (BFU) in the well under an optical microscope with a 10X objective lens. Dilutions 
where 30-200 BFUs per well were observed were used for calculations of titres. 
 
5.3 Results and Discussion 
5.3.1 Choice of binary model solute solutions for separation or fractionation 
studies 
As described earlier in Section 4.1.2 of Chapter 4, three model solutes; BSA, TG and BSA 
nanoparticles were selected for their size similarity with most abundant host cell proteins, 
smaller Adeno-associated viruses and larger Adenoviruses respectively. A typical virus-rich feed 
from mammalian cell culture contains host cell proteins (impurity) and virus particles (product). 
The objective of any separation process is to remove impurities from the product. TG (~20 nm) 
and BSA nanoparticles (~80-90nm) have hydrodynamic sizes similar to common viral vectors, 
adeno-associated viruses and Adenovirus respectively. BSA, a 67kDa protein is used as a 
model impurity solute for average size range for the host cell proteins produced by mammalian 
cell culture. Hence two types of feeds were used in these experiments, i.e. BSA + TG mixture 
and BSA + BSA nanoparticles mixture. The idea is to simulate a partially purified virus-rich feed 
for two different virus particle sizes (i.e. TG for 20 nm AAV and BSA nanoparticles for 90 nm 
AdV). The mixture of TG and BSA nanoparticles was not tested. However, such preparations 
could be tested if the intention is to study the effect of virus feed containing aggregated virus 
particles. 
5.3.2 Comparison of filtration of single solute and binary solute solutions of 
protein model solutes through 20 nm PAA and 300 kDa PES membranes 
Following from Section 4.3.5 from Chapter 4 where filtration of single solute solutions of three 
model solutes was studied, this section attempts to compare the performance of two membrane 
types (PAA and PES) for the filtration of binary solute feed (mixtures of two solutes). Membrane 
performance (flux decay, transmission and recovery in buffer permeability) were compared with 
that observed during single solute filtrations to assess the impact of the binary solute system.  
To draw a direct comparison with single solute filtrations, the same values of various process 
parameters such as transmembrane pressure (0.6 bar), stirring speed (1500 rpm), membrane 
loading (~25 L/m
2
) and filtrate output (~20 L/m
2
) were used except the feed composition. 
However, final concentrations of each solute in the mixed solute feed were similar to the 
concentrations of solute used in single solute filtrations. Filtrations were carried out with two 
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types of binary feeds 1). BSA and TG mixture in PBS with final concentrations of 1.0 and 0.2 
mg/mL respectively and 2). BSA and BSA nanoparticles mixture in PBS with final 
concentrations of 1mg/mL for both solutes. Same membrane lots were used for filtration of the 
binary solute feeds as used for single solute filtrations as discussed in Chapter 4.  
5.3.2.1 Comparing flux decline and fouling mechanisms 
Flux decline through both membranes showed similar trends as observed with filtration of a 
solution of single solutes (reported in Chapter 4) indicating that mechanism of fouling has not 
changed significantly with the addition of a smaller solute. For single solute filtrations, BSA 
alone did not result in significant flux decline for PAA membranes where filtrate flux was above 
80% of the initial buffer flux throughout the filtration run. However, 300 kDa membranes filtered 
BSA solution at a relatively lower fraction (50 %) of the initial buffer flux through these 
membranes. Larger solutes, i.e. TG and BSA nanoparticles were concluded to be the fouling 
solutes for both membranes.  
Comparison of filtration of binary and single solute solutions did not show any appreciable 
differences in the filtrate fluxes or change in the flux decline curves as shown in Figure 5-3. 
Flux decline curves were normalised with initial buffer fluxes for the respective membranes to 
include the differences in the membrane permeability between several membranes used for 
single solute and binary solute filtrations. Compared to single solutes, membranes filtered the 
mixed feeds at slightly higher normalised fluxes. This effect appears to be high for polymeric 
membranes for both TG and BSA nanoparticles containing feeds. Another reason for elevated 
normalised fluxes for BSA NP + BSA feed in polymeric membranes could be reduced NP 
penetration in membrane pores which are now completed by relatively smaller high molecular 
weight components of BSA in the mixed feed.  However, large standard deviations represented 
by large error bars also imply higher variations in membrane performance for polymeric 
membranes. Large standard errors for polymeric membranes meant that the average values of 
fluxes could vary significantly over the course of filtration using different membranes. For PAA 
membranes, flux decline curves for solutions TG alone and TG with BSA were similar for PAA 
membranes. Similarly, flux decline curves for BSA nanoparticles solutions with and without BSA   
were also found to be identical. Fouling mechanisms identified for filtration binary solute 
solutions were found similar to those identified for single solute solutions of foulant solutes.  
When comparing the filtrations of single solute and binary solute solution of TG or BSA 
nanoparticles, the same membrane lots were used for both membrane types. Comparison of 
hydraulic permeability of membranes used for such pairs (TG/ TG+BSA or BSA NP/ BSA 
NP+BSA) for both membranes concluded no significant differences (p-values > 0.05 for all 
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pairs). Similarly, process fluxes and recovery of buffer permeability also didn’t change 
significantly (Table 5-1).  
 
 
Figure 5-3 Comparison of flux decline for protein solutions through PAA membranes (A, 
C) and 300 kDa PES membranes (B, D) for single solutes feeds (TG and BSA 
nanoparticles) and binary solute mixtures of TG and BSA nanoparticles with BSA.  
The comparison shows no difference in the filterability of single solute or binary solute systems. 
Similar filtration conditions (TMP 0.6 bars, stirring speed of 1500 rpm) and feeds (both single 
and binary solutes) were prepared in PBS with 0.2 mg/mL for TG and 1 mg/mL for BSA and 
BSA nanoparticles as final concentrations in both single solute and binary solute feeds. 
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Membrane Solute 
Hydraulic 
permeability 
(LMH/bar) 
Filtrate flux, 
(LMH) 
Recovered 
membrane 
permeability % 
20 nm 
PAA 
TG 2030 ± 40 350 ± 20 65 ± 3 
TG + BSA 2100 ± 150 360 ± 40 60 ± 0 
BSA NP 1990 ± 40 90 ± 01 94 ± 1 
BSA NP + BSA 2080 ± 80 110 ± 10 97 ± 2 
300 kDa 
PES 
TG 1590 ± 540 170 ± 10 27 ± 5 
TG + BSA 1930 ± 120 220 ± 20 26 ± 1 
BSA NP 2480 ± 90 72 ± 02 43 ± 6 
BSA NP + BSA 1790 ± 460 70 ± 02 52 ± 6 
 
Table 5-1 Comparison of single solute and binary solute filtrations by the hydraulic 
permeability of clean membranes, cumulative filtrate flux for protein solutions and 
recovered membranes permeability(%) after protein filtration.  
No significant changes in process fluxes for protein solutions and recovery of buffer permeability 
after filtrations irrespective of single or binary solute composition of the feed (Values ± SD for 
triplicate runs) 
 
5.3.2.2 Comparing transmission of the model solutes  
 
Feed Solutes 
Observed sieving coefficients, 
Sobs 
20 nm  
PAA 
300 kDa 
 PES 
Single solute 
BSA 0.96 ± 0.03 0.96 ± 0.02 
TG 0.60 ± 0.04 0.21 ± 0.08 
BSA NP 0.03 ± 0.01 0.01 ± 0.00 
Binary solutes 
BSA + TG 
BSA 0.89 ± 0.03 0.76 ± 0.01 
TG 0.67 ± 0.09 0.43 ± 0.03 
Binary solutes 
BSA + BSA NP 
BSA 0.68 ± 0.03 0.54 ± 0.06 
BSA NP 0.18 ± 0.03 0.00 ± 0.00 
 
Table 5-2 Comparison of single solute and binary solute filtrations through PAA and PES 
membranes by observed sieving coefficients for various solutes. 
Similar process conditions and similar solute concentrations were used for filtration of single 
solute and binary solute solutions. (Mean value ± one SD for triplicate runs)  
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Impact of the fouling by TG and BSA nanoparticles was significant for transmission of the 
smaller solute, BSA. For both membranes, transmission of BSA was lower in the presence of 
the fouling solutes. In the absence of these solutes, both membranes showed high transmission 
(~96%) of BSA molecules. Impact of the fouling by TG and BSA was more prominent on the 
transmission of BSA through the polymeric membrane as compared to PAA membranes. 
Relative to the high transmission of BSA in a pure BSA solution, transmission of BSA dropped 
by 7% and 20% for PAA and PES membranes respectively in the presence of TG in the feed. 
Similarly, BSA transmission reduced by 29% and 44% respectively in PAA and PES 
membranes in the presence of BSA nanoparticles. These changes were found to be statistically 
significant with a p-value of less than 0.05 when means were compared using two-tailed t-tests. 
Surprisingly, for both membranes transmission of the larger fouling solutes (TG or BSA 
nanoparticles) when filtering their mixtures with BSA was found to be increased as compared to 
filtration of single solute solutions of these fouling solutes. For thyroglobulin, transmission 
through the polymeric membrane was found to be doubled which could be attributed to the 
higher hydraulic permeability of the PES membranes used for filtration of TG+BSA mixture as 
compared those used for TG alone. Increased transmission of TG was also observed through 
PAA membranes, but the increment was modest and not statistically significant. BSA 
nanoparticles transmission, on the other hand, was significantly high for PAA membranes when 
a mixture of nanoparticles and BSA was filtered through it.  
No transmission of BSA nanoparticles was observed in size exclusion chromatogram of the 
permeate samples collected after filtration of a mixture of BSA nanoparticles and BSA through 
polymeric membranes. Presence of BSA is unlikely to increase the permeability of larger solutes 
through membranes. Thus, likely explanation for increased transmission across PAA membrane 
could be due to different defect densities in the membranes or change in particle size. Reduced 
transmission of BSA nanoparticles in BSA + BSA NP filtrations through PES membranes is 
consistent with fouling hypothesis that the high molecular weight component of BSA are 
competing with protein nanoparticles for access to the pores. Thus preventing nanoparticles’ 
penetration into the pores which also leads to membranes operating at higher normalised fluxes 
when compared to filtration of BSA nanoparticles alone. Another possibility for the variations 
observed in transmission is the sampling error or analytical measurement errors. Nonetheless, 
PAA membranes were observed to result in significant leakage of larger solutes (TG and BSA 
nanoparticles) whether single solute solutions or a mixture of these solutes with BSA were 
used. High sieving of BSA NP through PAA membranes in the binary mixture was considered 
as an anomalous reading and was not observed in further experiments. 
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5.3.3 Fractionation of mixtures of protein model solutes using discontinuous 
diafiltration through PAA membranes 
PAA membranes were evaluated for fractionation of protein mixtures of model solutes (TG + 
BSA or BSA NP + BSA). For the experiments conducted so far only 4 to 5 fold concentration 
step was used for protein separation which could only remove 40 to 60 % of the total BSA in the 
feed. The retentate obtained were still not purified to satisfactory levels. Thus, a diafiltration step 
was carried out in addition to the initial concentration step to remove BSA from the retentate 
further. Since these are not comparison studies with polymeric membranes, thus filtrations for 
greater feed loadings (35 L/m
2
) and greater filtrate output (26 L/m
2
) were carried out. These 
parameters were constrained by the loading capacity of the stirred cell and different active 
filtration areas of the membranes used in previous experiments. 
5.3.3.1 Fractionation of BSA and TG mixture 
5.3.3.1.1 Effect of diafiltration cycles on flux through the membranes and fouling 
The goal of the fractionation process is to remove the maximum amount of impurities (BSA) and 
retain the maximum amount of product (TG) from a feed with a mixture of two proteins. 
Discontinuous diafiltration is alternating between concentration and dilution of feed in a stirred 
cell by filtration and then the addition of buffer to retentate. Protein solution (TG+BSA) in PBS 
buffer was initially 5 fold concentrated from 10mL to a retentate volume of 2mL. Each 
diafiltration step was then carried out by dilution of the retentate using PBS and further 
concentration by 4-5 fold. 
Flux decline during diafiltration steps and initial concentration steps were compared. Both 
diafiltration steps have similar flux decline and same final filtrate flux at the end of the filtration 
cycle. Flux decline curve was steeper for the initial concentration step as the fresh membrane 
was exposed to the fouling solutes. Final filtrate flux for the initial concentration step and 
diafiltration steps was found to be similar suggesting no significant fouling occurring in 
diafiltration steps. For diafiltration steps, initial filtrate fluxes (at 0 L/m
2
) are slightly higher than 
the filtrate fluxes observed at the end of the initial concentration step.  This was possibly due to 
an interruption in the applied pressure across the membrane between the diafiltration and initial 
concentration steps. The interruption was because of the manual dilution of the retentate before 
proceeding for the next filtration step. This resulted in the diluted feed on membrane surface 
thus reducing the concentration polarisation above the membrane. Internal fouling which 
occurred during the first step or initial concentration step remains un-mitigated by such dilutions 
and upon the application of the pressure concentration polarisation manifest again on the 
surface of the fouled membrane. A control experiment was also performed where the feed was 
only processed for the initial concentration step without any subsequent diafiltration. 
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Analysis of the total permeate collected for initial concentration and diafiltration steps revealed 
74% BSA monomers removal as opposed to 47% for the control run without diafiltration. Total 
loss of TG, on the other hand, was similar for both with and without diafiltration. These trends 
were also reflected for retentate solutions with low residual BSA measured in retentate obtained 
after the diafiltration process. Recovery of the initial membrane permeability (of the clean 
membrane) was marginally lower for runs with diafiltration (48 ± 1 %) than the control run (57 ± 
5 %). The slight decrease was expected for the runs with diafiltration as pores were exposed to 
longer filtration cycles and more transmission of the smaller solute, BSA. This proved that 
fractionation yield could be improved using a diafiltration process without significant loss in the 
flux after the initial concentration step.  
 
 
Figure 5-4 Flux decline during the initial concentration step and two subsequent 
diafiltration (DF1 and 2) steps for TG/BSA fractionation by PAA membranes in 
ultrafiltration-diafiltration process. 
Error bars represent one standard deviation for triplicate runs. Control run included only the 
initial concentration step without subsequent diafiltration steps. Filtrations are carried out at 
TMP of 0.6 bar and 1500 rpm in a stirred cell. Feeds were concentrated 4-fold in initial 
concentration step followed by two diafiltration steps (4 fold dilution of the retentate followed by 
~4 fold concentration). Dilutions were carried out manually. Cumulative filtrate fluxes (at the end 
of filtrations) for DF steps and initial concentrations steps were similar indicating no further 
fouling in diafiltration steps. 
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5.3.3.1.2 Effect of diafiltration cycles or diavolumes on fractionation  
It is desirable that maximum fractionation could be carried out with minimal time and volume of 
the diafiltration buffer used. The previous experiment established the role of diafiltration in 
increasing removal of BSA for only two diafiltration cycles (with approximately 4 diavolumes of 
the buffer used per cycle). An experiment was thus conducted to study the impact of the 
number of diafiltration cycles or diavolumes on the removal of BSA. The protocol was slightly 
modified for this experiment with 7.5 mL filtrate collected per filtration run instead of 8 mL 
collected in the previous experiments.  This meant that retentate volume is 2.5mL with the 
modified protocol compared to 2mL collected previously. Significant frothing was observed in 
the stirred cell when the liquid volume was below 2mL resulting in loss of some of the retentate 
volume thus such modification was necessary. For diafiltration, each DF cycle now represented 
3 diavolumes. A total of 4 DF cycles or 12 diavolumes were applied with samples collected after 
each diafiltration cycle (3 DVs). 
Cumulative filtrate flux did not change significantly for the diafiltration cycles as shown in Figure 
5-4 but was slightly lower than that for the initial concentration step (at 0 diavolume). No loss of 
TG was observed in any diafiltration cycle. BSA removal increased with increase in the 
diavolumes in a non-linear fashion. BSA removal was highest for the initial concentration step 
and first diafiltration cycle. A maximum of 80 % of the BSA could be removed at the end of 12 
diavolumes of the diafiltration process. Removal achieved per DF reduced from 0 to 12 
diavolumes, and it was confirmed by a reduction in the peak area of the BSA monomer in size 
exclusion chromatograms of the permeate collected after each step. Such non-linear removal 
was expected because the concentration of BSA left after each diafiltration cycle reduces and 
since the constant volume of the filtrate is processed for each cycle the amount of the BSA 
removed will decrease. This is assuming that the sieving coefficient of the BSA is similar for all 
of the filtration runs which is possible as no change in the fouling was observed with diafiltration 
steps. This can be remedied by either increasing the volume concentration factor or reducing 
the dilution factor during the diafiltration steps. However, such action means reducing the 
number of diavolumes per cycle thus requiring more frequent manual interventions for dilutions. 
A continuous diafiltration strategy could be used to further minimise the diavolumes as well as 
the process time by maintaining a constant volume of retentate by continuous addition of buffer 
and simultaneous filtration. It should be noted that TG transmission in permeate was found to 
be ~10% in this experiment while it was approximate ~50% for previous experiments (Section 
5.3.2). A possible reason was that the current experiment used lot 3 of the membrane but 
previous experiments used lot 5 of the PAA membranes. Mean pore size of the lot 3 membrane 
was significantly smaller (~30 nm) compared to that of lot 5 membranes (~50 nm). Further, 
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diafiltration experiments were conducted with higher protein feed loading of 35 L/m
2
 compared 
to 20 L/m
2
 in previous experiments.  
Optimising the diafiltration process in a UF/DF operation is critical to minimise the amount of 
buffer and processing time. Since UF/DF operations are run in batch mode, a longer process 
can delay the processing of subsequent batches of the feed resulting in longer hold times. 
Longer hold time increase risk of contamination, reduce protein stability and occupy facility 
space.  Increasing filtration area or adding more filtration system increases capital cost and the 
facility space.  
 
Figure 5-5 Effect of dia-volumes on the transmission of BSA and TG through 20 nm PAA 
membranes (Lot 3) when 5 cycles of discontinuous diafiltration (1 cycle = 3 diavolumes) 
were carried out on initially 4 fold concentrated samples.  
Error bars represent one standard deviation for triplicate runs. Cumulative transmission of BSA 
starts to level off after 2 DF cycles. TG loss is observed only for the initial concentration step (at 
DV=0). Cumulative filtrate flux (shown is grey) remains constant through diafiltration indicating 
no significant fouling in DF phase. 
Purification factor for TG increased from 1.5 ± 0.1 without diafiltration to 3.0 ± 0.5 and 4.1 ± 0.6 
after 2
nd
 and 4
th
 DF step respectively. Analysis of both permeate and retentate collected after 0, 
2
nd
 and 4
th
 DF cycles show no change in TG recovery but significant differences for BSA 
recovery as shown in Figure 5-6. Effect of diafiltration is also observed in retentate with a 
reduction in the peak area of BSA as shown in Figure 5-7. 
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Figure 5-6 Effect of diafiltration (DF) and the number of DF cycles (0, 2 and 4) on 
fractionation of BSA (A) and TG (B) in permeate and final retentate obtained after 
processing through 20 nm PAA membranes.   
W/o diafiltration represents the control (i.e. 0 DF cycles/ initial concentration step only). Error 
bars represent one standard deviation for triplicate runs. Blue bars indicate statistical 
significance among data columns where NS represents no significant differences (ANOVA p> 
0.05 and * represents significant differences (ANOVA p<0.01) among the data columns. 
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For future experiments, DF up to 2 cycles, with 3 DVs per cycle will be used since any effect of 
the treatment will likely be visible into 1
st
 or 2
nd
 DF cycle and from the results obtained for DV 
studies, 1 DF cycle can achieve a modest 60 % removal of BSA. Using more DF cycles does 
not result in a significant increase in BSA removal, however, increases the total processing 
time. Most of the experiments in the following sections used one diafiltration step of 3 
diavolumes for fractionation experiments. 
5.3.3.1.3 Effect of TG concentration and stirring speed on fractionation of BSA and TG 
Three TG concentrations (0.2, 0.4 and 1.0 mg/mL) were tested in UF/DF mode with one 
diafiltration cycle (3 DVs) at 1500 rpm. Feed consisted of TG at selected concentration level 
along with 1mg/mL of BSA in PBS. Purification factor for TG decreased from 3 to 1.3 with an 
increase in TG concentration. This was due to increased fouling by a higher concentration of TG 
as evident by reduction in recovery %age of initial membrane permeability of the membranes 
from 48 % at 0.2 mg/mL TG to 36 % at 1.0 mg/mL TG concentration. Increased fouling resulted 
in reduced BSA transport through the membrane with only 20 % of total BSA measured in 
permeate at 1.0 mg/mL TG concentrations as opposed to 80% BSA removal observed at 0.2 
mg/mL. 
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Figure 5-7 Overlay of HP-SEC chromatograms of retentate collected after 0, 2 and 4 
cycles of diafiltration for fractionation of TG and BSA using PAA membranes showing 
effect of diafiltration on residual BSA. 
Chromatograms were obtained by injecting 50µL of samples on to TSKgel3000SWXL (7.8 x 
300 mm) column at flow rate of 0.6 mL/min and under isocratic elution with PBS. Retentate 
samples are 4 fold concentrated compared to the feed sample.  Peaks were detected using 280 
nm wavelength.  
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Effect of stirring was studied at three stirring levels (0, 500 and 1500 rpm) with a feed containing 
0.2 mg/mL TG and 1.0 mg/mL of BSA filtered at 0.5 bar transmembrane pressure. Recovery 
%age of initial buffer flux of membranes improved with increasing stirring rate. Greater stirring 
speed leads to reduced concentration polarisation at the membrane surface thus lowering 
effective concentration at the membrane surface. Purification factor for TG increased from 2.8 to 
5.7 with a reduction in stirring speed from 1500 to 0 rpm. Increased purification factor was due 
to differentially BSA removal (>92%) at 0 rpm but at the expense of TG loss with only 37 % yield 
in the retentate. Stirring helped retain both TG and BSA molecules. For low volume and high-
value products such as viral vectors, operating conditions would be prioritised on the basis of 
the yield of the product in ultrafiltration. Thus the use of higher stirring rate is justified for any 
future experiments. 
5.3.3.1.4 Effect of the PAA membrane lot variability on separation performance 
In the previous chapter (Chapter 4), six lots of 20 nm PAA membranes were tested for hydraulic 
permeability and pore morphology using SEM. It was found that the hydraulic permeability of 
lots varied from 1500 to 2200 LMH/bar. This was correlated with the morphology of the active 
surface of the membranes when observed under SEM. SEM data revealed significant variations 
in the pore size distribution with only lot #1 and #3 having a mean pore size less than 30 nm 
(Table 5-3). Fractionation of BSA and TG was compared for different PAA lots to assess the 
impact of lot variability on the purification factor for TG. 
 
 
 
 
Table 5-3 Transmission of BSA (removal) and TG (loss) in permeate collected after UF/DF 
based fractionation of BSA and TG from four different lots of 20 nm PAA membranes and 
mean pore diameter of different lots of membrane were estimated by analysis of SEM 
images of the membrane surface.  
Similar filtration conditions (TMP =0.5 bar, 1500 rpm, membrane loading of 35 L/m
2
 with 1 
diafiltration cycle of 3 dia-volumes). The composition of feed used for all of the filtrations was 
similar, i.e. 0.2 and 1.0 mg/mL of TG and BSA in PBS solution. (Average values ± one SD for 
triplicate runs). 
Lot #1 and #3 have similar performance and lowest TG losses in permeate (less than 20 %).  
These lots had narrower pore size distribution as well as lower mean pore size (<32 nm), which 
Lot No. 
Mean pore 
diameter (nm) 
% BSA 
removal 
% TG 
loss 
Purification 
factor (for TG) 
#1 27 ± 2 62 ±  8 14 ± 4 2.0 ±  0.5 
#2 44 ± 5 74 ±  3 38 ± 3 2.5 ±  0.5 
#3 32 ± 4 62 ±  8 16 ± 6 2.5 ±  0.7 
#4 55 ± 7 72 ±  3 43 ± 8 2.4 ±  0.3 
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is close to the hydrodynamic size of TG protein (~21 nm). Fractional losses of the total 
thyroglobulin in permeate for different lots were found to be in linear correlation with the 
hydraulic permeability of the membrane lots (as shown in Figure 5-8). On the other hand, both 
lot#2 and #4 showed significantly high TG losses (40-50 %) and higher mean pore sizes (40-55 
nm). The contribution of large structural defects in higher transmissions could not be factored in 
due to non-uniform distribution and low frequency of such large defects. Since transmission of 
both BSA and TG increased with increase in the hydraulic permeability, the purification factor 
for thyroglobulin did not change significantly and ranged from 2 to 3 for all four lots ( See Table 
5-3).  
 
 
  
 
 
 
 
 
Figure 5-8 Effect of PAA membrane lot variations on TG loss through the membrane 
during TG/BSA fractionation: correlation of the hydraulic permeability and TG 
transmission (%) into the permeate for four different lots of the membrane. 
Error bars represent one standard deviation for triplicate runs (3 membranes of each lot). A 
linear fit was attempted to describe the correlation between the TG transmission and the 
hydraulic permeability with a regression coefficient (R
2
) of 0.99 for the fit. 
Thus lot selection is crucial if the yield of retained product (TG in this case) is a priority rather 
than the purity of the final product. A difference of 300 LMH/bar in hydraulic permeability of PAA 
membranes could lead to 2-3 times higher losses of product. 
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5.3.3.2 Fractionation of BSA and BSA nanoparticles mixture  
A mixture of 80 nm BSA nanoparticles and BSA (both 1 g/L) was tested for fractionation using 
20 nm PAA membranes. Conditions similar to those used for TG/BSA fractionation were used. 
The high stirring rate was used to ensure low concentration polarisation hence low nanoparticle 
loss. Discontinuous mode diafiltration was carried out for 1 diafiltration cycle (3 diavolumes) and 
resulted in a purification factor of 3.5 ± 0.5 for BSA nanoparticles. Figure 5-9 shows the effect of 
diafiltration on residual BSA in the retentates collected after a fractionation process with and 
without a diafiltration step. BSA levels in retentate were lower when diafiltration was used. 
 
 
 
 
 
Though the diafiltration step was able to remove more BSA from BSA NP and BSA mixture, the 
residual amount of BSA in the retentate is still high when compared to diafiltration runs for TG 
and BSA mixture as shown in Figure 5-8. One reason for low removal is that only one DF step 
was used for BSA NP and BSA fractionation compared to 2 or 4 used. In Section 5.3.2.2, it was 
observed that the concentration polarisation due to BSA NP results in the lower transmission of 
BSA than the transmission observed with fouling by TG. Hence, more DF steps are required for 
fractionation of BSA NP and BSA. However, a single DF step was used for most of the 
experiments in this thesis because of time constraints for performing experiments in triplicate. 
Figure 5-9 Overlay of HP-SEC chromatograms of retentate collected after 0 (w/o DF) and 1 
step of diafiltration for fractionation of BSA nanoparticles and BSA using 20 nm rated 
PAA membranes showing residual BSA peaks. Retentate samples are ~4 fold 
concentrated compared to the feed samples. 
Chromatograms were obtained by injecting 20µL of samples on to BIOSEC 5 (7.8 x 300 mm) 
column at flow rate of 0.8 mL/min and under isocratic elution with PBS. Peaks were detected 
using 280nm wavelength. Similar processing (TMP and membrane loading) were used for both 
runs. However, feed composition for both runs was slightly different. 
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5.3.4 Approaches to improve separation performance of the 20 nm rated PAA 
membranes  
5.3.4.1 Influence of electrostatic interactions on the separation performance of 
fractionation using PAA membranes 
Membrane performance is a function of solute interactions with the membrane material. Both 
steric and ionic interactions can affect the sieving of solutes through membrane pores. 
Variations in pH and salt concentration of protein solution were investigated for their effects on 
flux and separation performance of the PAA membranes for fractionation of BSA and larger 
solutes, TG and BSA nanoparticles. Initial screening experiments (for salt concentrations and 
solution pH) were performed with TG/BSA fractionation, and the selected conditions were later 
verified for BSANP/BSA fractionation. 
 
5.3.4.1.1 Effect of salt concentration in protein solution on the fractionation of BSA and 
TG through PAA membranes 
Fluxes for the solutions of protein mixture were not significantly affected by high salt 
concentration. However, cumulative filtrate flux was significantly higher for solutions without any 
NaCl than with NaCl added despite having the same protein concentrations (See Figure 5-10). 
Recovery of the initial membrane permeability was also similar (~50 %) for all salt 
concentrations. Buffer composition itself did not have any effect on membrane permeability as 
the buffer fluxes for different buffers (varying salt concentrations) were similar. Thus, any 
difference in the fluxes for protein solutions could be attributed to the solute-salt interaction and 
not to any change in hydraulic permeability of the PAA membrane due to the salt solution. 
Removal of BSA in permeate was considerably higher (~80%) for the feed solution without any 
NaCl as compared to those solutions with NaCl added. However, varying the concentration of 
NaCl from 50 to 300 mM in the protein solution did not change the removal of BSA in permeate 
(~60%) or amount of BSA remaining in the final retentate (See Figure 5-11). Increasing salt 
concentration resulted in higher TG transmission into the permeates thus higher loss of TG. 
Loss of TG in the permeate increased from ~10% to 20% as salt concentration is increased 
from 0 to 300 mM. Opposite trend was reflected when TG recovery was estimated in final 
retentate solutions. In terms of purification factor of TG in the final retentate, at 0mM NaCl 
concentration the purification factor was 4.8 ± 0.7 compared to 2.2 ± 0.3 for all of the other 
solution. Recovery was estimated by ‘mass’ balancing of the peak areas of TG and BSA in 
various samples and taking into account the respective volumes.  
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Figure 5-10 Cumulative flux for filtrates collected after initial concentration and DF step 
and recovered membrane permeability (%) after filtration of solutions of BSA and TG 
mixture with different salt concentrations through 20 nm PAA membranes. 
Protein solutions were filtered at a TMP of 0.5 bar and 1500 rpm stirring rate in a stirred cell. Lot 
#3 of the PAA membranes were used. All solutions were prepared in phosphate buffer, pH 7.4. 
Error bars indicate one standard deviation for triplicate runs. 
 
Figure 5-11 Recovery of BSA and TG solutes in permeates and retentate collected after 
UF/DF using 20 nm PAA membranes with different NaCl concentration in the protein 
solution and diafiltration buffer solutions.  
TG transmission (permeate) increased with increasing salt concentration. BSA removal was 
significantly high (~80%) for 0mM NaCl concentration compared to 60% removal for other 
higher salt concentrations. PF for TG was highest (4.8) without salt, compared to 2.2 for 
solutions with salt. Error bars indicate one standard deviation for triplicate runs. 
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It was suspected that high salt concentration could lead to aggregation of the protein solutes, 
especially TG. However, such a process would reduce the flux and transmission of the protein 
at higher salt concentrations. Further, no such aggregation was observed in HP-SEC 
chromatograms and particle size analysis using DLS. For HP-SEC analysis, to avoid non-
specific protein binding to the resin, samples with lower salt concentrations were appropriately 
diluted to adjust a final salt concentration of 150mM before injection. This ensured that all peak 
analysis of all of the samples was not affected by the different sample conditions. Dilutions were 
appropriately accounted for when ‘mass’ balancing for each of the protein solutes.  
Cheang and Zydney (2003), have reported similar findings for protein fractionation using 100 
kDa polymeric membranes and attributed it to electrostatic interactions. At low concentrations of 
salt, the thickness of the electric double layer (also referred to as Debye’s length) around 
charged solutes and surfaces increases. The increased thickness of the electric double layer 
increases the effective sizes of solutes and reduces the effective pore diameter assuming 
anodic alumina membrane are charged. Increase in the salt concentration leads to screening of 
the surface charge and reduces the thickness of the electric double layer as illustrated in Figure 
5-12. Solute permeability will be affected for solutes such as TG with dimensions (~20 nm) near 
the pore size (20-40 nm).  
Low salt concentration results in loss of charge screening or masking by salt thus increase in 
electrostatic forces between solute molecules and between solutes and membrane surface. 
These electrostatic forces can affect the sieving of solutes depending upon the nature (repulsive 
or attractive) and the magnitude of the electrostatic forces. For both TG and BSA, the isoelectric 
point is similar (~4.8). At buffer pH 7.4, both proteins would be highly negatively charged. In the 
absence of salt ions, this charge is not screened thus resulting in high repulsion forces between 
TG and BSA as well as among the molecules of same proteins. Increased effective size of TG 
and similar pore size results in the electrostatic exclusion of the TG from the pores as the 
electrical double layer of protein and pore surface would tend to overlap. Assuming that 
membrane is also negatively charged at this pH, very high potential energy would be required 
for TG molecules to overcome the energy barrier to disrupt the repulsion in the overlapping the 
electric double layers, which would be thermodynamically unfavourable. BSA molecule, on the 
other hand, is much smaller than the pore diameter and can escape the repulsive forces 
between pore wall and solute surface as the electrostatic forces are inversely proportional to the 
distance between the charges. A weak membrane surface charge or weak BSA charge can also 
explain the increased transmission of BSA.   
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Figure 5-12 Illustration of the effect of salt concentration on solute-membrane 
interactions and solute-solute interactions showing the impact of the increased electric 
double layer (shown as thicker boundaries on solute and pores) at very low salt 
concentrations resulting in reduced effective pore radius and increased effective solute 
radius and increased repulsion forces among solutes. In case of BSA, TG and BSA 
nanoparticles all of the solutes will have similar charge (though different magnitudes) at 
any given pH due to similar isoelectric points. 
Another factor could be loose polarisation layer of the TG molecules above membrane surface 
(after initial fouling) due to large surface charge on TG resulting in TG-TG repulsions but 
increased permeability as evident by high filtrate flux. Zeta potential measurements for BSA and 
TG show larger surface charge for TG molecules for various pH values on either side of pI 
points (see Appendix H). Repulsion from TG rich loosely polarised region at the membrane 
surface also contributes to increased BSA transmission through pores. An accurate modelling of 
these effects, however, would require measurement of surface charge of the membrane pore 
surface. 
5.3.4.1.2 Effect of pH of protein solution on the fractionation of BSA and TG 
Low salt concentration solutions were selected for studying the effect of solution pH on 
separations as screening by salt will mask the effect of surface charges of pore walls and 
solutes on separation performances as observed in the previous section (5.3.4.1.1). Effect of 
solution pH was more pronounced on process flux than the effect of salt concentration. Flux 
decline, as shown in Figure 5-13, was most prominent for the feed solution with pH 5.2. 
Process fluxes were similar for pH 6.5, 7.4 and 8.4 but higher than the fluxes at pH 3.7 and 5.2. 
Lowest process flux was observed with pH 5.2 which indicates interactions between solute or 
solute and membrane. 
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Figure 5-13 Effect of pH of feed and buffer solution on flux decline during initial 
concentration and diafiltration step during fractionation of TG and BSA using 20 nm PAA 
membrane. 
Flux is normalised with the initial buffer (1115 ± 34 LMH at 0.5 bar) flux. The solution with pH 
5.2 shows the fastest flux decline. Filtrate output is collected filtrate volume normalised with filter 
area at TMP of 0.5 bar and stirring rate of 1500 rpm in a stirred cell. Lot#3 of the PAA 
membrane was used. 
 
Figure 5-14 Effect of pH on the recovery of TG and BSA in the retentate and permeate 
fractions displayed in a stacked chart showing highest separation performance of PAA 
membrane at pH 6.5 and loss of proteins at pH 5.2.  
Error bars indicate one standard deviation for triplicate runs. 
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Significant differences were observed in protein transmission as well with higher % of total BSA 
in permeate for pH levels equal and above 6.5 (see Figure 5-14). TG transmission was found 
the minimum (~2.4%) at pH 6.5 and increased significantly at pH levels below and above the pH 
of 6.5. This leads to maximum purification factor of 10 being observed at pH 6.5. Effect of pH on 
separation is visible from the chromatograms of retentates collected at different pH (See 
Appendix I-1). Net recovery (permeate and retentate) of both BSA and TG was found to be 
minimum (<70%) for pH 5.2 indicating loss of protein. This was unexpected as the PAA 
membranes are marketed as negligible protein binding material. Due to similar isoelectric 
points, electrostatic interaction between the two solutes (TG and BSA) is always going to be 
repulsive. An electrostatic attraction between larger solute and membranes can result in higher 
fouling by ionic adsorption, especially with the larger solute. Adsorption will also reduce the total 
protein recovery after UF/DF experiment. Abnormally high BSA transmission at pH 6.5 and very 
low TG transmission can be possible if the membrane does not have any net surface charge at 
that pH resulting in increased permeability for smaller BSA molecules due to lack of repulsive 
forces between BSA and pore walls but significant steric hindrance to the larger TG molecules 
which are charged and have thick electric double layer. 
Based on the trend observed in transmission and fluxes at various pH values it could be 
speculated that the isoelectric point (pI) of the 20 nm rated PAA membranes is approximately 
6.5 which is also what has been reported by Pedimonte et al. (2014b) for custom made PAA 
membranes with a similar rating (15nm). This was however contradictory to the isoelectric point 
of 3-4 observed by Bowen and Hughes, (1991) for 100nm rated commercial PAA membrane. 
Impact of the fabrication conditions has been shown to influence the pore size as well as the 
surface charge on anodic alumina membranes strongly (Pedimonte et al., 2014b). Bowen and 
Hughes, (1991) also reported different isoelectric points for 100 and 200 nm rated PAA 
membranes. Incorporation of anions using acidic organic electrolytes such as oxalic acid, the 
phosphoric acid used for fabrication of anodic alumina membranes have been shown to shift 
membrane pI (Chen et al., 2005). Membrane pI was also found to be lower than that expected 
for amorphous alumina (pI 8-9) and varied with the pore size of the anodic membranes. 
Membrane pI has not been reported for 20 nm rated commercial PAA membrane used in the 
present experiment. Unlike TG and BSA, membrane pI could not be estimated form DLS based 
electrophoretic measurements due to a different format of the equipment required for 
measurements for solid samples.  
Assuming the isoelectric point of the membrane is 6.5, the low recovery of both proteins at pH 
5.2 could be attributed to the adsorption loss of proteins on membrane surface as proteins and 
membrane will have opposite charges at pH 5.2. To verify this, batch adsorption studies carried 
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out at two pH values (8.4 and 5.2) confirming the presence of ionic interactions between 
membrane and solutes. Loss of free protein was observed in the solution when membranes 
were incubated with a protein solution with pH 5.2 at room temperature (See Figure 5-15). 
Proteins (BSA and TG) are negatively charged at pH 5.2 so the loss of protein is due to the 
binding of protein molecules to the positively-charged membrane at pH 5.2. Protein solution at 
pH 8.4, where both solutes and membrane will be negatively charged did not result in loss of 
the protein from solution. To ensure that loss of protein is not due to protein binding to the 
container (PP tubes), control with the same volume of the protein solution in the container was 
also incubated. Control solutions did not show protein loss at any of the pHs tested. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 5-15 Batch adsorption of TG (A) and BSA (B) solutions at different solution pH 
(5.2 and 8.4) showing loss of protein in solution incubated with  porous anodic alumina 
material in PP tubes (Treatment) compared to protein solution incubated in PP tubes 
without alumina material (Control) after incubating for 1.5 hours at room temperature. 
Error bars represent one standard deviation for trpilicate measurements of absorbance of the 
sample. 
Control
(0 hr)
Control 
(1.5 hr)
Treatment
 (1.5 hr)
0.0
0.2
0.4
0.6
0.8
1.0
1.2
A
2
8
0
 (
n
o
rm
a
lis
e
d
 t
o
 in
tia
l, 
t=
0
 h
r)
 pH 5.2    pH 8.4
Control
(0 hr)
Control 
(1.5 hr)
Treatment
 (1.5 hr)
0.0
0.2
0.4
0.6
0.8
1.0
1.2
A
2
8
0
 (
n
o
rm
a
lis
e
d
 t
o
 in
tia
l, 
t=
0
 h
r)
 pH 5.2    pH 8.4
A 
B 
  
[182] 
  
A (at pH 7.4) 
 
B (at 0 mM NaCl) 
NaCl (mM) PF (TG) pH PF (TG) 
0 4.8 ± 0.7 3.7 1.8 ± 0.4 
50 2.3 ± 0.3 5.2 1.1 ± 0.2 
150 2.4 ± 0.5 6.5 9.9 ± 0.4 
300 2.2 ± 0.2 7.4 5.2 ± 0.2 
 
8.4 4.4 ± 0.3 
 
Table 5-4 Effect of salt concentrations (A) and solution pH (B) on purification factors of 
TG during fractionation of BSA and TG mixture (in 10mM phosphate buffers) using 20 nm 
PAA membrane. Data are presented as average value ± one standard deviation for 
triplicate runs. 
5.3.4.1.3 Effect of electrostatic interactions on fractionation of BSA and BSA 
nanoparticles  
Based on trends observed for electrostatic effects on BSA and TG fractionation and since the 
isoelectric point of BSA nanoparticles is similar to that of BSA and TG, only selected buffer 
conditions were tried for BSA nanoparticles. Trends observed in TG/BSA fractionation 
experiments indicate that operating at membrane pI of 6.5 results in best fractionation 
performance compared to other pH levels. Thus, comparing the performance of separation of 
BSANP and BSA at pH 6.5 with pH 7.4 would be sensible. To investigate if the pH effect is 
observed at high salt concentrations, separation performance was compared for solutions in 10 
mM phosphate buffer at pH 7.4 and pH 6.5 both with 150 mM NaCl. Finally, the effect of salt 
concentration was studied at pH 6.5 with two salt levels, 0 and 150 mM. Flux through the 
membrane was found to be higher for protein solution without any NaCl when compared to the 
same for with 150 mM NaCl. This effect was observed throughout the filtration including 
diafiltration steps.  
Membranes used for both filtration experiments were from the same lot but showed the 
difference in initial buffer fluxes, varying by ~ 70 LMH (~ 5%). It is possible that this difference in 
the membrane permeability resulted in differences in flux observed with the protein solution. As 
seen in Figure 5-16, normalised flux decline curves for both protein solutions with 0 and 150 
mM NaCl are identical in shape, but membranes used for 0mM NaCl operated at higher 
normalised fluxes from the initial period of the filtration. It is also possible that the differences in 
membrane permeability are not significant for the flux decline but solute charge and repulsive 
forces played a role in variations in fluxes. High repulsion between protein nanoparticles at 0mM 
NaCl could result in a loose concentration polarisation layer resulting in lower resistance to the 
convective flow of the liquid. 
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Figure 5-16 Effect of solution pH and salt concentration on flux decline during the initial 
concentration step of UF/DF based fractionation of BSA NP and BSA through 20 nm PAA 
membrane.   
Process flux normalised with initial buffer flux (Jo) through membranes and all of the protein 
solutions were prepared using 10mM phosphate buffer. Same membrane lot and the same 
operating conditions (TMP and stirring) and feed were used for all solutions. Error bars indicate 
one standard deviation for triplicate runs. 
 
Figure 5-17 Effect of solution pH and salt concentration on purification factor and yield of 
the BSA nanoparticles and BSA removal in the fractionation of BSA NP and BSA mixture 
using 20 nm PAA membranes.  
Purification factor for BSA NP decreased with the addition of salt even at membrane pI (pH 6.5) 
indicating the role of solute-solute interactions. Error bars represent one standard deviation of 
triplicate runs. 
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Improvement in purification factor (PF) was observed for separation of BSA nanoparticle from 
BSA at pH 6.5 and 0 mM salt concentration. PF of 7.2 was found for feed without NaCl as 
compared to 2.5 seen for feed with 150 mM NaCl as shown in Figure 5-17. The improvement 
was driven by an increase in BSA transmission and a decrease in transmission of BSA 
nanoparticles (for chromatogram overlays see Appendix I-2). This resulted in improved purity 
(60%) of BSA nanoparticles in the final retentate solution at 0mM NaCl compared to 40% purity 
observed at 150 mM NaCl. The purity of BSA nanoparticles in the feed was 21.5%. The 
decrease in the effective diameter of the pore at low salt concentrations would significantly 
reduce transmission of large protein nanoparticles. However, the reduction is not significant 
enough for smaller solutes like BSA. The absence of any significant steric hindrance and lack of 
electrostatic interactions results in high BSA transmission. However, low BSA transmission for a 
150mM solution cannot be explained. However, it should also be noted that electrostatic 
repulsion would be higher among protein solutes at 0 mM NaCl as compared to repulsion forces 
at higher salt concentrations where solute charges will be masked. Since BSA nanoparticles 
cannot enter pore due to steric hindrance and charge repulsion of BSA and BSA nanoparticles 
would likely result in BSA transmission through neutral pores. 
 
5.3.4.2 Effect of permeate backpressure on separation performance of 20 nm PAA 
membranes for BSA/TG fractionation 
Applying pressure on the permeate line resulted in high BSA removal without loss of TG when 
compared to similar filtration runs but without any permeate backpressure. Permeate tubing was 
pinched with a manual pinch valve to apply a back pressure on permeate as shown in Figure 5-
18. The purification factor for TG increased by 85%, from 1.4 for control to 2.6 with the 
application of backpressure while applying the same feed pressure (Table 5-5). 
 
 
Figure 5-18 Manual pinch valve on the permeate line of stirred cell setup used for 
applying back pressure on the permeate line 
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Treatment 
Filtrate 
flux 
BSA 
removal % 
Retained 
TG % 
Purification 
Factor (TG) 
Control 230 ± 15 39 ± 2 74 ± 9 1.4 ± 0.3 
Backpressure (BP) 156 ± 35 60 ± 3 74 ± 3 2.6 ± 0.3 
 
Table 5-5 Filtrate flux and separation performance (% of BSA removed in permeate, % of 
TG retained and purification factor for TG) upon application of permeate backpressure on 
permeate in comparison to control (without backpressure) at similar operating 
conditions (applied feed pressure =0.5 bar, 1500 rpm, and same feed).  
Only initial concentration step was carried out for both control and backpressure treatment 
without any diafiltration step.  Data represented as average value ± one standard deviation for 
triplicate runs. 
 
Figure 5-19 Enhancement in the sieving of BSA through 20 nm PAA membranes upon 
application of backpressure on permeate line during fractionation of TG and BSA. 
Backpressure runs (BP) show a sustained sieving coefficient (~0.9) for BSA throughout the 
filtration run (up to 26 L/m
2
) as compared to reducing sieving coefficient in control. Sieving of TG 
remained unaffected by backpressure.  Error bars represent one standard deviation for triplicate 
runs. 
HP-SEC analysis of fractions collected throughout filtration run shows high and sustained 
transmission of BSA when permeate backpressure was applied. Figure 5-19, above, shows 
enhancement of the observed sieving coefficient for BSA (concentration ratio of permeate and 
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feed) when backpressure was applied in contrast to reducing trend in control runs. TG sieving 
was not affected by the application of backpressure. A possible explanation for enhanced BSA 
transmission could be a change in the nature of fouling layer of TG due to the reduction of the 
effective transmembrane pressure (as the filtrate flux was also reduced) upon to pressurisation 
of permeate line in the vicinity of the membrane. It is also possible that permeate backpressure 
creates a transient backflow through the pores resulting in increased turbulence at pore inlet 
which increases BSA permeability. This hypothesis is not tested in the present study but could 
be explored further for a better understanding of enhancement observed with backpressure 
experiment. Such an approach has been described for hollow-fibre TFF based purification of 
Adenovirus (Weggeman, 2013), where low TMP control was not possible without permeate 
backpressure due to the requirement of high minimum feed pressure. Authors reported high 
recovery of the virus particles using permeate backpressure approach and suggested it as an 
alternative to chromatography. 
5.3.4.3 Effect of transmembrane pressure on fractionation of BSA nanoparticles and BSA 
Figure 5-20 Effect of the transmembrane pressure (TMP) on fractionation of BSA 
nanoparticles and BSA during the initial concentration step using PAA membranes. 
Except for TMP, the same operating conditions were used for all of the filtration runs including 
the membrane lots. Diafiltration step was not used in this experiment. Error bars represent one 
standard deviation for triplicate runs. 
As discussed in the last section, the permeate backpressure effect could be due to the reduced 
effective transmembrane pressure. Concentration polarisation is strongly dependent upon 
applied transmembrane pressure and more prevalent for highly retained large solutes such as 
BSA nanoparticles. It was found that the purification factor of BSA nanoparticles can be 
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improved by reducing the transmembrane pressure applied as shown in Figure 5-20. Enhanced 
purification factors were primarily because of increased removal of BSA with decreasing TMP.  
 
Figure 5-21 Effect of transmembrane pressure on flux decline during fractionation of BSA 
nanoparticles and BSA mixture using 20 nm PAA membranes. 
 
Figure 5-22 Effect of transmembrane pressure on sieving of BSA monomer through 20 
nm PAA membranes during fractionation of BSA nanoparticles and BSA. BSA 
nanoparticles sieving was below 0.1 for all TMPs. 
Error bars represent one standard deviation for triplicate runs. 
The yield of BSA nanoparticles or retention of BSA nanoparticles did not change significantly. 
Likely reason is that the nature of the concentration polarisation layers such as layer thickness 
or density changes with increasing TMP which alters the permeability of the polarised layer for 
BSA molecules. This is also evident from the flux decline curves for different pressures. At low 
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pressures (<0.4 bar) membranes operated at a very high value of normalised flux as shown in 
Figure 5-21. The layer is more permeable at lower TMPs resulting in the high removal of BSA. 
Sieving coefficient for BSA was high for lower TMPs (0.4 bar or lower) as shown in  
Figure 5-22. Lower TMPs also showed uniform sieving throughout the course of filtration (up to 
25 L/m2) when fractions of filtrate were analysed for BSA. BSA sieving dropped significantly 
during filtration when higher TMPs (0.8 and 1.6 bar) were used. This shows more permeable 
polarisation layer at lower TMPs. Recovery %age of initial membrane permeability also 
decreased to 88% at highest TMP indicating some irreversible solute-membrane interaction with 
high concentration polarisation. Actual process fluxes only increased marginally from 66 to 76 
LMH with an increase in TMP.  
5.3.4.4 Membrane performance over extended UF/DF process for complete fractionation 
of BSA nanoparticles and BSA: comparison of 20 nm PAA and 300 and 500 kDa PES 
membranes 
A robust membrane performance in UF/DF based fractionation should result in maximum 
separation with minimum processing time, minimum buffer consumption and minimum 
irreversible fouling of the membranes. A UF/DF process at pilot and manufacturing scale would 
normally be operated in a continuous diafiltration mode to achieve robust performance. For 
most of the experiments conducted so far in the thesis, the discontinuous mode has been used 
with 1 or 2 diafiltration cycles with each cycle consisting of 3 diavolumes. Limitation of the small 
volume capacity of the stirred cell, handling and risk of spillage and lack of automation for 
stirred cell filtration makes it challenging to use it in continuous mode. However, using smaller 
DVs per diafiltration cycle in discontinuous mode will simulate a separation performance closer 
to that of the continuous mode by increasing the convective transport of the impurities per cycle.  
Hence, a UF/DF process with 12 discontinuous DF cycles each of 1 diavolume (i.e. manual 2-
fold dilution of the retentate with buffer followed by 2-fold concentration step) was carried out for 
fractionation of feed mixture of BSA nanoparticles and BSA. The goal was to observe 
differences in cumulative flux, protein transmission through DF steps to maximise fractionation 
and see if membrane fouling increases with DF steps. As functionally the operation is still 
discontinuous, requiring the repeated manual addition of the diafiltration buffer, pressurisation 
and depressurisation of the setup, only single fractionation runs were studied for each 
membrane. Equal protein loading per membrane area (~28 L/m
2
), filtrate output (~20 L/m
2
), 
transmembrane pressure (0.6 bar) and stirring rate (1500 rpm) were used for all of the 
membranes. Figure 5-23 A shows the diafiltration cycle with 1 diavolume (retentate volume) 
across the time for 12 diavolumes UF/DF process. The time required for manual dilution was not 
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accounted in the process time for data analysis. No further flux decline was observed for any of 
the membranes during the DF step up to 12 dia-volumes as seen in Figure 5-23 B.  
 
 
 
 
 
Membrane Retained NP (%) Residual BSA (%) PF (BSA NP) 
20 nm PAA 86.0 0.04 2170 
300 kDa PES 99.6 0.13 780 
500 kDa PES 82.2 0.08 990 
 
Table 5-6 Purification factor, BSA nanoparticle retention and residual BSA after 
BSANP/BSA fractionation using PAA and PES membranes in extended UF/DF process 
(12 DF cycles) 
Figure 5-23 Extended UF/DF process (with 12 DF steps each of 1 diavolume) for 
fractionation of a mixture of BSA nanoparticles and BSA using 20 nm PAA, 300 and 500 
kDa PES membranes showing filtrate output for the discontinuous DF mode (A) and flux 
decline (B) during UF/DF process for different membranes. 
Time taken for 12 dia-volumes filtration is significantly shorter for PAA membranes due to 
higher average flux compared to PES membranes. 
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Analysis of the final retentates collected after 12 diavolumes of UF/DF process using HP-SEC 
shows very low residual BSA for all of the membranes with a minimum for PAA membrane as 
shown in Table 5-6. Retention of the protein nanoparticles was least for 500 kDa PES 
membrane and maximum for 300 kDa PES membrane. The 300 kDa PES membrane was, 
however, more retentive to BSA as well (for chromatogram overlays see Appendix J). The 
purification factor for BSA nanoparticles was maximum for PAA membranes (2170 ± 220), 
almost three times of that for 300 kDa membrane.  Based on the final purity of retentate, PAA 
membranes were suitable for achieving high purity BSA nanoparticles preparations at a modest 
yield of 86% in the retentate. This shows that PAA membranes may be suitable in applications 
where the focus is mainly on high purity, and faster processing and yield can be traded off to 
some extent. PAA membrane also maintained higher process flux than both PES membranes 
throughout the process which resulted in the shortest processing times of ~70 minutes in 
comparison to 90 minutes using PES membranes.  
Previously PAA membranes have been shown to exhibit very low irreversible fouling compared 
to the PES membranes. However, those experiments were done for limited processing times. 
Thus recovery of the membrane permeability after extended UF/DF process was measured as a 
percentage of initial buffer flux recovered after a buffer rinse of membrane surface and module. 
PAA membranes did not show any loss of membrane permeability with 96% of the initial 
permeability recovered after rinsing of the membrane surface, thus requiring no further cleaning 
procedure as shown in Figure 5-24. PES membranes, on the other hand, showed poor 
recovery of the membrane permeability with a buffer rinse. Only 33 and 14% of the initial 
membrane permeability could be recovered for 300 and 500 kDa PES membranes respectively. 
For similar membrane loadings, the recovery of the membrane permeability value was 50% and 
97% for 300 kDa PES and 20 nm PAA membrane respectively when no diafiltration process 
was used (refer to Table 5-1 in Section 5.3.2.1). Thus extended UF/DF processes have more 
impact on the fouling of the polymeric membrane. Thus a cleaning step for the regeneration of 
the membrane permeability is required for the polymeric membranes.  
Various chemical treatments were applied to the two polymeric membranes starting with 
soaking in a salt solution of high concentrations, backflushing, alkaline soak and protein 
degrading enzymes. Despite these treatments, only 45 to 68% of the membrane permeability 
could be recovered (as shown in Figure 5-24). It should also be noted that 500 kDa membranes 
were fouled the most by protein nanoparticles as only 14% and 45% of the initial membrane 
permeability was restored after protein filtration and subsequent chemical cleaning. This was 
despite the fact that 500 kDa PES membranes had a hydraulic permeability of ~5000 LMH/bar, 
more than twice of that of 300 kDa PES or 20 nm PAA membranes. This is likely due to large 
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pores observed in 500 kDa membranes allowing more pore penetration by fouling 
nanoparticles. 
 
Figure 5-24 Recoverable membrane permeability (% of membrane permeability for fresh 
membranes) for PAA membrane and PES membranes after an extended UF/DF 
experiment (12 DF cycles each of one diavolume) for fractionation of a mixture of BSA 
and BSA nanoparticles and effect of various chemical treatments to remove fouling. 
Membranes were treated (in sequence) with 1M NaCl soak for 24 hours; buffer backflush (2 x 
TMP used in protein filtration), 0.1 N NaOH soak for an hour and proteolytic enzyme treatment 
for 18 hours at room temperature). PAA membrane showed ~96% of initial buffer flux recovered 
after rinsing with buffer. Polymeric membranes could not be restored to similar levels even with 
the chemical treatments. 
Tedious and time-consuming chemical cleaning can take significantly increase total processing 
time of a UF/DF cycle and can only restore membrane permeability to a limited extent for PES 
membranes. Other harsher treatment such as alkaline solution mixture of proteases and 
detergents (for example Tergazyme, a commercial product) or sodium hypochlorite may be 
required for complete cleaning. These treatments, however, can result in leachates and need to 
be validated for low carryovers of the fouling protein as well as the cleaning chemicals. PAA 
membranes did not require such treatments and thus can be used to further reduce the 
processing times by a much easier buffer wash procedure to regenerate the membrane. Thus, 
PAA membrane could be used in single-pass UF/DF processes or processes requiring quicker 
turnaround for the filtration system to process multiple batches and minimise hold time for the 
batches. The later can be useful in processing large volumes of low titre viral feeds where hold 
time can be significant for viral infectivity. 
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5.3.5 UF/DF of clarified Adenovirus feed: comparison of 20 nm PAA and 300 kDa 
PES membranes 
Commercial PAA membranes have not been tested for virus separation applications so far. A 
major concern during such separations is a loss of virus particles in permeate and loss of 
infectivity of the virus particles thus affecting recovery of infectivity. Impact of the material 
(chemistry, surface roughness) on virus infectivity needs to be examined. 
 
5.3.5.1 Characterisation of the virus feed 
Low particle and infectious titres were observed for the feed used in this study. Total particle 
titre (~10
10 
particle per mL) in the feed was obtained using nanoparticles tracking analysis (NTA) 
and was found to be much higher than the infectivity titres (~6x10
8 
IFU per mL) which could be 
due to protein aggregates or exosomes present in the clarified Adenovirus feed.  Though titres 
are improving for Adenovirus and AAV, for viral vectors like Lentiviruses (another 100nm sized 
virus) such low titres are the current scenario. Membrane loading of 26 L/m
2
 similar to that used 
in the limited literature available for Adenovirus ultrafiltration (Nestola et al., 2014a) was used in 
this experiment. 
 
5.3.5.2 Flux decline for the filtration of crude clarified virus feed and growth media 
For similar membrane loading and conversion ratio (fraction of the feed filtered), cumulative flux 
was found to be higher for PAA membranes (116 ± 6 LMH) by more than 20 LMH (93 ± 1 LMH 
for PES membranes), and the difference was statistically significant. Table 5-7 shows the 
cumulative filtrate fluxes for two membranes at the end of each step of the UF/DF process.  A 
similar trend was observed in the previous experiments when the two membranes types were 
compared for filtration of BSA nanoparticles solution (~1x10
11 
particles per mL of 80 nm 
nanoparticles) with similar membrane loading (26 L/m
2
). Both membranes showed the identical 
shape of flux decline curves for viral feed as shown in Figure 5-25, and fouling mechanism was 
also identified to be cake filtration dominated. The impact of fouling by viral feed was more 
pronounced for polymeric membrane than for the PAA membrane.  
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PAA membrane PES membrane 
UF/DF steps Cumulative filtrate flux (LMH) 
Initial conc. step 116 ± 6 93 ± 1 
DF cycle 1 (3 DVs) 113 ± 6 85 ± 7 
DF cycle 2 (6 DVs) 111 ± 7 99 ± 1 
 
Fouling resistance 
Initial buffer flux 
(LMH at 0.6 bar) 
1266 ± 32 1110 ± 48 
Recoverable 
membrane 
permeability (%) 
27 ± 1 18 ± 3 
 
Table 5-7 Cumulative filtrate fluxes for various UF/DF steps, initial buffer fluxes of the 
membranes used, recoverable membrane permeability of PAA and PES membranes used 
for UF/DF processing of crude and clarified Adenovirus feed.  
Data presented as average value ± one standard deviation for multiple filtration runs (n=3 for 
PAA and n=2 for PES membranes). 
 
Figure 5-25 Flux decline for filtration of crude, clarified Adenovirus feed in growth media 
and growth media alone through 20 nm PAA and 300 kDa PES membranes.  
Filtrations were carried out at TMP of 0.6 bar and stirring speed of 1500 rpm in a stirred cell. 
Flux decline is shown for the initial concentration step. Error bars on the virus flux data 
represent one standard deviation for multiple filtration runs (n=3 for PAA and n=2 for PES 
membranes). Lot #5 of PAA membranes was used. 
Filterability of the serum-rich growth media was also evaluated. It was observed that serum-rich 
media contributes to a significant proportion of the flux decline observed for viral filtration 
through PAA membrane as similar flux declines were observed for filtration of growth media and 
clarified virus feed (see Figure 5-25). For PES membranes, flux decline was not significant for 
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the growth media alone, but the viral feed significantly fouled these membranes with 
membranes operating below 15% of the initial buffer flux. PAA membranes were observed to be 
more susceptible to fouling by growth media as compared to the PES membranes. Though a 
chief component of growth media is bovine albumin at 4-5 g/L concentration, it would appear 
that something else may be responsible for the fouling observed as filtration of a similar volume 
of BSA solution of 5 g/L through PAA membranes has shown the meagre effect on flux decline 
and transmission.  
Recoverable membrane permeability after virus filtration was also found higher for PAA 
membranes compared to the PES membrane, as shown in Table 5-7, indicating higher fouling 
resistance exhibited by PAA membrane for similar protein loading. Differences in the 
recoverable membrane permeability between two membranes were found to be statistically 
significant (with ANOVA p-values less than 0.01). Values of the recovered membrane 
permeability for virus feed, however, are lower than those observed for the filtrations of 80nm 
BSA nanoparticles where more than 90% of initial membrane permeability was recovered for 
PAA membranes (see Section 5.3.1). Lower recovery was observed due to the compositional 
differences among two different feeds. Virus feed used in the study is a crude, complex mixture 
of multiple host cell proteins, undigested viral and host cell nuclear acids, exosomes, lipids, 
protein aggregates, serum media components and fragments of virus capsids along with intact 
virus particles. Some of these particles can be in a very low amount below detection limits of UV 
detector in HPLC and may be masked by light scattering of larger virus particles when analysed 
in light scattering based size and titer analytical techniques such as NTA. 
5.3.5.3 Transmission of the proteins through the membranes 
HP-SEC chromatograms of feed, retentate and permeate samples were analysed for both 
experiments (filtration of virus-rich feed and growth media only). Filtration of growth media 
through membrane showed better protein transmission of serum albumin through PES than 
PAA membrane, indicated by higher peak area for serum albumin in permeate collected through 
former (Shown in Figure 5-26 B). Interestingly, a high molecular weight (HMW) peak (> 660 
kDa) of the growth media feed was absent from permeate collected through PAA membrane but 
present in permeate from PES membrane. This suggests a role of this HMW component in the 
flux decline for PAA membrane. For viral filtration, however, this HMW peak was absent from 
the permeate collected from both membranes suggesting another foulant also playing a role 
(Figure 5-26 C). A thorough characterisation of virus feed will be necessary to identify the 
foulant species. Intact Adenovirus particles will be unlikely to result in the internal fouling of PAA 
membranes but more likely for PES membranes due to increased pore accessibility of such 
membranes with broad pore size distributions. Adenovirus particles could not be observed on 
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HP-SEC chromatogram due to low titre. Transmission of virus particles was studied using more 
sensitive infectivity assay. Removal of serum albumin (BSA) was approximately 47±2% and 58 
±4% for PAA and PES membranes respectively when measured from permeate collected. 
Residual serum albumin in retentates (Figure 5-26D) were also measured to higher (35±4%) for 
PAA membrane than PES membrane (29±3%). The lower difference in residual levels of 
albumin is because of difficulty in retrieving all of the retentates from the stirred cell, especially 
for PAA membrane. Proteins smaller than albumin were removed to a high extent (>80%) and 
residual levels were not detected in SEC. 
Figure 5-26 Comparison of HP-SEC chromatograms viral feed and serum rich growth 
media (A), and permeates collected for growth media filtration (B) and permeates (C) 
and retentates (D) collected for viral filtrations through PAA and PES membranes. 
*Retentates were diluted (~4 fold) to the level of initial feed volume. PAA membrane show 
reduced transmission of growth media components compared to PES membrane. Notice the 
HMW peak (arrow in B) absent form PAA permeate of growth media filtration. Same peak was 
absent from permeates from both membranes for viral feed filtrations indicating impact of other 
components of viral feed on membrane performance including reduction of serum albumin 
(main peak, ~15 min) removal. Chromatograms were obtained by injecting 50µL of the 
samples onto BioSEC-5 size exclusion column (7.8x300 mm) at 0.8 mL/min with PBS as 
mobile phase. 
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5.3.5.4 Recovery of virus infectivity  
PAA membranes were found to be leaky with less than 2% of the total infective titre of the feed 
was recovered in permeate. This could be because of the defects in the active layer of the 
membrane. The effect was more pronounced in one of the three PAA membranes used where 
significant losses (~0.7%) were observed for concentration and each DF step. Losses were 
prominent for DF steps using all three PAA membranes. PES membrane showed almost no 
leakage or particle passage into the permeate. The total number of virus particles observed in 
the undiluted permeate solutions were very low (less than 5) per sample hence not significant 
sample size for accurate estimation of the titre. 
 
Figure 5-27 Recovery of infectious recombinant Adenovirus (ß-galactosidase gene) 
particles in different fractions collected during UF/DF of crude and clarified Adenovirus 
feed using PAA and PES membranes.  
Blue forming units (BFUs) are formed upon staining of recombinant virus-infected (transfected) 
HEK293 cells producing ß-galactosidase enzyme breaking assay substrate to release blue 
coloured compound. 
 
For both membranes, most of the invective particles were recovered in the retentate and the 
rinse solution after cleaning the membrane surface. Around 61 ± 10 % and 68 ± 11 % of the 
total infective units (BFU) of the feed were retained (retentate + rinse solution) by the PES and 
PAA membranes respectively. Differences in the infectivity recoveries between two membranes 
were found to be statistically insignificant (ANOVA p values >0.1) due to large standard 
deviations. Net recoveries of the infective titre (in all the fractions) were similar to recoveries 
found in the retained volume. Loss of total infective units (15 to 40 %) could be due to the 
exposure to shear due to stirring conditions in the stirred cell. Figure 5-28 shows blue forming 
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units formed on monolayers of cells by infective virus particles leaked through membranes into 
the permeate solutions. 
. 
 
 
 
 
 
These results indicate compatibility of PAA membrane material for processing of viruses like 
Adenoviruses as similar recoveries of infectivity was observed as seen with the traditionally 
used membrane materials such as PES. Further work could be extended to test the 
compatibility of this membrane material for more delicate, enveloped viruses like lentiviruses. 
Results also show that trends observed for various process outputs such as process flux, 
transmission of solutes and fouling resistance when comparing PES and PAA membranes 
using protein nanoparticles are valid for virus feeds but not in absolute values of these process 
Figure 5-28 Infected HEK 293 cells (observed as dark green dots using the infectivity 
assay) for the sterile growth media, virus rich feed and permeates collected after 
filtration of the viral feed through 20 nm PAA and 300 kDa PES membranes. 
Images from light microscopy were obtained for the plate wells after staining the infected cells in 
the wells. All the spots for each well were counted using a grid to avoid duplicate counting of 
same spots. More dots can be seen in permeate collected using PAA than permeate collected 
for PES membranes. AdV infected and transformed cells produce   the enzyme , galactosidase 
which converts substrate releasing green colored dye.  
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outputs. Given the fouling observed with growth media and viral feed, it should be noted that 
studies for protein nanoparticles filtrations are more likely to better simulate a UF/DF step after 
an initial chromatography-based purification step rather than direct UF/DF of a crude viral 
preparation. Modelling a complex mixture such as protein nanoparticles mixture with the 
addition of growth media as well as other model impurities such as bacterial and bacteriophage 
DNA could be useful for a crude viral preparation.  
5.4 Conclusion 
The objective of the chapter was to study the separation performance of the 20 nm rated PAA 
membranes using binary solute mixtures of the larger model solutes for viral vectors (TG or BSA 
nanoparticles) with BSA as a model solute for impurities such as host cell proteins. 
Fractionation experiments comparing 20 nm rated PAA membrane with 300 kDa polymeric 
membrane revealed different separation performance with PAA membranes showing leaky 
transmission of BSA nanoparticles resulting in lower selectivity as compared to the polymeric 
membranes (Section 5.3.2.2). It was observed that the presence of a large solute in the feed 
hinders the transmission of smaller solutes such as BSA resulting in lower selectivity.  
A diafiltration aided process was found to be effective for removal of residual BSA thus 
improving purification factors for the large solutes by 2-3 folds (Section 5.3.3). Fine tuning of the 
ionic environment of the protein solution was found to be the most effective strategy for 
improvement of the purification factors. Operating at isoelectric point (pH 6.5) of the membrane 
and very low salt concentrations in protein solutions dramatically improved the separation 
performance (Section 5.3.4.1). This demonstrates the potential for improvement in separation 
by tailoring membrane surface possibly reducing risks posed by the membrane defects. 
Operating at low transmembrane pressure also improved the purification factors without any 
significant reduction in the flux. This demonstrates that PAA membranes can be used as 
effective ultrafiltration membranes if operating parameters are optimised. 
Adenovirus UF/DF runs demonstrated biocompatibility of the PAA membranes for virus 
ultrafiltration as the net recovery of the infectious virus particles was found to be similar to 
traditionally used polymeric membranes (Section 5.3.5.4). Comparison of the two membranes 
for Virus UF/DF runs also showed similar trends of performance parameters as observed using 
BSA nanoparticles such as higher particle transmission, higher flux and superior fouling 
resistance for PAA membranes. Thus protein nanoparticles could be successfully used for the 
studies such as comparison of membranes for potential use for viral separation.  
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CHAPTER 6 CONCLUSIONS AND FUTURE WORK 
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6.1 Conclusions 
A systematic approach to the study of porous anodic alumina membranes for viral separations 
was presented in this thesis. 
Objective 1: Preparation and characterisation of the BSA nanoparticles as a mimic of virus 
particles 
Lack of sufficient viral material and the associated requirements for the sophisticated analytical 
and containment facilities for such studies were addressed by establishing the use of protein 
nanoparticles as a mimics for virus particles. Synthesis of such protein nanoparticles was 
described in chapter 3. A protocol for the preparation of 80-90nm albumin nanoparticles was 
developed from previously reported literature. The resulting method was shown to be both 
reproducible, and high yielding with more than 97% of BSA converted into nanoparticles. The 
time required for synthesis was further from overnight to under 4 hours by studying the impact 
of the length crosslinking step on particle size characteristics of the nanoparticles. Preparations 
were highly monodisperse with polydispersity index as low as 0.04 as measured by the dynamic 
light scattering and confirmed using nanoparticle tracking analysis. Particle shape was however 
not ideal spherical instead of globular structures formed from 2-3 smaller spherical nano 
particulates when observed under transmission electron microscope. This observation warrants 
the cautious use of the nanoparticles as physical mimics to highly symmetrical virus particles. A 
filtration study comparing 90nm protein nanoparticles and Adenovirus rich feed showed 
similarity in shape of the flux decline curve but lower values of the average fluxes for 
Adenovirus which was ascribed to the presence of other impurities such as host cell protein, 
DNA, protein aggregates, virus fragments and aggregates in the viral feed. 
Objective 2: Characterisation of porous anodic alumina (PAA) membranes for filterability of 
protein solution of single model solutes 
A systematic approach was followed to screen different ratings of the PAA and polymeric 
membranes and compare the selected membranes for filterability studies with protein model 
solutes of different sizes (8nm BSA as model protein impurity, 22 nm TG as model for smaller 
virus particles such as AAV and 80-90 nm BSA nanoparticles as model for larger viral particles 
such as AdV). PAA membrane rated 20 nm (lowest pore rating available) and polymeric 
membrane rated 300 kDa were selected among three different ratings for each membrane 
material. The selection was on the basis of comparable hydraulic permeability, similar mean 
pore size, and dextran sieving characteristics. PAA membrane rated 20 nm showed 
approximately two-fold lower 90% rejection value of 850 kDa than that observed for the 300 kDa 
polymeric membrane. However, dextran sieving curve for the PAA membrane was sharper than 
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that of the polymeric membranes. For protein solute filtrations, sieving coefficients for solutes 
decreased with increasing model solute size for both membranes, as was expected. Both 
membranes were highly retentive (with observed sieving coefficient being less than 0.05) to 
protein nanoparticles however PAA membranes showed ~3.6 times higher transmission. The 
leaky transmission was attributed to the presence of the large surface defects (> 1 um in 
dimensions) on the active layer surface of PAA membranes which were observed using SEM. 
These large defects exposed the underlying support layer with large pores. Unexpectedly, PAA 
membranes also showed higher fouling resistance exhibiting restoration of >90% of initial 
membrane permeability after a simple buffer rinse while polymeric membranes could only be 
restored to 50% of their initial permeability.  
It is hypothesised that fundamental differences in the membrane architecture are responsible for 
these observations. Polymeric membranes show wide pore size distribution where pores larger 
than solutes are accessible to the solutes. However, the tortuous pore channels and thicker 
membrane bed causes the entrapment of the solute particles resulting in internal fouling and 
low transmission. Higher transmission of BSA nanoparticles, on the other hand, is the result of 
the presence of the surface defect exposing large highly permeable support layer pores and 
straight channels in thinner membrane bed (2 times lower than polymeric membranes). Majority 
of the pores in narrow pore size distribution of the PAA membranes are smaller than solute 
particles and hence are not accessible to the solutes resulting in very low internal fouling. This 
hypothesis explains the differences in transmission and fouling behaviour of the two 
membranes. The hypothesis could not be verified as internal fouling and its location in the 
membranes could not be discernibly observed in the electron microscopy and would require 
alternative methods such as confocal laser fluorescence microscopy.  
Objective 3: Separation performance of porous anodic alumina (PAA) membranes for binary 
mixtures of the model solutes 
Filtration of the binary solute mixtures of large model solutes and smaller impurity (BSA) 
showed similar flux decline, cumulative flux, and restoration of membrane permeability as 
observed for the filtration single solute solutions of large solutes. However, fractionation was low 
for both polymeric and PAA membranes due to the fouling by large solute reducing the 
transmission of the model impurity by 10-45 % compared to complete transmission of the BSA 
in pure BSA solution. Hence different approaches to aid in the removal of BSA were further 
investigated using PAA membranes. Addition of discontinuous diafiltration steps was found to 
be effective in increasing the BSA removal from 40% to 70% with 3-diavolumes of buffer 
exchange and improved purification of TG by 2- fold. Improvement in purification factor of BSA 
  
[202] 
  
nanoparticles was also observed upon addition of diafiltration steps. A continuous diafiltration 
would likely be more effective but could not be used with the current experimental setup. An 
extended UF/DF process with 12 diavolumes for fractionation of BSA NP and BSA showed 
complete removal of BSA with both PAA and polymeric membranes. PAA membranes showed 
higher flux, 3-fold higher purification factors, however, lower BSA NP recovery. PAA 
membranes also did not foul significantly with only 10% loss of membrane permeability 
compared to a 67 % loss observed for the polymeric membrane. Fractionation was also 
enhanced by operating at low feed conductivity and pH near determined isoelectric point (6.5) of 
the PAA membranes. Highest purification factors of 9.9 and 7.3 for TG and BSA NP were 
observed at such feed conditions which were 4 and 2 fold higher than those observed at pH 7 
and high salt concentrations. Operating at low transmembrane pressures also improved the 
purification factors without significant loss in flux. With suitable surface modifications, PAA 
membranes can be used for separation of viral particles and host cell protein impurities by 
utilising the ionic environment of the feed. 
For Adenovirus purification from a crude, clarified mammalian cell culture feed, both PAA, and 
polymeric membranes showed similar recovery of 60-70% of the infective virus particles, 
primarily retained by the membranes, thus demonstrating the compatibility of the PAA 
membranes for viral processes. Similar to experiments with BSA nanoparticles, PAA 
membranes showed leaky transmission of the infective virus particles while polymeric 
membranes did not show any leakage. As predicted with filtration experiments with BSA 
nanoparticles, trends observed in the comparison of the two membranes were also observed for 
virus filtration such as higher recovery of membrane permeability and flux for PAA membranes 
although absolute values were different. Removal of the host cell impurities was slightly higher 
for the PES membrane (58%) compared to PAA membrane (47%), but the final purification 
factor of infective virus particles in the retentate was found to be similar at 3.0.  
Studying commercial PAA membrane limited the scope of the present work as limited 
commercial products are available with formats compatible with stirred cells and modules 
compatible for cross-flow filtration are not yet developed for PAA membranes. Custom built 
modules could be developed, but such work is constrained by lack of membrane sheets and 
brittle nature of the membranes. Large membrane lot to lot variability in the commercial product 
also complicated the study, which was characterised in Chapter 4 and its effect of separation 
performance studied in Chapter 5. Most of the previous studies exploring bioseparation 
applications including virus purifications used custom-made membranes which are more refined 
membranes compared to the commercial product used in this thesis. Membranes used in this 
study were not as refined.  
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Despite these limitations, the present study is the first study conducted so far to evaluate 
commercial PAA membranes for viral separations especially using model systems and offering 
a parallel comparison with traditional polymeric membranes for filterability of these model 
systems. Useful insights gained in this study will help to improve the fabrication of PAA 
membranes and design new membranes for viral separations. 
 
6.2 Future work 
Various issues regarding the porous anodic alumina membranes and their UF applications were 
identified in this study. Findings from this study can be used as guidelines for future 
developments of these membranes as ultrafiltration membranes for viral vector separations.  
Based on the observations made in the present study, following different studies are suggested 
for further work in this area: 
 
6.2.1 Optimising protein nanoparticles synthesis for better model solutes 
Protein nanoparticles produced in the current work were found to be non-spherical in shape 
formed of aggregates of smaller globular nano-particulates (Chapter 3). These particles despite 
having similar hydrodynamic size as of viral vectors are far from the highly organised and 
symmetrical structures of viruses. Influence of the shape of protein nanoparticles in sieving 
through membranes was not considered in the present study. To obtain spherical nanoparticles, 
the greater understanding of the impact of process parameters on particle shape and size as 
well as distribution is crucial. To this end, the present study identified gaps in current literature 
where factors such as reaction vessel dimensions, mixing and quality of the protein feed 
(presence of impurities such as lipids, protein dimers, and higher molecular weight aggregates) 
are not evaluated. Use of multivariate data analysis such as principal component and partial 
least square analysis could be used to identify the crucial factors, and these factors could be 
optimised through the design of experiment approach. 
 
6.2.2 Confocal light scattering microscopy experiments to prove the differences 
in mechanism of retention of nanoparticles by quasi-isoporous PAA membranes 
with cylindrical pores and conventional polymeric membranes with tortuous 
pores and broad pore size distribution 
Confocal microscopy could be used to study how fluorescently labelled protein nanoparticles 
traverse through membrane bed. Resistance faced by protein nanoparticles could be studied by 
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estimating penetration depth and time for fluorescent nanoparticles through the bed, and these 
estimates could be used in modelling of the sieving process. 
Fouling of the various membrane layers could be studied by measuring fluorescence intensity 
across the membrane bed after filtration of protein solutions. The build-up of the fluorescence 
above the membrane surface could be studied to estimate the thickness of the concentration 
polarisation layer. Solute build-up across the membrane thickness and above it could be helpful 
to prove the differences in retention mechanisms. This is a challenging task as it requires 
operation under flowing conditions thus requiring fabrication of a flow cell capable of replicating 
flow and shear conditions observed in a stirred cell. Another challenge is to use this flow cell for 
brittle PAA membranes. These challenges require a significant investment of time and efforts in 
the fabrication of flow cell and were thus not in the scope of the present study.  
 
6.2.3 Addressing the lot to lot variations in membranes  
The present study reports significant variations in hydraulic permeability and pore size 
distribution of all the PAA membranes lots used in this study (Chapter 4) and its impact on 
protein losses (Chapter 5). Besides differences in pore size distributions, large structural defects 
were also observed, however, their contribution towards hydraulic permeability could not be 
calculated due to their low frequency and random distribution. However, such large defects can 
still contribute to a significant fraction of total hydraulic permeability as well as protein 
transmission. Electron microscopy fails to accurately measure the density of such defects due to 
low scanning area usually in few µm2. 
 
Mutually complementary characterisation techniques such as small angle X-ray spectroscopy 
(SAXS), high-resolution X-ray computerised tomography (CT) scanning and porosimetry could 
be used to scan a large area of membranes to identify and quantify the defect density. 
Correlation of such defect density along with mean pore size of the membrane with more 
commonly used and non-destructive techniques such as integrity testing of membranes will thus 
be crucial for any further studies or applications of these membranes. Well established 
characterisation methods and fundamental understanding of the mechanisms of the defect 
formation is thus necessary to fabricate defect-free membranes. Optimisation of fabrication 
procedure and control strategy needs to be undertaken to minimise deviations in mean pore 
sizes and defects. 
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6.2.4 Thyroglobulin as a model solute for selectivity permeability analysis of UF 
membranes targeted for separations of large biomolecules 
Increasingly membranes with MWCO rating of 300 kDa and above are being marketed by some 
manufacturers for the applications in virus separations. These relatively new products are not 
tested for virus related applications. Membrane ratings by manufacturers can vary significantly 
due to the lack of standardised characterisation methods. Mehta and Zydney (2005) have 
proposed a selectivity permeability curve, similar to Robeson plot used for gas separation 
membranes, to compare different membranes for the trade-off in separation performance and 
permeability. However, these authors have used BSA as the model solute to generate this 
curve for a range of membranes. Larger solutes such as TG which is similar in dimensions to 
smaller viral vectors such as AAVs can be used instead of BSA to compare membranes 
targeted towards virus separations. The current study shows that TG transmission was sensitive 
to the variations in lots of commercial anodic alumina membranes.  
A caveat in such analysis is that theoretical curve generated does not account for actual feed 
properties and impact of fouling associated which is inevitable in real-world applications of 
membranes. Impact of the module, feed properties and fouling on deviations from the 
theoretical selectivity permeability curve needs to be explored further. 
 
6.2.5 Performance of PAA membranes in cross-flow conditions 
Stirred cell module used in this study is an excellent tool to study the effect of various 
treatments to feed or membrane. However, mass transfer properties of the stirred cell module 
are not at par with cross-flow or tangential flow filtration modules. At the industrial scale, the 
cross-flow mode is almost unanimously preferred over stirred cell filtration due to the ease of 
automation and control available in the former. The present study could not test PAA 
membranes in cross-flow conditions due to lack of availability of commercial membrane in flat 
sheet or hollow fibre format. A spiral cross-flow module which could accommodate circular discs 
of PAA membranes is thus highly desirable. XFlo76 (TangenX Corp., USA) is such a marketed 
module designed for membrane screening in cross-flow mode but using 76 mm circular discs. 
This module is however fabricated for compressible polymeric membranes and not for brittle 
ceramic membranes. Further, the commercial PAA membranes are only available up to 43 mm 
disc diameter. 
Cross-flow mode is a more appropriate module to study the scalability of the separations of both 
model solutes and viral vectors using PAA membranes. Thus the designing of custom-built 
cross-flow modules compatible with brittle membranes is crucial. Fabrication of large sheet of 
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PAA membranes would also need to be studied. Another workaround is fabricating tubular 
anodic alumina membranes, which have been reported in the literature (Lee and Mattia, 2013, 
Attaluri et al., 2009). However, challenges to fabrications of such membranes are not discussed, 
and no such product is commercially available. In theory, these tubular membranes could be 
used as hollow fibres in TFF mode. However, limitation of fabrication methods on the internal 
diameter and length of the membrane tubes would need to be investigated. 
 
6.2.6 Fine tuning of membrane morphology of PAA to enhance separation 
performance 
Commercial PAA membranes used in the present study are offered in limited pore ratings (20, 
100 and 200 nm), which restrict their applications for a variety of viral vectors ranging from 20 to 
500 nm in size. PAA membranes with more pore size ratings will be helpful in selecting and 
studying ultrafiltration of viral vectors or model solutes with optimal pore ratings. Another 
commercial product from InRedox LLC (USA) has been marketed with a broader range of pore 
ratings and even customised pore ratings. Studying viral separations using these membranes 
would be useful to design better ultrafiltration processes. 
Pore morphology itself can affect separation performance. It is well known that slit-like pores 
have better selectivity-permeability characteristics compared to circular pores (Feinberg et al., 
2018, Kanani et al., 2010). Fabrication of porous anodic alumina membranes with different pore 
shapes such as triangular pores has been reported (Smith et al., 2008) but not yet studied for 
their separation performances, especially for viral vectors. Besides the commercial product had 
quasi-isoporous pore size distribution with polygonal pores rather than circular pores. Custom 
fabricated membranes reported in the literature (Ni et al., 2014) though have highly uniform 
pore size distributions. It would be interesting to see if higher selectivity could be obtained for 
viral vector separations using these non-commercial but refined membranes. 
Another interesting aspect could be functionalisation of the porous anodic alumina membranes 
using chemical groups. Functionalisation can be done to minimise the fouling (Lee et al., 2005), 
tune effective pore size of the membrane through polymer groups on internal pore surfaces 
such as PEG coating (Popat et al., 2004) and aid separation of large biomolecules from smaller 
impurities by providing differential steric and electrostatic repulsions by functionalising only the 
pore entrance with a mesh of polymer brushes such as polyacrylic acid brushes as described in 
literature (Nagale et al., 2000). The goal of such an approach is to improve separations without 
compromising the permeability thus processing time. The inclusion of surface charge groups on 
membrane surface such as hydroxyl groups (Jeong and Yi, 2013) and manipulation of 
  
[207] 
  
isoelectric point of membranes with respect to targeted bio-separation such as different viruses 
and impurities can also be investigated.  
These approaches have been illustrated in Figure 6-1. It would be interesting to see how these 
modified membranes could be used with complex feeds containing viral particles. 
 
6.2.7 Studying iso-porous polymeric membranes  
Challenges with the fabrication of brittle, porous anodic alumina membranes could be avoided if 
membranes offering uniform surface pore size distribution are available in the polymeric 
material. Block co-polymeric (BCP) membranes are a newer class of polymeric membranes 
which are fabricated by manipulating the self-assembly of the residues during the 
polymerisation process. BCP membranes have surface topology similar (shown in inset D of 
Figure 6-1) to that of PAA membranes with narrow pore size distributions. BCP membranes 
have highly interconnected support layer unlike PAA membranes but similar narrow pore size 
distributions (Yu et al., 2016). BCP membranes with slit-like lamellar pores have also been 
reported. These membranes are worth investigating to see if they operate with similar 
separation mechanisms such as PAA membranes and have similar or superior fouling 
resistance.  
From the issues and potential solutions discussed above, it is clear that a multi-disciplinary 
approach would be necessary for the development of these membranes as viable commercial 
products for bio-manufacturing. These challenges call for synergies of material scientists, 
inorganic chemists, module fabrication engineers and bioprocess engineers. Some of these 
approaches are illustrated in Figure 6-1. All of these approaches for designing new or improved 
membranes will require a cost-benefit analysis to assess the commercial feasibility of these 
membranes by comparison to traditional polymeric membranes currently used for viral vector 
purifications. 
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Figure 6-1 Future work: Various approaches to developing new membranes for viral 
vector separations.  
Fabrication of defect-free PAA membrane with narrower pore size distribution (inset a 
reproduced from (Ni et al., 2014) than the commercial membranes used in this study, would 
require an understanding of the fabrication process and better characterisation tools for defects.  
Use of different pore geometry such as triangular pores (as in inset b reproduced from (Smith et 
al., 2008) can also be studied for improved separation performance.  
Scalable modules with the cross-flow mode of operations can be studied by fabricating tubular 
PAA membranes, as shown in inset C reproduced from(Lee and Mattia, 2013) or flat sheets 
membranes.  
Smart membranes with multiple mechanisms of sieving can be created by chemical alteration of 
pore surface and entrance for selective transport of impurities without compromising 
permeability including fouling remediation.  
Finally, using alternative materials such as polymeric BCP membranes, shown in inset e and d, 
reproduced from (Yu et al., 2016) could help bypass the fabrication issues faced with PAA 
membranes. All the images were reused with permissions from cited sources. 
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APPENDIX A 
Size exclusion chromatography used for calculation of residual BSA in final 
protein nanoparticle preparations 
 
Appendix A-1: Protein molecular weight standards and BSA preparation used for nanoparticles 
preparations on a size exclusion column, Superose 6/12 (with a column volume of 24 mL). 
Equilibration and elution were carried out using PBS. A sample volume of 100µl was injected. 
Peak labels represent the molecular weight (kDa) of the peak protein. 
 
Appendix A-2: Standard curve for BSA on SEC column at 0.5 mL/min flow rate in isocratic 
elution under PBS as the mobile phase. Superose 6/12 column (column volume of 24 mL) was 
used to plot a standard curve for BSA. The plot was used to measure residual BSA 
concentration in nanoparticle preparations. 
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APPENDIX B 
Effect of vessel dimensions on nanoparticle preparation 
Parameters 
Beaker  
50 mL 
Beaker 
30 mL 
Beaker 
100 mL 
Vessel Height /Diameter mm/mm  (Ratio) 
60/31 
(1.93) 
40/30  
(1.33) 
66/45 
(1.43) 
Effective Height /Diameter 
(with liquid level of 20mL solution) 
24/31 
(0.80) 
24/30  
(0.80) 
15/45 
(0.33) 
Initial BSA concentration (% w/v) 1 1 1 
Initial BSA volume (mL) 20 20 20 
Stirring (rpm) 1000 1000 1000 
Volume of ethanol added (mL) 15 14 30 
Foaming observed NO NO YES 
Particle diameter, nm 
(after 15 mL addition) 
129 ± 6 100 ± 1 71 ± 2 
Polydispersity index, PDI 
0.14 
± 0.05 
0.25 
± 0.01 
0.48 
± 0.01 
Particle diameter, nm 
(Final, after crosslinking) 
129 ± 6 100 ± 1 139 ± 17 
Polydispersity index, PDI 
0.137 
± 0.05 
0.245 
± 0.007 
0.334 
± 0.018 
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APPENDIX C 
Effect of volumetric scale-up of BSA nanoparticle synthesis using method 
C 
 
Differences in the particle size distribution between nanoparticle preparations prepared 
with an original volume of 1 mL (A) and scaled-up volume of 3 mL (B) for method C. 
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APPENDIX D 
Particle size distribution of various model solutes used in filtration studies and 
latex size standard  
 
Protein solutions in PBS with concentrations 1.0, 0.5 and 1.0 mg/mL for BSA, TG and BSA 
nanoparticles were used for measurement of particle size using dynamic light scattering 
(Zetasizer, Malvern UK) Monodisperse solution of latex nanoparticles (46 nm, Nanosphere, 
ThermoScientific) was used as size standard to check calibration of the equipment. 
  
1 10 100 1000
0
10
20
30
40
%
V
o
lu
m
e
Hydrodynamic diameter (nm)
 BSA
 TG
 BSA NPs
 Latex beads
  
[229] 
  
APPENDIX E 
Debris observed on the surface of PAA membranes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Elemental analysis of the debris observed on the surface of anodic alumina membrane using 
energy dispersive X-ray spectroscopy (EDS). Elements identified are Al-Aluminium, O-Oxygen 
and Au-Silver deposited during sputter coating. 
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APPENDIX F 
Calculation of mass transfer coefficient for a solute in stirred cell filtration 
Mass transfer coefficient (km) for a solute of a given bulk diffusivity (D) in solution with given bulk 
properties (viscosity, μ, and density ρ) can be calculated in a stirred cell of a given diameter (T) 
operating at a given rotation speed (ω) using following equations (as described by Smith and 
Colton, 1972): 
Calculate Reynold’s number for the stirred cell and the bulk solution 
𝑅𝑒 =
𝜌𝜔(𝑇 2⁄ )
2
𝜇
 
Calculate Sherwood number for the stirred cell using empirical relationship described for 
Sherwood number and Reynold’s and Schmidt number 
𝑆𝑐 =
𝜇
𝜌𝐷
 
𝑆ℎ = 0.285𝑅𝑒0.567𝑆𝑐0.33 ;   8000 < 𝑅𝑒 < 32000 
Calculate mass transfer coefficient (km) using the following expression  
𝑆ℎ =
𝑘𝑚(
𝑇
2⁄ )
𝐷
 
 
For calculations, bulk properties of all protein solutions were assumed similar (as dilute protein 
solutions were used) with a viscosity of 0.00099 kg/m.s and fluid density of 997 kg/m
3
. 
For a stirred cell with 25mm diameter (T) and stirring speed of 1500 rpm, the mass transfer 
coefficients (km) for different model solutes were calculated to be: 
Solute Solute size (nm) D (μm
2
/s) km (m/s) 
BSA 8 56.9 9.4 x 10
-6
 
TG 22 21.6 6.3 x 10
-6
 
BSA NP 80 5.7 2.2 x 10
-6
 
Table: Particle size and diffusivity values were obtained from DLS analysis. 
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APPENDIX G 
Permeability, process flux, mass transfer coefficient and sieving coefficients values for filtration of various solutes through 20 nm PAA and 
300 kDa PES membranes, Actual sieving coefficient is calculated as  𝑺𝒂 =
𝑺𝒐𝒃𝒔
𝑺𝒐𝒃𝒔+[(𝟏−𝑺𝒐𝒃𝒔)∗𝒆𝒙𝒑
(𝑱 𝒌𝒎⁄ )]
 (as described by Mehta and Zydney, (2005)) 
Membrane Solute 
Hydraulic  
permeability, Lp  
(m/s/Pa  x 10
-9
) 
Process 
flux, 𝑱  
(m/s  x 10
-4
) 
Mass transfer 
coefficient 
 𝒌𝒎  
(m/s  x 10
-6
) 
Polarisation 
index, 
 𝑱 𝒌𝒎⁄  
Observed 
sieving  
coefficients, 
𝑺𝒐𝒃𝒔 
Actual 
sieving 
coefficient
 𝑺𝒂  
Separation 
factor, 𝟏/𝑺𝒂 
20 nm PAA 
membrane 
(Anodisc) 
BSA 
6.0 3.5 
9.4 
37.5 0.927 6.7 x 10
-16
 1.5 x 10
15
 
5.3 3.1 33.1 0.969 1.4 x 10
-13
 7.3 x 10
12
 
5.7 3.4 35.7 0.974 1.2 x 10
-14
 8.4 x 10
13
 
TG 
5.5 0.8 
6.3 
13.8 0.494 1.0 x 10
-06
 9.8 x 10
05
 
5.7 1.0 16.5 0.569 8.8 x 10
-08
 1.1 x 10
07
 
5.7 1.0 15.9 0.567 1.6 x 10
-07
 6.1 x 10
06
 
BSA NP 
6.1 0.3 
2.2 
11.6 0.027 2.6 x 10
-07
 3.8 x 10
06
 
5.6 0.3 11.7 0.035 2.9 x 10
-07
 3.4 x 10
06
 
5.4 0.3 12.6 0.012 4.2 x 10
-08
 2.4 x 10
07
 
300 kDa PES  
membrane 
(Biomax) 
BSA 
3.6 1.7 
9.4 
18.4 0.943 1.7 x 10
-07
 5.9 x 10
06
 
2.8 1.3 13.2 0.943 2.9 x 10
-05
 3.4 x 10
04
 
3.6 1.7 17.7 0.981 1.1 x 10
-06
 9.0 x 10
05
 
TG 
5.7 0.5 
6.3 
7.8 0.257 1.5 x 10
-04
 6.7 x 10
03
 
2.8 0.4 6.9 0.107 1.3 x 10
-04
 8.0 x 10
03
 
4.8 0.6 8.9 0.237 4.5 x 10
-05
 2.2 x 10
04
 
BSA NP 
6.6 0.2 
2.2 
9.0 0.007 9.8 x 10
-07
 1.0 x 10
06
 
7.0 0.2 9.4 0.006 4.9 x 10
-07
 2.0 x 10
06
 
7.1 0.2 9.7 0.007 4.3 x 10
-07
 2.4 x 10
06
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APPENDIX H 
Surface charge on protein solutes and membrane surface 
 
TG and BSA zeta potentials were measured in 10mM phosphate buffers. Zeta potentials for 
PAA membrane surface (open symbols) are approximations from literature and are measured at 
a much lower salt concentration ( 1mM KCl), so the magnitude of values could be lower in 
buffer conditions similar to those for BSA and TG. 
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APPENDIX I 
Effect of pH on fractionation of binary mixtures of model solutes  
I-1 Size exclusion chromatograms of the retentates collected for fractionation of TG and 
BSA using PAA membranes: Effect of various solution pH  
Overlay of HP-SEC chromatograms of retentates obtained after fractionation of different pH 
solutions of BSA and TG mixture. 50uL of samples was injected onto TSKgel3000swxl (7.8 x 
300 mm, the flow rate of 0.6 mL/min) column equilibrated and eluted with PBS. Abnormal TG 
peak (9.8 min) observed at pH 3.7 was also observed in the feed solution. Retentate with pH 
6.5 shows the smallest BSA peak (~residual BSA). 
 
I-2 Size exclusion chromatograms of the retentates collected for fractionation of BSA 
nanoparticle and BSA using PAA membranes at pH 6.5 (with and without NaCl) 
Chromatograms were obtained by injecting 20uL of samples onto BIOSEC 5 (7.8 x300 mm; flow 
rate 0.8 mL/min) column equilibrated and eluted using PBS. Lowest residual BSA (small BSA 
peak) and high BSA NP recovery are achieved at pH 6.5 without salt. Retentates are ~4 fold 
concentrated compared to the feed.  
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APPENDIX J 
Overlay of HP-SEC chromatograms for retentates obtained after extended UF/DF (12 
diavolumes) for fractionation of BSA nanoparticles and BSA mixture using PAA and PES 
membranes. 
 
Chromatograms were obtained by injecting 20uL of samples onto BIOSEC 5(7.8 x300 mm; flow 
rate 0.8 mL/min) column equilibrated and eluted using PBS. Inset (chromatogram magnified at 
retention time 14-18 minutes) shows peaks of residual BSA in the retentates. 300 kDa PES 
showed highest residual BSA and highest BSA NP retention. Retentates are ~4 fold 
concentrated compared to the feed. 
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